Background  ||| S:24 E:43 ||| NNP
Cellular  ||| S:43 E:52 ||| NNP
events  ||| S:52 E:59 ||| NNS
are  ||| S:59 E:63 ||| VBP
based  ||| S:63 E:69 ||| VBN
on  ||| S:69 E:72 ||| IN
specific  ||| S:72 E:81 ||| JJ
inter-  ||| S:81 E:88 ||| JJ
and  ||| S:88 E:100 ||| CC
intra-molecular  ||| S:100 E:116 ||| JJ
interactions  ||| S:116 E:129 ||| NNS
of  ||| S:129 E:132 ||| IN
many  ||| S:132 E:137 ||| JJ
molecules ||| S:137 E:146 ||| NNS
.  ||| S:146 E:148 ||| .
To  ||| S:148 E:159 ||| TO
experimentally  ||| S:159 E:174 ||| VB
dissect  ||| S:174 E:182 ||| JJ
such  ||| S:182 E:187 ||| JJ
interactions ||| S:187 E:199 ||| NNS
,  ||| S:199 E:201 ||| ,
it  ||| S:201 E:204 ||| PRP
is  ||| S:204 E:207 ||| VBZ
important  ||| S:207 E:225 ||| JJ
to  ||| S:225 E:228 ||| TO
maintain  ||| S:228 E:237 ||| VB
as  ||| S:237 E:240 ||| RB
closely  ||| S:240 E:248 ||| RB
as  ||| S:248 E:251 ||| IN
possible  ||| S:251 E:260 ||| JJ
the  ||| S:260 E:264 ||| DT
cytosolic  ||| S:264 E:282 ||| JJ
environment  ||| S:282 E:294 ||| NN
of  ||| S:294 E:297 ||| IN
the  ||| S:297 E:301 ||| DT
living  ||| S:301 E:308 ||| NN
cell ||| S:308 E:312 ||| NN
.  ||| S:312 E:314 ||| .
Detergents  ||| S:314 E:325 ||| NNS
are  ||| S:325 E:329 ||| VBP
frequently  ||| S:329 E:348 ||| RB
employed  ||| S:348 E:357 ||| VBN
to  ||| S:357 E:360 ||| TO
disrupt  ||| S:360 E:368 ||| VB
cells  ||| S:368 E:374 ||| NNS
for  ||| S:374 E:378 ||| IN
the  ||| S:378 E:382 ||| DT
demonstration  ||| S:382 E:396 ||| NN
and  ||| S:396 E:408 ||| CC
isolation  ||| S:408 E:418 ||| NN
of  ||| S:418 E:421 ||| IN
functionally  ||| S:421 E:434 ||| JJ
relevant  ||| S:434 E:443 ||| JJ
protein  ||| S:443 E:451 ||| NN
complexes  ||| S:451 E:461 ||| NNS
and ||| S:461 E:464 ||| CC
/ ||| S:464 E:465 ||| NNP
or  ||| S:465 E:476 ||| CC
to  ||| S:476 E:479 ||| TO
selectively  ||| S:479 E:491 ||| RB
extract  ||| S:491 E:499 ||| VB
certain  ||| S:499 E:507 ||| JJ
proteins ||| S:507 E:515 ||| NNS
.  ||| S:515 E:517 ||| .
For  ||| S:517 E:521 ||| IN
example ||| S:521 E:528 ||| NN
,  ||| S:528 E:530 ||| ,
the  ||| S:530 E:542 ||| DT
non-ionic  ||| S:542 E:552 ||| JJ
detergents  ||| S:552 E:563 ||| NNS
Triton  ||| S:563 E:570 ||| NNP
X-100 ||| S:570 E:575 ||| NNP
,  ||| S:575 E:577 ||| ,
Tween  ||| S:577 E:583 ||| NNP
20  ||| S:583 E:586 ||| CD
or  ||| S:586 E:589 ||| CC
Brij ||| S:589 E:593 ||| NNP
,  ||| S:593 E:595 ||| ,
have  ||| S:595 E:608 ||| VBP
been  ||| S:608 E:613 ||| VBN
widely  ||| S:613 E:620 ||| RB
used  ||| S:620 E:625 ||| VBN
for  ||| S:625 E:629 ||| IN
histochemical  ||| S:629 E:643 ||| JJ
purposes  ||| S:643 E:652 ||| NNS
or  ||| S:652 E:655 ||| CC
in  ||| S:655 E:666 ||| IN
biochemical  ||| S:666 E:678 ||| JJ
experiments  ||| S:678 E:690 ||| NNS
to  ||| S:690 E:693 ||| TO
separate  ||| S:693 E:702 ||| VB
detergent-soluble  ||| S:702 E:720 ||| JJ
from  ||| S:720 E:733 ||| IN
a  ||| S:733 E:735 ||| DT
detergent-resistant  ||| S:735 E:755 ||| JJ
residue  ||| S:755 E:763 ||| NNS
[  ||| S:763 E:765 ||| -LRB-
1 ||| S:765 E:766 ||| CD
,  ||| S:766 E:768 ||| ,
2 ||| S:768 E:769 ||| CD
,  ||| S:769 E:771 ||| ,
3 ||| S:771 E:772 ||| LS
] ||| S:772 E:773 ||| -RRB-
.  ||| S:773 E:775 ||| .
The  ||| S:775 E:779 ||| DT
latter  ||| S:779 E:786 ||| NN
is  ||| S:786 E:797 ||| VBZ
commonly  ||| S:797 E:806 ||| RB
referred  ||| S:806 E:815 ||| VBN
to  ||| S:815 E:818 ||| TO
as  ||| S:818 E:821 ||| IN
the  ||| S:821 E:825 ||| DT
"cytoskeleton ||| S:825 E:838 ||| NN
"  ||| S:838 E:840 ||| ''
or  ||| S:840 E:843 ||| CC
"membrane  ||| S:843 E:861 ||| CD
skeleton ||| S:861 E:869 ||| NN
"  ||| S:869 E:871 ||| ''
[  ||| S:871 E:873 ||| -LRB-
4 ||| S:873 E:874 ||| LS
] ||| S:874 E:875 ||| -RRB-
.  ||| S:875 E:877 ||| .
During  ||| S:877 E:884 ||| IN
cell  ||| S:884 E:889 ||| NN
activation  ||| S:889 E:900 ||| NNS
discrete  ||| S:900 E:909 ||| VBP
signaling  ||| S:909 E:927 ||| VBG
molecules  ||| S:927 E:937 ||| NNS
are  ||| S:937 E:941 ||| VBP
known  ||| S:941 E:947 ||| VBN
to  ||| S:947 E:950 ||| TO
associate  ||| S:950 E:960 ||| NN
with  ||| S:960 E:965 ||| IN
or  ||| S:965 E:968 ||| CC
to  ||| S:968 E:971 ||| TO
disassociate  ||| S:971 E:992 ||| VB
from  ||| S:992 E:997 ||| IN
the  ||| S:997 E:1001 ||| DT
plasma  ||| S:1001 E:1008 ||| JJ
membrane  ||| S:1008 E:1017 ||| NN
and  ||| S:1017 E:1021 ||| CC
both ||| S:1021 E:1025 ||| DT
,  ||| S:1025 E:1027 ||| ,
the  ||| S:1027 E:1031 ||| DT
cytoskeleton  ||| S:1031 E:1044 ||| NN
and  ||| S:1044 E:1056 ||| CC
membrane  ||| S:1056 E:1065 ||| JJ
skeleton  ||| S:1065 E:1074 ||| NNS
undergoes  ||| S:1074 E:1084 ||| VBP
significant  ||| S:1084 E:1096 ||| JJ
changes  ||| S:1096 E:1104 ||| NNS
as  ||| S:1104 E:1107 ||| IN
well  ||| S:1107 E:1112 ||| RB
[  ||| S:1112 E:1122 ||| -LRB-
4 ||| S:1122 E:1123 ||| CD
,  ||| S:1123 E:1125 ||| ,
5 ||| S:1125 E:1126 ||| CD
,  ||| S:1126 E:1128 ||| ,
6 ||| S:1128 E:1129 ||| CD
,  ||| S:1129 E:1131 ||| ,
7 ||| S:1131 E:1132 ||| CD
] ||| S:1132 E:1133 ||| -RRB-
.  ||| S:1133 E:1135 ||| .
For  ||| S:1135 E:1139 ||| IN
cytochemical  ||| S:1139 E:1152 ||| JJ
purposes ||| S:1152 E:1160 ||| NNS
,  ||| S:1160 E:1162 ||| ,
however ||| S:1162 E:1169 ||| RB
,  ||| S:1169 E:1171 ||| ,
detergents  ||| S:1171 E:1190 ||| NNS
cannot  ||| S:1190 E:1197 ||| RB
be  ||| S:1197 E:1200 ||| VB
used  ||| S:1200 E:1205 ||| VBN
before  ||| S:1205 E:1212 ||| IN
cells  ||| S:1212 E:1218 ||| NNS
have  ||| S:1218 E:1223 ||| VBP
been  ||| S:1223 E:1228 ||| VBN
fixed ||| S:1228 E:1233 ||| VBN
,  ||| S:1233 E:1235 ||| ,
as  ||| S:1235 E:1238 ||| IN
non-ionic  ||| S:1238 E:1256 ||| JJ
detergent  ||| S:1256 E:1266 ||| NN
treatment  ||| S:1266 E:1276 ||| NN
causes  ||| S:1276 E:1283 ||| VBZ
removal  ||| S:1283 E:1291 ||| NN
of  ||| S:1291 E:1294 ||| IN
the  ||| S:1294 E:1298 ||| DT
cells  ||| S:1298 E:1304 ||| NNS
from  ||| S:1304 E:1309 ||| IN
their  ||| S:1309 E:1323 ||| PRP$
supporting  ||| S:1323 E:1334 ||| JJ
surface  ||| S:1334 E:1342 ||| NN
( ||| S:1342 E:1343 ||| -LRB-
e.g.  ||| S:1343 E:1348 ||| RB
cover  ||| S:1348 E:1354 ||| VB
glass ||| S:1354 E:1359 ||| NN
) ||| S:1359 E:1360 ||| -RRB-
.  ||| S:1360 E:1362 ||| .
The  ||| S:1362 E:1366 ||| DT
choice  ||| S:1366 E:1373 ||| NN
of  ||| S:1373 E:1384 ||| IN
fixative  ||| S:1384 E:1393 ||| NN
for  ||| S:1393 E:1397 ||| IN
a  ||| S:1397 E:1399 ||| DT
particular  ||| S:1399 E:1410 ||| JJ
cytochemical  ||| S:1410 E:1423 ||| JJ
study  ||| S:1423 E:1429 ||| NN
is  ||| S:1429 E:1432 ||| VBZ
often  ||| S:1432 E:1438 ||| RB
a  ||| S:1438 E:1448 ||| DT
difficult  ||| S:1448 E:1458 ||| JJ
task  ||| S:1458 E:1463 ||| NN
owing  ||| S:1463 E:1469 ||| VBG
to  ||| S:1469 E:1472 ||| TO
the  ||| S:1472 E:1476 ||| DT
limited  ||| S:1476 E:1484 ||| JJ
available  ||| S:1484 E:1494 ||| JJ
information  ||| S:1494 E:1514 ||| NN
about  ||| S:1514 E:1520 ||| IN
the  ||| S:1520 E:1524 ||| DT
effects  ||| S:1524 E:1532 ||| NNS
of  ||| S:1532 E:1535 ||| IN
fixatives  ||| S:1535 E:1545 ||| NN
on  ||| S:1545 E:1548 ||| IN
cultured  ||| S:1548 E:1557 ||| JJ
cells ||| S:1557 E:1562 ||| NNS
.  ||| S:1562 E:1572 ||| .
Considering  ||| S:1572 E:1584 ||| VBG
their  ||| S:1584 E:1590 ||| PRP$
effect  ||| S:1590 E:1597 ||| NN
on  ||| S:1597 E:1600 ||| IN
proteins ||| S:1600 E:1608 ||| NNS
,  ||| S:1608 E:1610 ||| ,
fixatives  ||| S:1610 E:1620 ||| VBG
in  ||| S:1620 E:1631 ||| IN
general  ||| S:1631 E:1639 ||| NN
can  ||| S:1639 E:1643 ||| MD
be  ||| S:1643 E:1646 ||| VB
divided  ||| S:1646 E:1654 ||| VBN
into  ||| S:1654 E:1659 ||| IN
two  ||| S:1659 E:1663 ||| CD
types ||| S:1663 E:1668 ||| NNS
:  ||| S:1668 E:1670 ||| :
"coagulant ||| S:1670 E:1680 ||| NNP
"  ||| S:1680 E:1682 ||| ''
or  ||| S:1682 E:1693 ||| CC
"non-coagulant ||| S:1693 E:1707 ||| NNP
" ||| S:1707 E:1708 ||| ''
.  ||| S:1708 E:1710 ||| .
Both  ||| S:1710 E:1715 ||| DT
groups  ||| S:1715 E:1722 ||| NNS
of  ||| S:1722 E:1725 ||| IN
fixatives  ||| S:1725 E:1735 ||| NNS
have  ||| S:1735 E:1740 ||| VBP
advantages  ||| S:1740 E:1759 ||| NNS
and  ||| S:1759 E:1763 ||| CC
disadvantages ||| S:1763 E:1776 ||| NNS
.  ||| S:1776 E:1778 ||| .
The  ||| S:1778 E:1782 ||| DT
coagulant  ||| S:1782 E:1792 ||| JJ
fixatives ||| S:1792 E:1801 ||| NN
,  ||| S:1801 E:1803 ||| ,
including  ||| S:1803 E:1821 ||| VBG
methanol  ||| S:1821 E:1830 ||| NN
[  ||| S:1830 E:1832 ||| -LRB-
8 ||| S:1832 E:1833 ||| CD
,  ||| S:1833 E:1835 ||| ,
9 ||| S:1835 E:1836 ||| CD
] ||| S:1836 E:1837 ||| -RRB-
,  ||| S:1837 E:1839 ||| ,
ethanol  ||| S:1839 E:1847 ||| NNS
[  ||| S:1847 E:1849 ||| -LRB-
10 ||| S:1849 E:1851 ||| CD
] ||| S:1851 E:1852 ||| -RRB-
,  ||| S:1852 E:1854 ||| ,
acetone  ||| S:1854 E:1862 ||| NNS
[  ||| S:1862 E:1864 ||| -LRB-
11 ||| S:1864 E:1866 ||| CD
] ||| S:1866 E:1867 ||| -RRB-
,  ||| S:1867 E:1869 ||| ,
and  ||| S:1869 E:1881 ||| CC
trichloroacetic  ||| S:1881 E:1897 ||| JJ
acid  ||| S:1897 E:1902 ||| NN
[  ||| S:1902 E:1904 ||| -LRB-
10 ||| S:1904 E:1906 ||| CD
,  ||| S:1906 E:1908 ||| ,
12 ||| S:1908 E:1910 ||| CD
] ||| S:1910 E:1911 ||| -RRB-
,  ||| S:1911 E:1913 ||| ,
denature  ||| S:1913 E:1922 ||| NN
and  ||| S:1922 E:1926 ||| CC
precipitate  ||| S:1926 E:1946 ||| JJ
proteins ||| S:1946 E:1954 ||| NNS
.  ||| S:1954 E:1956 ||| .
These  ||| S:1956 E:1962 ||| DT
fixatives  ||| S:1962 E:1972 ||| JJ
stop  ||| S:1972 E:1977 ||| NN
biological  ||| S:1977 E:1988 ||| JJ
reactions  ||| S:1988 E:2006 ||| NNS
instantaneously  ||| S:2006 E:2022 ||| NN
and  ||| S:2022 E:2026 ||| CC
presumably  ||| S:2026 E:2037 ||| RB
leave  ||| S:2037 E:2043 ||| VB
proteins  ||| S:2043 E:2052 ||| NNS
in  ||| S:2052 E:2055 ||| IN
their  ||| S:2055 E:2069 ||| PRP$
original  ||| S:2069 E:2078 ||| JJ
locations ||| S:2078 E:2087 ||| NNS
.  ||| S:2087 E:2089 ||| .
Due  ||| S:2089 E:2093 ||| JJ
to  ||| S:2093 E:2096 ||| TO
extraction  ||| S:2096 E:2107 ||| VB
of  ||| S:2107 E:2110 ||| IN
membrane  ||| S:2110 E:2127 ||| JJ
structures  ||| S:2127 E:2138 ||| NNS
by  ||| S:2138 E:2141 ||| IN
such  ||| S:2141 E:2146 ||| JJ
fixatives  ||| S:2146 E:2156 ||| NN
it  ||| S:2156 E:2159 ||| PRP
is  ||| S:2159 E:2162 ||| VBZ
not  ||| S:2162 E:2166 ||| RB
necessary  ||| S:2166 E:2176 ||| JJ
to  ||| S:2176 E:2179 ||| TO
add  ||| S:2179 E:2191 ||| VB
detergents  ||| S:2191 E:2202 ||| NNS
during  ||| S:2202 E:2209 ||| IN
staining  ||| S:2209 E:2218 ||| NN
with  ||| S:2218 E:2223 ||| IN
membrane  ||| S:2223 E:2232 ||| JJ
impermeable  ||| S:2232 E:2244 ||| JJ
probes  ||| S:2244 E:2259 ||| NNS
such  ||| S:2259 E:2264 ||| JJ
as  ||| S:2264 E:2267 ||| IN
antibodies ||| S:2267 E:2277 ||| NNS
.  ||| S:2277 E:2279 ||| .
However ||| S:2279 E:2286 ||| RB
,  ||| S:2286 E:2288 ||| ,
the  ||| S:2288 E:2292 ||| DT
denaturation  ||| S:2292 E:2305 ||| NN
of  ||| S:2305 E:2308 ||| IN
proteins  ||| S:2308 E:2325 ||| NNS
seen  ||| S:2325 E:2330 ||| VBN
with  ||| S:2330 E:2335 ||| IN
these  ||| S:2335 E:2341 ||| DT
fixatives  ||| S:2341 E:2351 ||| NN
has  ||| S:2351 E:2355 ||| VBZ
disadvantages  ||| S:2355 E:2369 ||| VBN
for  ||| S:2369 E:2373 ||| IN
some  ||| S:2373 E:2378 ||| DT
probes  ||| S:2378 E:2393 ||| NNS
[  ||| S:2393 E:2395 ||| -LRB-
8 ||| S:2395 E:2396 ||| CD
,  ||| S:2396 E:2398 ||| ,
12 ||| S:2398 E:2400 ||| CD
]  ||| S:2400 E:2402 ||| -RRB-
and  ||| S:2402 E:2406 ||| CC
for  ||| S:2406 E:2410 ||| IN
visualizing  ||| S:2410 E:2422 ||| JJ
intact  ||| S:2422 E:2429 ||| JJ
cell  ||| S:2429 E:2434 ||| NN
surfaces ||| S:2434 E:2442 ||| NN
.  ||| S:2442 E:2452 ||| .
Moreover ||| S:2452 E:2460 ||| RB
,  ||| S:2460 E:2462 ||| ,
it  ||| S:2462 E:2465 ||| PRP
is  ||| S:2465 E:2468 ||| VBZ
not  ||| S:2468 E:2472 ||| RB
known  ||| S:2472 E:2478 ||| VBN
if  ||| S:2478 E:2481 ||| IN
and  ||| S:2481 E:2485 ||| CC
to  ||| S:2485 E:2488 ||| TO
what  ||| S:2488 E:2493 ||| WP
extent  ||| S:2493 E:2500 ||| NN
proteins  ||| S:2500 E:2517 ||| NNS
are  ||| S:2517 E:2521 ||| VBP
lost  ||| S:2521 E:2526 ||| VBN
during  ||| S:2526 E:2533 ||| IN
specimen  ||| S:2533 E:2542 ||| JJ
preparation  ||| S:2542 E:2554 ||| NN
for  ||| S:2554 E:2558 ||| IN
microscopic  ||| S:2558 E:2578 ||| JJ
observation  ||| S:2578 E:2590 ||| NNS
( ||| S:2590 E:2591 ||| -LRB-
e.g.  ||| S:2591 E:2596 ||| NNP
during  ||| S:2596 E:2603 ||| IN
incubation  ||| S:2603 E:2614 ||| NN
or  ||| S:2614 E:2617 ||| CC
washing  ||| S:2617 E:2625 ||| JJ
procedures ||| S:2625 E:2635 ||| NNS
) ||| S:2635 E:2636 ||| -RRB-
.  ||| S:2636 E:2646 ||| .
The  ||| S:2646 E:2650 ||| DT
non-coagulant  ||| S:2650 E:2664 ||| JJ
fixatives  ||| S:2664 E:2674 ||| NNS
are  ||| S:2674 E:2678 ||| VBP
mainly  ||| S:2678 E:2685 ||| RB
chemical  ||| S:2685 E:2702 ||| JJ
crosslinkers  ||| S:2702 E:2715 ||| NN
that  ||| S:2715 E:2720 ||| WDT
include  ||| S:2720 E:2728 ||| VBP
glutaraldehyde ||| S:2728 E:2742 ||| VBN
,  ||| S:2742 E:2744 ||| ,
formaldehyde ||| S:2744 E:2756 ||| NN
,  ||| S:2756 E:2766 ||| ,
acrolein ||| S:2766 E:2774 ||| NN
,  ||| S:2774 E:2776 ||| ,
and  ||| S:2776 E:2780 ||| CC
dithiobis  ||| S:2780 E:2790 ||| NNS
( ||| S:2790 E:2791 ||| -LRB-
succinimidylpropionate ||| S:2791 E:2813 ||| LS
) ||| S:2813 E:2814 ||| -RRB-
.  ||| S:2814 E:2816 ||| .
They  ||| S:2816 E:2821 ||| PRP
are  ||| S:2821 E:2833 ||| VBP
used  ||| S:2833 E:2838 ||| VBN
to  ||| S:2838 E:2841 ||| TO
preserve  ||| S:2841 E:2850 ||| VB
surface  ||| S:2850 E:2858 ||| NN
morphology  ||| S:2858 E:2869 ||| NN
of  ||| S:2869 E:2872 ||| IN
cells  ||| S:2872 E:2878 ||| NNS
and  ||| S:2878 E:2882 ||| CC
to  ||| S:2882 E:2893 ||| TO
immobilize  ||| S:2893 E:2904 ||| VB
cellular  ||| S:2904 E:2913 ||| JJ
components  ||| S:2913 E:2924 ||| NNS
before  ||| S:2924 E:2931 ||| IN
extraction  ||| S:2931 E:2942 ||| NN
with  ||| S:2942 E:2955 ||| IN
detergents  ||| S:2955 E:2966 ||| NNS
[  ||| S:2966 E:2968 ||| -LRB-
8 ||| S:2968 E:2969 ||| CD
,  ||| S:2969 E:2971 ||| ,
13 ||| S:2971 E:2973 ||| CD
,  ||| S:2973 E:2975 ||| ,
14 ||| S:2975 E:2977 ||| CD
] ||| S:2977 E:2978 ||| -RRB-
.  ||| S:2978 E:2980 ||| .
However ||| S:2980 E:2987 ||| RB
,  ||| S:2987 E:2989 ||| ,
excess  ||| S:2989 E:2996 ||| JJ
crosslinking  ||| S:2996 E:3017 ||| NNS
frequently  ||| S:3017 E:3028 ||| RB
masks  ||| S:3028 E:3034 ||| JJ
binding  ||| S:3034 E:3042 ||| JJ
domains  ||| S:3042 E:3050 ||| NN
for  ||| S:3050 E:3054 ||| IN
probes  ||| S:3054 E:3061 ||| NNS
while  ||| S:3061 E:3075 ||| IN
inadequate  ||| S:3075 E:3086 ||| JJ
fixation  ||| S:3086 E:3095 ||| NN
may  ||| S:3095 E:3099 ||| MD
not  ||| S:3099 E:3103 ||| RB
preserve  ||| S:3103 E:3112 ||| VB
structures  ||| S:3112 E:3123 ||| NNS
to  ||| S:3123 E:3126 ||| TO
leave  ||| S:3126 E:3140 ||| VB
them  ||| S:3140 E:3145 ||| PRP
susceptible  ||| S:3145 E:3157 ||| VBP
to  ||| S:3157 E:3160 ||| TO
mechanical  ||| S:3160 E:3171 ||| JJ
forces  ||| S:3171 E:3178 ||| NNS
during  ||| S:3178 E:3185 ||| IN
specimen  ||| S:3185 E:3202 ||| JJ
processing ||| S:3202 E:3212 ||| NN
.  ||| S:3212 E:3214 ||| .
The  ||| S:3214 E:3218 ||| DT
latter  ||| S:3218 E:3225 ||| NN
is  ||| S:3225 E:3228 ||| VBZ
quite  ||| S:3228 E:3234 ||| RB
critical  ||| S:3234 E:3243 ||| JJ
especially  ||| S:3243 E:3254 ||| RB
to  ||| S:3254 E:3265 ||| TO
preserve  ||| S:3265 E:3274 ||| VB
fine  ||| S:3274 E:3279 ||| NN
and  ||| S:3279 E:3283 ||| CC
fragile  ||| S:3283 E:3291 ||| JJ
cellular  ||| S:3291 E:3300 ||| JJ
microextensions  ||| S:3300 E:3316 ||| JJ
such  ||| S:3316 E:3321 ||| JJ
as  ||| S:3321 E:3332 ||| IN
filopodia  ||| S:3332 E:3342 ||| NN
or  ||| S:3342 E:3345 ||| CC
retraction  ||| S:3345 E:3356 ||| JJ
fibers  ||| S:3356 E:3363 ||| NNS
[  ||| S:3363 E:3365 ||| -LRB-
15 ||| S:3365 E:3367 ||| CD
,  ||| S:3367 E:3369 ||| ,
16 ||| S:3369 E:3371 ||| CD
] ||| S:3371 E:3372 ||| -RRB-
.  ||| S:3372 E:3382 ||| .
We  ||| S:3382 E:3385 ||| PRP
have  ||| S:3385 E:3390 ||| VBP
been  ||| S:3390 E:3395 ||| VBN
interested  ||| S:3395 E:3406 ||| VBN
in  ||| S:3406 E:3409 ||| IN
the  ||| S:3409 E:3413 ||| DT
formation  ||| S:3413 E:3423 ||| NN
and  ||| S:3423 E:3427 ||| CC
function  ||| S:3427 E:3436 ||| NN
of  ||| S:3436 E:3447 ||| IN
microextensions  ||| S:3447 E:3463 ||| NN
because  ||| S:3463 E:3471 ||| IN
of  ||| S:3471 E:3474 ||| IN
their  ||| S:3474 E:3480 ||| PRP$
dynamic  ||| S:3480 E:3488 ||| JJ
and  ||| S:3488 E:3492 ||| CC
universal  ||| S:3492 E:3510 ||| JJ
nature ||| S:3510 E:3516 ||| NN
,  ||| S:3516 E:3518 ||| ,
and  ||| S:3518 E:3522 ||| CC
since  ||| S:3522 E:3528 ||| IN
moesin ||| S:3528 E:3534 ||| NN
,  ||| S:3534 E:3536 ||| ,
an  ||| S:3536 E:3539 ||| DT
actin-binding  ||| S:3539 E:3553 ||| JJ
protein  ||| S:3553 E:3561 ||| NN
is  ||| S:3561 E:3572 ||| VBZ
enriched  ||| S:3572 E:3581 ||| VBN
in  ||| S:3581 E:3584 ||| IN
these  ||| S:3584 E:3590 ||| DT
structures  ||| S:3590 E:3601 ||| NNS
[  ||| S:3601 E:3603 ||| -LRB-
17 ||| S:3603 E:3605 ||| CD
,  ||| S:3605 E:3607 ||| ,
18 ||| S:3607 E:3609 ||| CD
] ||| S:3609 E:3610 ||| -RRB-
.  ||| S:3610 E:3612 ||| .
The  ||| S:3612 E:3616 ||| DT
F-actin-binding  ||| S:3616 E:3640 ||| JJ
activity  ||| S:3640 E:3649 ||| NN
of  ||| S:3649 E:3652 ||| IN
moesin  ||| S:3652 E:3659 ||| NN
is  ||| S:3659 E:3662 ||| VBZ
regulated  ||| S:3662 E:3672 ||| VBN
by  ||| S:3672 E:3675 ||| IN
both  ||| S:3675 E:3680 ||| DT
phosphorylation  ||| S:3680 E:3696 ||| NN
and  ||| S:3696 E:3708 ||| CC
polyphosphoinositides  ||| S:3708 E:3730 ||| NNS
( ||| S:3730 E:3731 ||| -LRB-
PIPs ||| S:3731 E:3735 ||| NNP
)  ||| S:3735 E:3737 ||| -RRB-
1 ||| S:3737 E:3738 ||| CD
.  ||| S:3738 E:3740 ||| .
Interestingly ||| S:3740 E:3753 ||| RB
,  ||| S:3753 E:3755 ||| ,
PIPs  ||| S:3755 E:3760 ||| NNP
could  ||| S:3760 E:3774 ||| MD
be  ||| S:3774 E:3777 ||| VB
substituted  ||| S:3777 E:3789 ||| VBN
for  ||| S:3789 E:3793 ||| IN
by  ||| S:3793 E:3796 ||| IN
a  ||| S:3796 E:3798 ||| DT
cationic  ||| S:3798 E:3807 ||| JJ
detergent ||| S:3807 E:3816 ||| NN
,  ||| S:3816 E:3826 ||| ,
dodecyltrimethylammonium  ||| S:3826 E:3851 ||| JJ
chloride  ||| S:3851 E:3860 ||| NN
( ||| S:3860 E:3861 ||| -LRB-
DOTMAC ||| S:3861 E:3867 ||| NNP
)  ||| S:3867 E:3878 ||| -RRB-
in  ||| S:3878 E:3881 ||| IN
vitro  ||| S:3881 E:3887 ||| NNS
[  ||| S:3887 E:3889 ||| -LRB-
19 ||| S:3889 E:3891 ||| CD
] ||| S:3891 E:3892 ||| -RRB-
.  ||| S:3892 E:3894 ||| .
This  ||| S:3894 E:3899 ||| DT
result  ||| S:3899 E:3906 ||| NN
was  ||| S:3906 E:3918 ||| VBD
consistent  ||| S:3918 E:3929 ||| JJ
with  ||| S:3929 E:3934 ||| IN
biochemical  ||| S:3934 E:3946 ||| JJ
extraction  ||| S:3946 E:3957 ||| NN
studies ||| S:3957 E:3964 ||| NNS
,  ||| S:3964 E:3966 ||| ,
since  ||| S:3966 E:3980 ||| IN
phosphorylated  ||| S:3980 E:3995 ||| JJ
moesin  ||| S:3995 E:4002 ||| NNS
specifically  ||| S:4002 E:4015 ||| RB
co-sedimented  ||| S:4015 E:4029 ||| JJ
with  ||| S:4029 E:4042 ||| IN
DOTMAC- ||| S:4042 E:4049 ||| NNP
,  ||| S:4049 E:4051 ||| ,
but  ||| S:4051 E:4055 ||| CC
not  ||| S:4055 E:4059 ||| RB
Triton  ||| S:4059 E:4066 ||| NNP
X-100-resistant  ||| S:4066 E:4082 ||| NNP
components ||| S:4082 E:4092 ||| NNS
,  ||| S:4092 E:4094 ||| ,
most  ||| S:4094 E:4107 ||| RBS
likely  ||| S:4107 E:4114 ||| JJ
because  ||| S:4114 E:4122 ||| IN
Triton  ||| S:4122 E:4129 ||| NNP
X-100  ||| S:4129 E:4135 ||| NNP
interfered  ||| S:4135 E:4146 ||| VBD
with  ||| S:4146 E:4151 ||| IN
the  ||| S:4151 E:4155 ||| DT
interaction  ||| S:4155 E:4175 ||| NN
between  ||| S:4175 E:4183 ||| IN
moesin  ||| S:4183 E:4190 ||| NN
and  ||| S:4190 E:4194 ||| CC
PIPs  ||| S:4194 E:4199 ||| NNP
[  ||| S:4199 E:4201 ||| -LRB-
19 ||| S:4201 E:4203 ||| CD
] ||| S:4203 E:4204 ||| -RRB-
.  ||| S:4204 E:4206 ||| .
This  ||| S:4206 E:4211 ||| DT
result  ||| S:4211 E:4218 ||| NN
also  ||| S:4218 E:4223 ||| RB
suggested  ||| S:4223 E:4241 ||| VBN
that  ||| S:4241 E:4246 ||| IN
Triton  ||| S:4246 E:4253 ||| NNP
X-100  ||| S:4253 E:4259 ||| NNP
extraction  ||| S:4259 E:4270 ||| NN
of  ||| S:4270 E:4273 ||| IN
cells  ||| S:4273 E:4279 ||| NNS
may  ||| S:4279 E:4283 ||| MD
not  ||| S:4283 E:4287 ||| RB
preserve  ||| S:4287 E:4304 ||| VB
moesin-actin  ||| S:4304 E:4317 ||| JJ
filament  ||| S:4317 E:4326 ||| JJ
complexes ||| S:4326 E:4335 ||| NNS
.  ||| S:4335 E:4345 ||| .
As  ||| S:4345 E:4348 ||| RB
expected ||| S:4348 E:4356 ||| VBN
,  ||| S:4356 E:4358 ||| ,
we  ||| S:4358 E:4361 ||| PRP
show  ||| S:4361 E:4366 ||| VBP
here  ||| S:4366 E:4371 ||| RB
that  ||| S:4371 E:4376 ||| IN
some  ||| S:4376 E:4381 ||| DT
of  ||| S:4381 E:4384 ||| IN
microextensions  ||| S:4384 E:4408 ||| NN
were  ||| S:4408 E:4413 ||| VBD
fragmented  ||| S:4413 E:4424 ||| VBN
by  ||| S:4424 E:4427 ||| IN
the  ||| S:4427 E:4431 ||| DT
standard  ||| S:4431 E:4440 ||| JJ
Triton  ||| S:4440 E:4447 ||| NNP
X-100  ||| S:4447 E:4461 ||| NNP
permeabilization  ||| S:4461 E:4478 ||| JJ
method ||| S:4478 E:4484 ||| NN
.  ||| S:4484 E:4486 ||| .
By  ||| S:4486 E:4489 ||| IN
contrast ||| S:4489 E:4497 ||| NN
,  ||| S:4497 E:4499 ||| ,
DOTMAC  ||| S:4499 E:4506 ||| NNP
completely  ||| S:4506 E:4525 ||| RB
extracted  ||| S:4525 E:4535 ||| VBN
membrane  ||| S:4535 E:4544 ||| JJ
lipids  ||| S:4544 E:4551 ||| NN
while  ||| S:4551 E:4557 ||| IN
maintaining  ||| S:4557 E:4569 ||| VBG
the  ||| S:4569 E:4581 ||| DT
cytoskeleton  ||| S:4581 E:4594 ||| NN
of  ||| S:4594 E:4597 ||| IN
microextensions ||| S:4597 E:4612 ||| NN
.  ||| S:4612 E:4622 ||| .
We  ||| S:4622 E:4625 ||| PRP
also  ||| S:4625 E:4630 ||| RB
observed  ||| S:4630 E:4639 ||| VBD
microextensions  ||| S:4639 E:4655 ||| VBN
having  ||| S:4655 E:4662 ||| VBG
a  ||| S:4662 E:4664 ||| DT
considerably  ||| S:4664 E:4685 ||| RB
smaller  ||| S:4685 E:4693 ||| JJR
diameter  ||| S:4693 E:4702 ||| NN
from  ||| S:4702 E:4707 ||| IN
those  ||| S:4707 E:4713 ||| DT
commonly  ||| S:4713 E:4722 ||| RB
seen  ||| S:4722 E:4727 ||| VBN
(  ||| S:4727 E:4728 ||| -LRB-
< ||| S:4728 E:4729 ||| SYM
0.05  ||| S:4729 E:4734 ||| FW
μm  ||| S:4734 E:4737 ||| FW
vs.  ||| S:4737 E:4749 ||| FW
0.  ||| S:4749 E:4752 ||| NNP
2  ||| S:4752 E:4754 ||| CD
μm ||| S:4754 E:4756 ||| CD
) ||| S:4756 E:4757 ||| -RRB-
.  ||| S:4757 E:4759 ||| .
Referred  ||| S:4759 E:4768 ||| VBN
to  ||| S:4768 E:4771 ||| TO
here  ||| S:4771 E:4776 ||| RB
as  ||| S:4776 E:4779 ||| IN
ultramicroextensions ||| S:4779 E:4799 ||| NN
,  ||| S:4799 E:4801 ||| ,
these  ||| S:4801 E:4815 ||| DT
extended  ||| S:4815 E:4824 ||| VBN
from  ||| S:4824 E:4829 ||| IN
cell  ||| S:4829 E:4834 ||| NN
bodies  ||| S:4834 E:4841 ||| NNS
and  ||| S:4841 E:4845 ||| CC
grew  ||| S:4845 E:4850 ||| VBD
out  ||| S:4850 E:4854 ||| RP
from  ||| S:4854 E:4859 ||| IN
the  ||| S:4859 E:4863 ||| DT
tips  ||| S:4863 E:4868 ||| NNS
of  ||| S:4868 E:4879 ||| IN
other  ||| S:4879 E:4885 ||| JJ
microextensions ||| S:4885 E:4900 ||| NN
.  ||| S:4900 E:4902 ||| .
DOTMAC  ||| S:4902 E:4909 ||| NNP
treatment  ||| S:4909 E:4919 ||| NN
exposed  ||| S:4919 E:4927 ||| VBN
and  ||| S:4927 E:4939 ||| CC
stabilized  ||| S:4939 E:4950 ||| VBD
their  ||| S:4950 E:4956 ||| PRP$
cytoskeleton  ||| S:4956 E:4969 ||| NN
as  ||| S:4969 E:4972 ||| IN
well ||| S:4972 E:4976 ||| RB
.  ||| S:4976 E:5000 ||| .
Results  ||| S:5000 E:5027 ||| NNP
Examination  ||| S:5027 E:5039 ||| NNP
of  ||| S:5039 E:5042 ||| IN
microextensions  ||| S:5042 E:5058 ||| NN
of  ||| S:5058 E:5061 ||| IN
NIH3T3  ||| S:5061 E:5068 ||| CD
fibroblast  ||| S:5068 E:5089 ||| NN
by  ||| S:5089 E:5092 ||| IN
scanning  ||| S:5092 E:5101 ||| JJ
electron  ||| S:5101 E:5110 ||| NNS
microscopy  ||| S:5110 E:5131 ||| VBP
We  ||| S:5131 E:5134 ||| PRP
used  ||| S:5134 E:5139 ||| VBD
NIH3T3  ||| S:5139 E:5146 ||| CD
cells  ||| S:5146 E:5152 ||| NNS
because  ||| S:5152 E:5160 ||| IN
their  ||| S:5160 E:5166 ||| PRP$
morphology  ||| S:5166 E:5177 ||| NN
and  ||| S:5177 E:5191 ||| CC
localization  ||| S:5191 E:5204 ||| NN
of  ||| S:5204 E:5207 ||| IN
cytoskeletal  ||| S:5207 E:5220 ||| JJ
proteins  ||| S:5220 E:5229 ||| NNS
including  ||| S:5229 E:5239 ||| VBG
actin ||| S:5239 E:5244 ||| NN
,  ||| S:5244 E:5256 ||| ,
tubulin ||| S:5256 E:5263 ||| NN
,  ||| S:5263 E:5265 ||| ,
vinculin ||| S:5265 E:5273 ||| NN
,  ||| S:5273 E:5275 ||| ,
and  ||| S:5275 E:5279 ||| CC
moesin  ||| S:5279 E:5286 ||| NNS
have  ||| S:5286 E:5291 ||| VBP
been  ||| S:5291 E:5296 ||| VBN
extensively  ||| S:5296 E:5318 ||| RB
investigated  ||| S:5318 E:5331 ||| VBN
using  ||| S:5331 E:5337 ||| VBG
various  ||| S:5337 E:5345 ||| JJ
fixatives ||| S:5345 E:5354 ||| NN
.  ||| S:5354 E:5356 ||| .
When  ||| S:5356 E:5361 ||| WRB
removed  ||| S:5361 E:5369 ||| VBN
from  ||| S:5369 E:5384 ||| IN
stock  ||| S:5384 E:5390 ||| NN
cultures  ||| S:5390 E:5399 ||| NNS
with  ||| S:5399 E:5404 ||| IN
trypsin  ||| S:5404 E:5412 ||| NN
and  ||| S:5412 E:5416 ||| CC
inoculated  ||| S:5416 E:5427 ||| NN
into  ||| S:5427 E:5442 ||| IN
coverslip-containing  ||| S:5442 E:5463 ||| JJ
dishes ||| S:5463 E:5469 ||| NNS
,  ||| S:5469 E:5471 ||| ,
NIH3T3  ||| S:5471 E:5478 ||| CD
cells  ||| S:5478 E:5484 ||| NNS
readily  ||| S:5484 E:5502 ||| RB
attached  ||| S:5502 E:5511 ||| VBN
to  ||| S:5511 E:5514 ||| TO
the  ||| S:5514 E:5518 ||| DT
serum-coated  ||| S:5518 E:5531 ||| JJ
substrate ||| S:5531 E:5540 ||| NN
,  ||| S:5540 E:5542 ||| ,
began  ||| S:5542 E:5548 ||| VBD
to  ||| S:5548 E:5551 ||| TO
spread  ||| S:5551 E:5568 ||| VB
and  ||| S:5568 E:5572 ||| CC
flattened  ||| S:5572 E:5582 ||| VBN
within  ||| S:5582 E:5589 ||| IN
one  ||| S:5589 E:5593 ||| CD
hour  ||| S:5593 E:5598 ||| NN
( ||| S:5598 E:5599 ||| -LRB-
data  ||| S:5599 E:5604 ||| NNS
not  ||| S:5604 E:5608 ||| RB
shown ||| S:5608 E:5613 ||| VBN
) ||| S:5613 E:5614 ||| -RRB-
.  ||| S:5614 E:5626 ||| .
Consistent  ||| S:5626 E:5637 ||| JJ
with  ||| S:5637 E:5642 ||| IN
the  ||| S:5642 E:5646 ||| DT
report  ||| S:5646 E:5653 ||| NN
by  ||| S:5653 E:5656 ||| IN
Rajaraman  ||| S:5656 E:5666 ||| NNP
et  ||| S:5666 E:5669 ||| FW
al. ||| S:5669 E:5672 ||| FW
[  ||| S:5672 E:5674 ||| -LRB-
20 ||| S:5674 E:5676 ||| CD
]  ||| S:5676 E:5678 ||| -RRB-
on  ||| S:5678 E:5691 ||| IN
human  ||| S:5691 E:5697 ||| JJ
diploid  ||| S:5697 E:5705 ||| NN
WI-38  ||| S:5705 E:5711 ||| CD
cells  ||| S:5711 E:5717 ||| NNS
and  ||| S:5717 E:5721 ||| CC
Albrecht-Buehler  ||| S:5721 E:5738 ||| JJ
and  ||| S:5738 E:5752 ||| CC
Goldman  ||| S:5752 E:5760 ||| NNP
[  ||| S:5760 E:5762 ||| -LRB-
21 ||| S:5762 E:5764 ||| CD
]  ||| S:5764 E:5766 ||| -RRB-
on  ||| S:5766 E:5769 ||| IN
3T3  ||| S:5769 E:5773 ||| CD
fibroblasts ||| S:5773 E:5784 ||| NN
,  ||| S:5784 E:5786 ||| ,
microextensions  ||| S:5786 E:5812 ||| NN
appeared  ||| S:5812 E:5821 ||| VBD
within  ||| S:5821 E:5828 ||| IN
20  ||| S:5828 E:5831 ||| CD
min  ||| S:5831 E:5835 ||| NN
after  ||| S:5835 E:5841 ||| IN
seeding ||| S:5841 E:5848 ||| NN
.  ||| S:5848 E:5850 ||| .
Initially  ||| S:5850 E:5860 ||| RB
during  ||| S:5860 E:5877 ||| IN
spreading ||| S:5877 E:5886 ||| VBG
,  ||| S:5886 E:5888 ||| ,
the  ||| S:5888 E:5892 ||| DT
cells  ||| S:5892 E:5898 ||| NNS
lost  ||| S:5898 E:5903 ||| VBD
microvilli  ||| S:5903 E:5914 ||| VBN
from  ||| S:5914 E:5919 ||| IN
their  ||| S:5919 E:5925 ||| PRP$
upper  ||| S:5925 E:5941 ||| JJ
cell  ||| S:5941 E:5946 ||| NN
surface  ||| S:5946 E:5954 ||| NN
and  ||| S:5954 E:5958 ||| CC
formed  ||| S:5958 E:5965 ||| VBD
microextensions  ||| S:5965 E:5981 ||| VBN
with  ||| S:5981 E:5986 ||| IN
a  ||| S:5986 E:5988 ||| DT
diameter  ||| S:5988 E:6007 ||| NN
of  ||| S:6007 E:6010 ||| IN
about  ||| S:6010 E:6016 ||| IN
0.2  ||| S:6016 E:6020 ||| CD
μm  ||| S:6020 E:6023 ||| NNS
and  ||| S:6023 E:6027 ||| CC
a  ||| S:6027 E:6029 ||| DT
maximal  ||| S:6029 E:6037 ||| JJ
length  ||| S:6037 E:6044 ||| NN
of  ||| S:6044 E:6047 ||| IN
about  ||| S:6047 E:6053 ||| IN
10  ||| S:6053 E:6056 ||| CD
μm ||| S:6056 E:6058 ||| NNS
.  ||| S:6058 E:6070 ||| .
Subsequently ||| S:6070 E:6082 ||| RB
,  ||| S:6082 E:6084 ||| ,
the  ||| S:6084 E:6088 ||| DT
cells  ||| S:6088 E:6094 ||| NNS
continued  ||| S:6094 E:6104 ||| VBD
to  ||| S:6104 E:6107 ||| TO
spread  ||| S:6107 E:6114 ||| VB
and  ||| S:6114 E:6118 ||| CC
to  ||| S:6118 E:6131 ||| TO
randomly  ||| S:6131 E:6140 ||| RB
elongate  ||| S:6140 E:6149 ||| VB
microextensions  ||| S:6149 E:6165 ||| VBN
up  ||| S:6165 E:6168 ||| RP
to  ||| S:6168 E:6171 ||| TO
40  ||| S:6171 E:6174 ||| CD
μm ||| S:6174 E:6176 ||| NNS
.  ||| S:6176 E:6178 ||| .
However ||| S:6178 E:6185 ||| RB
,  ||| S:6185 E:6197 ||| ,
closer  ||| S:6197 E:6204 ||| JJR
examination  ||| S:6204 E:6216 ||| NN
of  ||| S:6216 E:6219 ||| IN
the  ||| S:6219 E:6223 ||| DT
fixed  ||| S:6223 E:6229 ||| JJ
cells  ||| S:6229 E:6235 ||| NNS
with  ||| S:6235 E:6240 ||| IN
a  ||| S:6240 E:6242 ||| DT
60°  ||| S:6242 E:6246 ||| JJ
tilt  ||| S:6246 E:6261 ||| NN
angle  ||| S:6261 E:6267 ||| NN
showed  ||| S:6267 E:6274 ||| VBD
numerous  ||| S:6274 E:6283 ||| JJ
additional  ||| S:6283 E:6294 ||| JJ
protrusions  ||| S:6294 E:6306 ||| NNS
extending  ||| S:6306 E:6326 ||| VBG
from  ||| S:6326 E:6331 ||| IN
the  ||| S:6331 E:6335 ||| DT
cell  ||| S:6335 E:6340 ||| NN
body  ||| S:6340 E:6345 ||| NN
with  ||| S:6345 E:6350 ||| IN
a  ||| S:6350 E:6352 ||| DT
diameter  ||| S:6352 E:6361 ||| NN
of  ||| S:6361 E:6364 ||| IN
only  ||| S:6364 E:6369 ||| RB
about  ||| S:6369 E:6375 ||| IN
0.05  ||| S:6375 E:6380 ||| CD
μm  ||| S:6380 E:6393 ||| NNS
( ||| S:6393 E:6394 ||| -LRB-
Figure  ||| S:6394 E:6401 ||| NNP
1 ||| S:6401 E:6402 ||| CD
) ||| S:6402 E:6403 ||| -RRB-
.  ||| S:6403 E:6405 ||| .
These  ||| S:6405 E:6411 ||| DT
structures  ||| S:6411 E:6422 ||| NNS
were  ||| S:6422 E:6427 ||| VBD
not  ||| S:6427 E:6431 ||| RB
observed  ||| S:6431 E:6440 ||| VBN
in  ||| S:6440 E:6443 ||| IN
cells  ||| S:6443 E:6459 ||| NNS
prior  ||| S:6459 E:6465 ||| RB
to  ||| S:6465 E:6468 ||| TO
12  ||| S:6468 E:6471 ||| CD
hours  ||| S:6471 E:6477 ||| NNS
after  ||| S:6477 E:6483 ||| IN
inoculation ||| S:6483 E:6494 ||| NN
.  ||| S:6494 E:6496 ||| .
At  ||| S:6496 E:6499 ||| IN
48  ||| S:6499 E:6502 ||| CD
hour ||| S:6502 E:6506 ||| NN
,  ||| S:6506 E:6508 ||| ,
about  ||| S:6508 E:6514 ||| IN
5 ||| S:6514 E:6515 ||| CD
%  ||| S:6515 E:6527 ||| NN
( ||| S:6527 E:6528 ||| -LRB-
7 ||| S:6528 E:6529 ||| CD
/ ||| S:6529 E:6530 ||| CD
130 ||| S:6530 E:6533 ||| CD
)  ||| S:6533 E:6535 ||| -RRB-
of  ||| S:6535 E:6538 ||| IN
the  ||| S:6538 E:6542 ||| DT
cells  ||| S:6542 E:6548 ||| NNS
had  ||| S:6548 E:6552 ||| VBD
extended  ||| S:6552 E:6561 ||| VBN
such  ||| S:6561 E:6566 ||| JJ
structures  ||| S:6566 E:6577 ||| NNS
that  ||| S:6577 E:6592 ||| WDT
usually  ||| S:6592 E:6600 ||| RB
were  ||| S:6600 E:6605 ||| VBD
< ||| S:6605 E:6607 ||| SYM
0.5  ||| S:6607 E:6611 ||| CD
μm  ||| S:6611 E:6614 ||| NN
in  ||| S:6614 E:6617 ||| IN
length ||| S:6617 E:6623 ||| NN
,  ||| S:6623 E:6625 ||| ,
and  ||| S:6625 E:6629 ||| CC
rarely  ||| S:6629 E:6636 ||| RB
exceeded  ||| S:6636 E:6645 ||| VBD
1  ||| S:6645 E:6657 ||| CD
μm ||| S:6657 E:6659 ||| NNS
.  ||| S:6659 E:6661 ||| .
Because  ||| S:6661 E:6669 ||| IN
of  ||| S:6669 E:6672 ||| IN
these  ||| S:6672 E:6678 ||| DT
unique  ||| S:6678 E:6685 ||| JJ
features ||| S:6685 E:6693 ||| NNS
,  ||| S:6693 E:6695 ||| ,
we  ||| S:6695 E:6698 ||| PRP
will  ||| S:6698 E:6703 ||| MD
use  ||| S:6703 E:6707 ||| VB
the  ||| S:6707 E:6721 ||| DT
term  ||| S:6721 E:6726 ||| NN
ultramicroextensions ||| S:6726 E:6746 ||| NN
.  ||| S:6746 E:6748 ||| .
Three  ||| S:6748 E:6754 ||| CD
days  ||| S:6754 E:6759 ||| NNS
after  ||| S:6759 E:6765 ||| IN
reaching  ||| S:6765 E:6784 ||| VBG
confluency  ||| S:6784 E:6795 ||| NNS
( ||| S:6795 E:6796 ||| -LRB-
at  ||| S:6796 E:6799 ||| IN
about  ||| S:6799 E:6805 ||| IN
one  ||| S:6805 E:6809 ||| CD
week  ||| S:6809 E:6814 ||| NN
in  ||| S:6814 E:6817 ||| IN
culture ||| S:6817 E:6824 ||| NN
) ||| S:6824 E:6825 ||| -RRB-
,  ||| S:6825 E:6827 ||| ,
about  ||| S:6827 E:6833 ||| IN
half  ||| S:6833 E:6838 ||| NN
of  ||| S:6838 E:6851 ||| IN
the  ||| S:6851 E:6855 ||| DT
surface  ||| S:6855 E:6863 ||| NN
of  ||| S:6863 E:6866 ||| IN
the  ||| S:6866 E:6870 ||| DT
cells  ||| S:6870 E:6876 ||| NNS
was  ||| S:6876 E:6880 ||| VBD
covered  ||| S:6880 E:6888 ||| VBN
with  ||| S:6888 E:6903 ||| IN
ultramicroextensions  ||| S:6903 E:6924 ||| NNS
( ||| S:6924 E:6925 ||| -LRB-
Figure  ||| S:6925 E:6932 ||| NNP
1 ||| S:6932 E:6933 ||| CD
,  ||| S:6933 E:6935 ||| ,
D ||| S:6935 E:6936 ||| NNP
, ||| S:6936 E:6937 ||| ,
E ||| S:6937 E:6938 ||| NNP
, ||| S:6938 E:6939 ||| ,
F ||| S:6939 E:6940 ||| NNP
) ||| S:6940 E:6941 ||| -RRB-
.  ||| S:6941 E:6943 ||| .
When  ||| S:6943 E:6948 ||| WRB
cells  ||| S:6948 E:6954 ||| NNS
were  ||| S:6954 E:6969 ||| VBD
inoculated  ||| S:6969 E:6980 ||| VBN
at  ||| S:6980 E:6983 ||| IN
high  ||| S:6983 E:6988 ||| JJ
density ||| S:6988 E:6995 ||| NN
,  ||| S:6995 E:6997 ||| ,
ultramicroextensions  ||| S:6997 E:7018 ||| NN
appeared  ||| S:7018 E:7037 ||| VBD
earlier ||| S:7037 E:7044 ||| RBR
,  ||| S:7044 E:7046 ||| ,
but  ||| S:7046 E:7050 ||| CC
ultramicroextensions  ||| S:7050 E:7071 ||| NNS
were  ||| S:7071 E:7076 ||| VBD
rarely  ||| S:7076 E:7083 ||| RB
seen  ||| S:7083 E:7088 ||| VBN
even  ||| S:7088 E:7103 ||| RB
after  ||| S:7103 E:7109 ||| IN
incubation  ||| S:7109 E:7120 ||| NN
for  ||| S:7120 E:7124 ||| IN
prolonged  ||| S:7124 E:7134 ||| JJ
periods  ||| S:7134 E:7142 ||| NNS
in  ||| S:7142 E:7145 ||| IN
sparse  ||| S:7145 E:7152 ||| JJ
cultures  ||| S:7152 E:7171 ||| NNS
or  ||| S:7171 E:7174 ||| CC
when  ||| S:7174 E:7179 ||| WRB
the  ||| S:7179 E:7183 ||| DT
cells  ||| S:7183 E:7189 ||| NNS
did  ||| S:7189 E:7193 ||| VBD
not  ||| S:7193 E:7197 ||| RB
make  ||| S:7197 E:7202 ||| VB
contact  ||| S:7202 E:7210 ||| NN
( ||| S:7210 E:7211 ||| -LRB-
data  ||| S:7211 E:7216 ||| NNS
not  ||| S:7216 E:7220 ||| RB
shown ||| S:7220 E:7225 ||| VBN
) ||| S:7225 E:7226 ||| -RRB-
.  ||| S:7226 E:7238 ||| .
Ultramicroextensions  ||| S:7238 E:7259 ||| NNS
originated  ||| S:7259 E:7270 ||| VBP
either  ||| S:7270 E:7277 ||| RB
from  ||| S:7277 E:7292 ||| IN
microextensions  ||| S:7292 E:7308 ||| NN
of  ||| S:7308 E:7311 ||| IN
neighboring  ||| S:7311 E:7323 ||| JJ
cells  ||| S:7323 E:7329 ||| NNS
or  ||| S:7329 E:7332 ||| CC
from  ||| S:7332 E:7337 ||| IN
tips  ||| S:7337 E:7342 ||| NNS
of  ||| S:7342 E:7355 ||| IN
other  ||| S:7355 E:7361 ||| JJ
microextensions  ||| S:7361 E:7377 ||| NN
in  ||| S:7377 E:7380 ||| IN
a  ||| S:7380 E:7382 ||| DT
broom-like  ||| S:7382 E:7393 ||| JJ
fashion  ||| S:7393 E:7401 ||| NN
( ||| S:7401 E:7402 ||| -LRB-
Figure  ||| S:7402 E:7419 ||| NNP
1G ||| S:7419 E:7421 ||| NNP
) ||| S:7421 E:7422 ||| -RRB-
.  ||| S:7422 E:7424 ||| .
Ultramicroextensions  ||| S:7424 E:7445 ||| NNP
also  ||| S:7445 E:7450 ||| RB
originated  ||| S:7450 E:7461 ||| VBN
from  ||| S:7461 E:7466 ||| IN
the  ||| S:7466 E:7470 ||| DT
cell  ||| S:7470 E:7485 ||| NN
surface  ||| S:7485 E:7493 ||| NN
similar  ||| S:7493 E:7501 ||| JJ
to  ||| S:7501 E:7504 ||| TO
microvilli  ||| S:7504 E:7515 ||| VB
( ||| S:7515 E:7516 ||| -LRB-
Figure  ||| S:7516 E:7523 ||| NNP
1H ||| S:7523 E:7525 ||| NNP
) ||| S:7525 E:7526 ||| -RRB-
,  ||| S:7526 E:7528 ||| ,
or  ||| S:7528 E:7531 ||| CC
as  ||| S:7531 E:7534 ||| IN
branches  ||| S:7534 E:7553 ||| NNS
from  ||| S:7553 E:7558 ||| IN
other  ||| S:7558 E:7564 ||| JJ
microextensions  ||| S:7564 E:7580 ||| NN
and  ||| S:7580 E:7584 ||| CC
ultramicroextensions  ||| S:7584 E:7615 ||| NNS
( ||| S:7615 E:7616 ||| -LRB-
Figure  ||| S:7616 E:7623 ||| NNP
1I ||| S:7623 E:7625 ||| NNP
) ||| S:7625 E:7626 ||| -RRB-
.  ||| S:7626 E:7628 ||| .
Identical  ||| S:7628 E:7638 ||| JJ
results  ||| S:7638 E:7646 ||| NNS
were  ||| S:7646 E:7651 ||| VBD
obtained  ||| S:7651 E:7660 ||| VBN
when  ||| S:7660 E:7665 ||| WRB
the  ||| S:7665 E:7679 ||| DT
cells  ||| S:7679 E:7685 ||| NNS
were  ||| S:7685 E:7690 ||| VBD
grown  ||| S:7690 E:7696 ||| VBN
on  ||| S:7696 E:7699 ||| IN
poly-L-lysine-coated  ||| S:7699 E:7720 ||| JJ
coverslips  ||| S:7720 E:7731 ||| NNS
( ||| S:7731 E:7732 ||| -LRB-
data  ||| S:7732 E:7747 ||| NNS
not  ||| S:7747 E:7751 ||| RB
shown ||| S:7751 E:7756 ||| VBN
) ||| S:7756 E:7757 ||| -RRB-
.  ||| S:7757 E:7787 ||| .
Exposure  ||| S:7787 E:7796 ||| NN
of  ||| S:7796 E:7799 ||| IN
cytoskeleton  ||| S:7799 E:7812 ||| NN
in  ||| S:7812 E:7815 ||| IN
microextensions  ||| S:7815 E:7831 ||| NN
and  ||| S:7831 E:7845 ||| CC
ultramicroextensions  ||| S:7845 E:7866 ||| NN
by  ||| S:7866 E:7869 ||| IN
DOTMAC  ||| S:7869 E:7876 ||| NNP
extraction  ||| S:7876 E:7897 ||| VBD
Fixation  ||| S:7897 E:7906 ||| NNP
with  ||| S:7906 E:7911 ||| IN
formaldehyde  ||| S:7911 E:7924 ||| VBG
followed  ||| S:7924 E:7933 ||| VBN
by  ||| S:7933 E:7936 ||| IN
extraction  ||| S:7936 E:7947 ||| NN
with  ||| S:7947 E:7962 ||| IN
Triton  ||| S:7962 E:7969 ||| NNP
X-100  ||| S:7969 E:7975 ||| NNP
is  ||| S:7975 E:7978 ||| VBZ
a  ||| S:7978 E:7980 ||| DT
fairly  ||| S:7980 E:7987 ||| RB
standard  ||| S:7987 E:7996 ||| JJ
method  ||| S:7996 E:8003 ||| NN
for  ||| S:8003 E:8017 ||| IN
immunofluorescence  ||| S:8017 E:8036 ||| JJ
microscopy  ||| S:8036 E:8047 ||| NN
of  ||| S:8047 E:8050 ||| IN
cells ||| S:8050 E:8055 ||| NNS
,  ||| S:8055 E:8057 ||| ,
but  ||| S:8057 E:8071 ||| CC
microextensions  ||| S:8071 E:8087 ||| NNS
were  ||| S:8087 E:8092 ||| VBD
fragmented  ||| S:8092 E:8103 ||| VBN
and  ||| S:8103 E:8107 ||| CC
sometimes  ||| S:8107 E:8117 ||| RB
even  ||| S:8117 E:8122 ||| RB
lost  ||| S:8122 E:8137 ||| VBN
during  ||| S:8137 E:8144 ||| IN
this  ||| S:8144 E:8149 ||| DT
treatment  ||| S:8149 E:8159 ||| NN
as  ||| S:8159 E:8162 ||| IN
shown  ||| S:8162 E:8168 ||| VBN
in  ||| S:8168 E:8171 ||| IN
Figure  ||| S:8171 E:8178 ||| NNP
2 ||| S:8178 E:8179 ||| CD
,  ||| S:8179 E:8181 ||| ,
A ||| S:8181 E:8182 ||| NNP
, ||| S:8182 E:8183 ||| ,
B ||| S:8183 E:8184 ||| NNP
, ||| S:8184 E:8185 ||| ,
C.  ||| S:8185 E:8188 ||| NNP
an  ||| S:8188 E:8201 ||| DT
alternative  ||| S:8201 E:8213 ||| JJ
method ||| S:8213 E:8219 ||| NN
,  ||| S:8219 E:8221 ||| ,
we  ||| S:8221 E:8224 ||| PRP
extracted  ||| S:8224 E:8234 ||| VBD
cells  ||| S:8234 E:8240 ||| NNS
also  ||| S:8240 E:8245 ||| RB
with  ||| S:8245 E:8250 ||| IN
DOTMAC  ||| S:8250 E:8267 ||| NNP
and  ||| S:8267 E:8271 ||| CC
discovered  ||| S:8271 E:8282 ||| VBN
that  ||| S:8282 E:8287 ||| IN
fixation  ||| S:8287 E:8296 ||| NN
and  ||| S:8296 E:8300 ||| CC
extraction  ||| S:8300 E:8311 ||| NN
with  ||| S:8311 E:8316 ||| IN
1.0  ||| S:8316 E:8320 ||| CD
%  ||| S:8320 E:8332 ||| NN
PFA ||| S:8332 E:8335 ||| NNP
/ ||| S:8335 E:8336 ||| CD
0.5  ||| S:8336 E:8340 ||| CD
%  ||| S:8340 E:8342 ||| NN
DOTMAC  ||| S:8342 E:8349 ||| NN
in  ||| S:8349 E:8352 ||| IN
PBS ||| S:8352 E:8355 ||| NNP
( ||| S:8355 E:8356 ||| -LRB-
+ ||| S:8356 E:8357 ||| NNP
)  ||| S:8357 E:8359 ||| -RRB-
on  ||| S:8359 E:8362 ||| IN
ice  ||| S:8362 E:8366 ||| NN
for  ||| S:8366 E:8370 ||| IN
5  ||| S:8370 E:8372 ||| CD
min ||| S:8372 E:8375 ||| NN
,  ||| S:8375 E:8377 ||| ,
followed  ||| S:8377 E:8386 ||| VBN
by  ||| S:8386 E:8399 ||| IN
fixation  ||| S:8399 E:8408 ||| NN
with  ||| S:8408 E:8413 ||| IN
1.0 ||| S:8413 E:8416 ||| CD
%  ||| S:8416 E:8418 ||| NN
PFA  ||| S:8418 E:8422 ||| NN
in  ||| S:8422 E:8425 ||| IN
PBS  ||| S:8425 E:8429 ||| NNP
on  ||| S:8429 E:8432 ||| IN
ice  ||| S:8432 E:8436 ||| NN
for  ||| S:8436 E:8440 ||| IN
20  ||| S:8440 E:8443 ||| CD
min  ||| S:8443 E:8457 ||| NNS
( ||| S:8457 E:8458 ||| -LRB-
DOTMAC ||| S:8458 E:8464 ||| NNP
/ ||| S:8464 E:8465 ||| NNP
PFA  ||| S:8465 E:8469 ||| NNP
method ||| S:8469 E:8475 ||| NN
) ||| S:8475 E:8476 ||| -RRB-
,  ||| S:8476 E:8478 ||| ,
preserved  ||| S:8478 E:8488 ||| VBN
not  ||| S:8488 E:8492 ||| RB
only  ||| S:8492 E:8497 ||| JJ
micropodia  ||| S:8497 E:8508 ||| NNS
( ||| S:8508 E:8509 ||| -LRB-
white  ||| S:8509 E:8525 ||| JJ
arrow ||| S:8525 E:8530 ||| NN
,  ||| S:8530 E:8532 ||| ,
Figure  ||| S:8532 E:8539 ||| NNP
2 ||| S:8539 E:8540 ||| CD
,  ||| S:8540 E:8542 ||| ,
Eand  ||| S:8542 E:8547 ||| NNP
2F ||| S:8547 E:8549 ||| NNP
) ||| S:8549 E:8550 ||| -RRB-
,  ||| S:8550 E:8552 ||| ,
but  ||| S:8552 E:8556 ||| CC
also  ||| S:8556 E:8561 ||| RB
microvilli  ||| S:8561 E:8572 ||| JJ
( ||| S:8572 E:8573 ||| -LRB-
black  ||| S:8573 E:8589 ||| JJ
arrow ||| S:8589 E:8594 ||| NN
,  ||| S:8594 E:8596 ||| ,
Figure  ||| S:8596 E:8603 ||| NNP
2Eand  ||| S:8603 E:8609 ||| NNP
2F ||| S:8609 E:8611 ||| NNP
) ||| S:8611 E:8612 ||| -RRB-
,  ||| S:8612 E:8614 ||| ,
and  ||| S:8614 E:8618 ||| CC
ultramicroextensions  ||| S:8618 E:8639 ||| NNS
( ||| S:8639 E:8640 ||| -LRB-
white  ||| S:8640 E:8656 ||| JJ
arrowhead ||| S:8656 E:8665 ||| NN
,  ||| S:8665 E:8667 ||| ,
Figure  ||| S:8667 E:8674 ||| NNP
2F ||| S:8674 E:8676 ||| NNP
) ||| S:8676 E:8677 ||| -RRB-
.  ||| S:8677 E:8679 ||| .
This  ||| S:8679 E:8684 ||| DT
treatment  ||| S:8684 E:8694 ||| NN
extracted  ||| S:8694 E:8704 ||| NN
lipids  ||| S:8704 E:8721 ||| NNS
( ||| S:8721 E:8722 ||| -LRB-
data  ||| S:8722 E:8727 ||| NNS
not  ||| S:8727 E:8731 ||| RB
shown ||| S:8731 E:8736 ||| VBN
)  ||| S:8736 E:8738 ||| -RRB-
and  ||| S:8738 E:8742 ||| CC
exposed  ||| S:8742 E:8750 ||| VBN
cytoplasmic  ||| S:8750 E:8762 ||| NNS
filaments  ||| S:8762 E:8772 ||| VBP
giving  ||| S:8772 E:8789 ||| VBG
origin  ||| S:8789 E:8796 ||| NN
to  ||| S:8796 E:8799 ||| TO
ultramicroextensions  ||| S:8799 E:8820 ||| VB
( ||| S:8820 E:8821 ||| -LRB-
Figure  ||| S:8821 E:8828 ||| NNP
2F ||| S:8828 E:8830 ||| NNP
) ||| S:8830 E:8831 ||| -RRB-
.  ||| S:8831 E:8833 ||| .
At  ||| S:8833 E:8836 ||| IN
the  ||| S:8836 E:8840 ||| DT
cell  ||| S:8840 E:8855 ||| NN
edge  ||| S:8855 E:8860 ||| NN
the  ||| S:8860 E:8864 ||| DT
ultramicroextensions  ||| S:8864 E:8885 ||| NNS
are  ||| S:8885 E:8889 ||| VBP
derived  ||| S:8889 E:8897 ||| VBN
from  ||| S:8897 E:8902 ||| IN
a  ||| S:8902 E:8904 ||| DT
deeper  ||| S:8904 E:8921 ||| RBR
cytoskeletal  ||| S:8921 E:8934 ||| JJ
meshwork  ||| S:8934 E:8943 ||| NNS
( ||| S:8943 E:8944 ||| -LRB-
white  ||| S:8944 E:8950 ||| JJ
arrowhead ||| S:8950 E:8959 ||| NN
,  ||| S:8959 E:8961 ||| ,
Figure  ||| S:8961 E:8968 ||| NNP
2F ||| S:8968 E:8970 ||| NNP
)  ||| S:8970 E:8972 ||| -RRB-
rather  ||| S:8972 E:8989 ||| RB
than  ||| S:8989 E:8994 ||| IN
from  ||| S:8994 E:8999 ||| IN
thick  ||| S:8999 E:9005 ||| JJ
cytoskeletal  ||| S:9005 E:9018 ||| JJ
filaments ||| S:9018 E:9027 ||| NN
.  ||| S:9027 E:9039 ||| .
We  ||| S:9039 E:9042 ||| PRP
have  ||| S:9042 E:9047 ||| VBP
performed  ||| S:9047 E:9057 ||| VBN
ultrastructural  ||| S:9057 E:9073 ||| JJ
analysis  ||| S:9073 E:9082 ||| NN
by  ||| S:9082 E:9085 ||| IN
SEM  ||| S:9085 E:9089 ||| NNP
of  ||| S:9089 E:9102 ||| IN
cells  ||| S:9102 E:9108 ||| NNS
fixed  ||| S:9108 E:9114 ||| VBN
and ||| S:9114 E:9117 ||| CC
/ ||| S:9117 E:9118 ||| NNP
or  ||| S:9118 E:9121 ||| CC
extracted  ||| S:9121 E:9131 ||| VBN
by  ||| S:9131 E:9134 ||| IN
the  ||| S:9134 E:9138 ||| DT
methods  ||| S:9138 E:9146 ||| NNS
listed  ||| S:9146 E:9153 ||| VBN
in  ||| S:9153 E:9166 ||| IN
Table  ||| S:9166 E:9172 ||| NNP
1 ||| S:9172 E:9173 ||| CD
.  ||| S:9173 E:9175 ||| .
When  ||| S:9175 E:9180 ||| WRB
the  ||| S:9180 E:9184 ||| DT
cells  ||| S:9184 E:9190 ||| NNS
were  ||| S:9190 E:9195 ||| VBD
treated  ||| S:9195 E:9203 ||| VBN
with  ||| S:9203 E:9208 ||| IN
coagulant  ||| S:9208 E:9228 ||| JJ
fixatives ||| S:9228 E:9237 ||| NN
,  ||| S:9237 E:9239 ||| ,
the  ||| S:9239 E:9243 ||| DT
cytoskeleton  ||| S:9243 E:9256 ||| NN
was  ||| S:9256 E:9260 ||| VBD
apparently  ||| S:9260 E:9271 ||| RB
exposed ||| S:9271 E:9278 ||| VBN
,  ||| S:9278 E:9280 ||| ,
but  ||| S:9280 E:9294 ||| CC
the  ||| S:9294 E:9298 ||| DT
three  ||| S:9298 E:9304 ||| CD
dimensional  ||| S:9304 E:9316 ||| CD
structures  ||| S:9316 E:9327 ||| NNS
at  ||| S:9327 E:9330 ||| IN
the  ||| S:9330 E:9334 ||| DT
edge  ||| S:9334 E:9339 ||| NN
of  ||| S:9339 E:9342 ||| IN
the  ||| S:9342 E:9346 ||| DT
cells  ||| S:9346 E:9362 ||| NNS
were  ||| S:9362 E:9367 ||| VBD
not  ||| S:9367 E:9371 ||| RB
preserved  ||| S:9371 E:9381 ||| VBN
as  ||| S:9381 E:9384 ||| IN
well  ||| S:9384 E:9389 ||| RB
as  ||| S:9389 E:9392 ||| IN
those  ||| S:9392 E:9398 ||| DT
prepared  ||| S:9398 E:9407 ||| VBN
by  ||| S:9407 E:9410 ||| IN
the  ||| S:9410 E:9424 ||| DT
DOTMAC ||| S:9424 E:9430 ||| NNP
/ ||| S:9430 E:9431 ||| NNP
PFA  ||| S:9431 E:9435 ||| NNP
method  ||| S:9435 E:9442 ||| NN
( ||| S:9442 E:9443 ||| -LRB-
data  ||| S:9443 E:9448 ||| NNS
not  ||| S:9448 E:9452 ||| RB
shown ||| S:9452 E:9457 ||| VBN
) ||| S:9457 E:9458 ||| -RRB-
.  ||| S:9458 E:9460 ||| .
When  ||| S:9460 E:9465 ||| WRB
the  ||| S:9465 E:9469 ||| DT
cells  ||| S:9469 E:9475 ||| NNS
were  ||| S:9475 E:9490 ||| VBD
extracted  ||| S:9490 E:9500 ||| VBN
with  ||| S:9500 E:9505 ||| IN
Triton  ||| S:9505 E:9512 ||| NNP
X-100 ||| S:9512 E:9517 ||| NNP
,  ||| S:9517 E:9519 ||| ,
NP-40  ||| S:9519 E:9525 ||| NNP
or  ||| S:9525 E:9528 ||| CC
saponin  ||| S:9528 E:9536 ||| NN
after  ||| S:9536 E:9552 ||| IN
relatively  ||| S:9552 E:9563 ||| RB
weak  ||| S:9563 E:9568 ||| JJ
fixation  ||| S:9568 E:9577 ||| NN
with  ||| S:9577 E:9582 ||| IN
formaldehyde ||| S:9582 E:9594 ||| NN
,  ||| S:9594 E:9596 ||| ,
the  ||| S:9596 E:9610 ||| DT
cytoskeleton  ||| S:9610 E:9623 ||| NN
apparently  ||| S:9623 E:9634 ||| RB
was  ||| S:9634 E:9638 ||| VBD
lost ||| S:9638 E:9642 ||| VBN
,  ||| S:9642 E:9644 ||| ,
fragmented ||| S:9644 E:9654 ||| JJ
,  ||| S:9654 E:9656 ||| ,
or  ||| S:9656 E:9659 ||| CC
scraped  ||| S:9659 E:9677 ||| VBG
off  ||| S:9677 E:9681 ||| RP
depending  ||| S:9681 E:9691 ||| VBG
on  ||| S:9691 E:9694 ||| IN
the  ||| S:9694 E:9698 ||| DT
concentration  ||| S:9698 E:9712 ||| NN
of  ||| S:9712 E:9715 ||| IN
detergents  ||| S:9715 E:9726 ||| NNS
and  ||| S:9726 E:9730 ||| CC
the  ||| S:9730 E:9744 ||| DT
period  ||| S:9744 E:9751 ||| NN
of  ||| S:9751 E:9754 ||| IN
incubation  ||| S:9754 E:9765 ||| NNS
( ||| S:9765 E:9766 ||| -LRB-
Table  ||| S:9766 E:9772 ||| NNP
2 ||| S:9772 E:9773 ||| CD
) ||| S:9773 E:9774 ||| -RRB-
.  ||| S:9774 E:9776 ||| .
Too  ||| S:9776 E:9780 ||| RB
high  ||| S:9780 E:9785 ||| JJ
a  ||| S:9785 E:9787 ||| DT
concentration  ||| S:9787 E:9811 ||| NN
of  ||| S:9811 E:9814 ||| IN
glutaraldehyde  ||| S:9814 E:9829 ||| NN
or  ||| S:9829 E:9832 ||| CC
incubation  ||| S:9832 E:9843 ||| NN
for  ||| S:9843 E:9847 ||| IN
extended  ||| S:9847 E:9856 ||| JJ
period  ||| S:9856 E:9863 ||| NN
of  ||| S:9863 E:9876 ||| IN
time  ||| S:9876 E:9881 ||| NN
in  ||| S:9881 E:9884 ||| IN
formaldehyde ||| S:9884 E:9896 ||| NN
,  ||| S:9896 E:9898 ||| ,
on  ||| S:9898 E:9901 ||| IN
the  ||| S:9901 E:9905 ||| DT
other  ||| S:9905 E:9911 ||| JJ
hand ||| S:9911 E:9915 ||| NN
,  ||| S:9915 E:9917 ||| ,
did  ||| S:9917 E:9921 ||| VBD
not  ||| S:9921 E:9925 ||| RB
allow  ||| S:9925 E:9931 ||| VB
to  ||| S:9931 E:9944 ||| TO
expose  ||| S:9944 E:9951 ||| VB
the  ||| S:9951 E:9955 ||| DT
cytoskeleton  ||| S:9955 E:9968 ||| NN
( ||| S:9968 E:9969 ||| -LRB-
data  ||| S:9969 E:9974 ||| NNS
not  ||| S:9974 E:9978 ||| RB
shown ||| S:9978 E:9983 ||| VBN
) ||| S:9983 E:9984 ||| -RRB-
.  ||| S:9984 E:10014 ||| .
Comparison  ||| S:10014 E:10025 ||| NN
of  ||| S:10025 E:10028 ||| IN
different  ||| S:10028 E:10038 ||| JJ
fixation ||| S:10038 E:10046 ||| NNS
/ ||| S:10046 E:10047 ||| VBP
extraction  ||| S:10047 E:10058 ||| JJ
methods  ||| S:10058 E:10076 ||| NNS
for  ||| S:10076 E:10080 ||| IN
preservation  ||| S:10080 E:10093 ||| NN
and  ||| S:10093 E:10097 ||| CC
fluorescence  ||| S:10097 E:10110 ||| JJ
labeling  ||| S:10110 E:10119 ||| NN
of  ||| S:10119 E:10132 ||| IN
microextensions  ||| S:10132 E:10158 ||| VBG
We  ||| S:10158 E:10161 ||| PRP
also  ||| S:10161 E:10166 ||| RB
compared  ||| S:10166 E:10175 ||| VBN
the  ||| S:10175 E:10179 ||| DT
different  ||| S:10179 E:10189 ||| JJ
fixation  ||| S:10189 E:10198 ||| NN
and  ||| S:10198 E:10202 ||| CC
extraction  ||| S:10202 E:10223 ||| JJ
procedures  ||| S:10223 E:10234 ||| NNS
listed  ||| S:10234 E:10241 ||| VBN
in  ||| S:10241 E:10244 ||| IN
Table  ||| S:10244 E:10250 ||| NNP
1  ||| S:10250 E:10252 ||| CD
with  ||| S:10252 E:10257 ||| IN
respect  ||| S:10257 E:10265 ||| NN
to  ||| S:10265 E:10268 ||| TO
fluorescence  ||| S:10268 E:10291 ||| VB
intensity  ||| S:10291 E:10301 ||| NN
and  ||| S:10301 E:10305 ||| CC
labeling  ||| S:10305 E:10314 ||| VBG
of  ||| S:10314 E:10317 ||| IN
actin  ||| S:10317 E:10323 ||| JJ
stress  ||| S:10323 E:10330 ||| NN
fibers  ||| S:10330 E:10337 ||| NNS
and  ||| S:10337 E:10351 ||| CC
microtubules ||| S:10351 E:10363 ||| NN
,  ||| S:10363 E:10365 ||| ,
and  ||| S:10365 E:10369 ||| CC
with  ||| S:10369 E:10374 ||| IN
respect  ||| S:10374 E:10382 ||| NN
to  ||| S:10382 E:10385 ||| TO
morphological  ||| S:10385 E:10409 ||| VB
preservation  ||| S:10409 E:10422 ||| VBN
of  ||| S:10422 E:10425 ||| IN
cells  ||| S:10425 E:10431 ||| NNS
and  ||| S:10431 E:10435 ||| CC
microextensions  ||| S:10435 E:10451 ||| NNS
( ||| S:10451 E:10452 ||| -LRB-
Table  ||| S:10452 E:10458 ||| NNP
2 ||| S:10458 E:10459 ||| CD
) ||| S:10459 E:10460 ||| -RRB-
.  ||| S:10460 E:10462 ||| .
The  ||| S:10462 E:10476 ||| DT
latter  ||| S:10476 E:10483 ||| NN
was  ||| S:10483 E:10487 ||| VBD
also  ||| S:10487 E:10492 ||| RB
assessed  ||| S:10492 E:10501 ||| VBN
from  ||| S:10501 E:10506 ||| IN
SEM  ||| S:10506 E:10510 ||| NNP
micrographs  ||| S:10510 E:10522 ||| NN
before  ||| S:10522 E:10529 ||| IN
and  ||| S:10529 E:10543 ||| CC
after  ||| S:10543 E:10549 ||| IN
preparation  ||| S:10549 E:10561 ||| NN
for  ||| S:10561 E:10565 ||| IN
fluorescence  ||| S:10565 E:10578 ||| JJ
microscopy  ||| S:10578 E:10589 ||| NN
and  ||| S:10589 E:10593 ||| CC
these  ||| S:10593 E:10609 ||| DT
results  ||| S:10609 E:10617 ||| NNS
are  ||| S:10617 E:10621 ||| VBP
summarized  ||| S:10621 E:10632 ||| VBN
in  ||| S:10632 E:10635 ||| IN
Table  ||| S:10635 E:10641 ||| NNP
2  ||| S:10641 E:10643 ||| CD
as  ||| S:10643 E:10646 ||| IN
well ||| S:10646 E:10650 ||| RB
.  ||| S:10650 E:10662 ||| .
Staining  ||| S:10662 E:10671 ||| NNP
of  ||| S:10671 E:10674 ||| IN
actin  ||| S:10674 E:10680 ||| NN
and  ||| S:10680 E:10684 ||| CC
tubulin  ||| S:10684 E:10692 ||| JJ
filaments  ||| S:10692 E:10702 ||| NNS
differed  ||| S:10702 E:10721 ||| VBP
depending  ||| S:10721 E:10731 ||| VBG
on  ||| S:10731 E:10734 ||| IN
the  ||| S:10734 E:10738 ||| DT
probe  ||| S:10738 E:10744 ||| NN
and  ||| S:10744 E:10748 ||| CC
on  ||| S:10748 E:10751 ||| IN
the  ||| S:10751 E:10755 ||| DT
fixative ||| S:10755 E:10763 ||| NN
.  ||| S:10763 E:10765 ||| .
Among  ||| S:10765 E:10771 ||| IN
the  ||| S:10771 E:10785 ||| DT
coagulant  ||| S:10785 E:10795 ||| JJ
fixatives ||| S:10795 E:10804 ||| NN
,  ||| S:10804 E:10806 ||| ,
acetone  ||| S:10806 E:10814 ||| VBD
produced  ||| S:10814 E:10823 ||| VBN
the  ||| S:10823 E:10827 ||| DT
best  ||| S:10827 E:10832 ||| JJS
results  ||| S:10832 E:10850 ||| NNS
with  ||| S:10850 E:10855 ||| IN
respect  ||| S:10855 E:10863 ||| NN
to  ||| S:10863 E:10866 ||| TO
preservation  ||| S:10866 E:10879 ||| VB
of  ||| S:10879 E:10882 ||| IN
microextensions ||| S:10882 E:10897 ||| NN
,  ||| S:10897 E:10899 ||| ,
staining  ||| S:10899 E:10918 ||| VBG
of  ||| S:10918 E:10921 ||| IN
actin  ||| S:10921 E:10927 ||| NN
with  ||| S:10927 E:10932 ||| IN
either  ||| S:10932 E:10939 ||| DT
phalloidin  ||| S:10939 E:10950 ||| NN
or  ||| S:10950 E:10953 ||| CC
with  ||| S:10953 E:10958 ||| IN
monoclonal  ||| S:10958 E:10979 ||| JJ
β-actin  ||| S:10979 E:10987 ||| JJ
antibodies ||| S:10987 E:10997 ||| NNS
,  ||| S:10997 E:10999 ||| ,
and  ||| S:10999 E:11003 ||| CC
staining  ||| S:11003 E:11012 ||| NN
of  ||| S:11012 E:11015 ||| IN
microtubules  ||| S:11015 E:11028 ||| NN
with  ||| S:11028 E:11033 ||| IN
a  ||| S:11033 E:11045 ||| DT
monoclonal  ||| S:11045 E:11056 ||| JJ
anti-β-tubulin  ||| S:11056 E:11071 ||| JJ
reagent ||| S:11071 E:11078 ||| NN
.  ||| S:11078 E:11080 ||| .
After  ||| S:11080 E:11086 ||| IN
methanol  ||| S:11086 E:11095 ||| NN
or  ||| S:11095 E:11108 ||| CC
ethanol  ||| S:11108 E:11116 ||| JJ
fixation ||| S:11116 E:11124 ||| NN
,  ||| S:11124 E:11126 ||| ,
some  ||| S:11126 E:11131 ||| DT
cells  ||| S:11131 E:11137 ||| NNS
were  ||| S:11137 E:11142 ||| VBD
partially  ||| S:11142 E:11152 ||| RB
detached  ||| S:11152 E:11161 ||| VBN
and  ||| S:11161 E:11175 ||| CC
changed  ||| S:11175 E:11183 ||| VBD
their  ||| S:11183 E:11189 ||| PRP$
shape ||| S:11189 E:11194 ||| NN
,  ||| S:11194 E:11196 ||| ,
but  ||| S:11196 E:11200 ||| CC
this  ||| S:11200 E:11205 ||| DT
did  ||| S:11205 E:11209 ||| VBD
not  ||| S:11209 E:11213 ||| RB
occur  ||| S:11213 E:11219 ||| VB
with  ||| S:11219 E:11224 ||| IN
other  ||| S:11224 E:11240 ||| JJ
coagulant  ||| S:11240 E:11250 ||| JJ
fixatives ||| S:11250 E:11259 ||| NN
.  ||| S:11259 E:11261 ||| .
Acetone  ||| S:11261 E:11269 ||| NNP
also  ||| S:11269 E:11274 ||| RB
provided  ||| S:11274 E:11283 ||| VBN
good  ||| S:11283 E:11298 ||| JJ
preservation  ||| S:11298 E:11311 ||| NN
of  ||| S:11311 E:11314 ||| IN
microextensions  ||| S:11314 E:11330 ||| VBG
even  ||| S:11330 E:11335 ||| RB
after  ||| S:11335 E:11341 ||| IN
preparing  ||| S:11341 E:11351 ||| VBG
the  ||| S:11351 E:11365 ||| DT
cells  ||| S:11365 E:11371 ||| NNS
for  ||| S:11371 E:11375 ||| IN
immunolabeling ||| S:11375 E:11389 ||| NN
,  ||| S:11389 E:11391 ||| ,
whereas  ||| S:11391 E:11399 ||| IN
some  ||| S:11399 E:11404 ||| DT
of  ||| S:11404 E:11407 ||| IN
the  ||| S:11407 E:11421 ||| DT
microextensions  ||| S:11421 E:11437 ||| NN
were  ||| S:11437 E:11442 ||| VBD
lost ||| S:11442 E:11446 ||| VBN
,  ||| S:11446 E:11448 ||| ,
when  ||| S:11448 E:11453 ||| WRB
cells  ||| S:11453 E:11459 ||| NNS
were  ||| S:11459 E:11464 ||| VBD
fixed  ||| S:11464 E:11470 ||| VBN
with  ||| S:11470 E:11485 ||| IN
other  ||| S:11485 E:11491 ||| JJ
coagulant  ||| S:11491 E:11501 ||| JJ
fixatives  ||| S:11501 E:11511 ||| NNS
( ||| S:11511 E:11512 ||| -LRB-
Table  ||| S:11512 E:11518 ||| NNP
2 ||| S:11518 E:11519 ||| CD
) ||| S:11519 E:11520 ||| -RRB-
.  ||| S:11520 E:11532 ||| .
Fixation  ||| S:11532 E:11541 ||| NNP
with  ||| S:11541 E:11546 ||| IN
chemical  ||| S:11546 E:11555 ||| JJ
crosslinkers ||| S:11555 E:11567 ||| NN
,  ||| S:11567 E:11569 ||| ,
followed  ||| S:11569 E:11578 ||| VBN
by  ||| S:11578 E:11591 ||| IN
extraction  ||| S:11591 E:11602 ||| NN
with  ||| S:11602 E:11607 ||| IN
detergents  ||| S:11607 E:11618 ||| NNS
or  ||| S:11618 E:11621 ||| CC
organic  ||| S:11621 E:11629 ||| JJ
solvents ||| S:11629 E:11637 ||| NNS
,  ||| S:11637 E:11639 ||| ,
are  ||| S:11639 E:11653 ||| VBP
standard  ||| S:11653 E:11662 ||| JJ
procedures  ||| S:11662 E:11673 ||| NNS
for  ||| S:11673 E:11677 ||| IN
preparing  ||| S:11677 E:11687 ||| VBG
cells  ||| S:11687 E:11693 ||| NNS
for  ||| S:11693 E:11707 ||| IN
immunofluorescence ||| S:11707 E:11725 ||| NN
.  ||| S:11725 E:11727 ||| .
First ||| S:11727 E:11732 ||| NNP
,  ||| S:11732 E:11734 ||| ,
we  ||| S:11734 E:11737 ||| PRP
investigated  ||| S:11737 E:11750 ||| VBD
effects  ||| S:11750 E:11758 ||| NNS
on  ||| S:11758 E:11761 ||| IN
the  ||| S:11761 E:11775 ||| DT
preservation  ||| S:11775 E:11788 ||| NN
of  ||| S:11788 E:11791 ||| IN
microextensions  ||| S:11791 E:11807 ||| NN
by  ||| S:11807 E:11810 ||| IN
variations  ||| S:11810 E:11821 ||| NNS
in  ||| S:11821 E:11834 ||| IN
detergent  ||| S:11834 E:11844 ||| NN
concentration  ||| S:11844 E:11858 ||| NN
and  ||| S:11858 E:11862 ||| CC
time  ||| S:11862 E:11867 ||| NN
of  ||| S:11867 E:11870 ||| IN
incubation  ||| S:11870 E:11881 ||| NN
with  ||| S:11881 E:11896 ||| IN
formaldehyde ||| S:11896 E:11908 ||| NN
.  ||| S:11908 E:11910 ||| .
As  ||| S:11910 E:11913 ||| IN
summarized  ||| S:11913 E:11924 ||| NN
in  ||| S:11924 E:11927 ||| IN
Table  ||| S:11927 E:11933 ||| NNP
2 ||| S:11933 E:11934 ||| CD
,  ||| S:11934 E:11936 ||| ,
with  ||| S:11936 E:11941 ||| IN
shorter  ||| S:11941 E:11949 ||| JJR
time  ||| S:11949 E:11964 ||| NN
periods  ||| S:11964 E:11972 ||| NNS
of  ||| S:11972 E:11975 ||| IN
fixation  ||| S:11975 E:11984 ||| NN
and  ||| S:11984 E:11988 ||| CC
with  ||| S:11988 E:11993 ||| IN
higher  ||| S:11993 E:12000 ||| JJR
detergent  ||| S:12000 E:12020 ||| NN
concentrations  ||| S:12020 E:12035 ||| NNS
more  ||| S:12035 E:12040 ||| JJR
cells  ||| S:12040 E:12046 ||| NNS
lost  ||| S:12046 E:12051 ||| VBD
microextensions ||| S:12051 E:12066 ||| VBN
.  ||| S:12066 E:12068 ||| .
For  ||| S:12068 E:12082 ||| IN
example ||| S:12082 E:12089 ||| NN
,  ||| S:12089 E:12091 ||| ,
when  ||| S:12091 E:12096 ||| WRB
cells  ||| S:12096 E:12102 ||| NNS
were  ||| S:12102 E:12107 ||| VBD
fixed  ||| S:12107 E:12113 ||| VBN
with  ||| S:12113 E:12118 ||| IN
3.7 ||| S:12118 E:12121 ||| CD
%  ||| S:12121 E:12123 ||| NN
FA  ||| S:12123 E:12126 ||| NN
for  ||| S:12126 E:12130 ||| IN
20  ||| S:12130 E:12133 ||| CD
min  ||| S:12133 E:12147 ||| NNS
and  ||| S:12147 E:12151 ||| CC
extracted  ||| S:12151 E:12161 ||| VBN
with  ||| S:12161 E:12166 ||| IN
0.2 ||| S:12166 E:12169 ||| CD
%  ||| S:12169 E:12171 ||| NN
TX100  ||| S:12171 E:12177 ||| NN
for  ||| S:12177 E:12181 ||| IN
5  ||| S:12181 E:12183 ||| CD
min  ||| S:12183 E:12187 ||| NNS
( ||| S:12187 E:12188 ||| -LRB-
Table  ||| S:12188 E:12194 ||| NNP
1 ||| S:12194 E:12195 ||| CD
) ||| S:12195 E:12196 ||| -RRB-
,  ||| S:12196 E:12198 ||| ,
stress  ||| S:12198 E:12215 ||| NN
fibers  ||| S:12215 E:12222 ||| NNS
were  ||| S:12222 E:12227 ||| VBD
stained  ||| S:12227 E:12235 ||| VBN
well  ||| S:12235 E:12240 ||| RB
with  ||| S:12240 E:12245 ||| IN
phalloidin ||| S:12245 E:12255 ||| NN
,  ||| S:12255 E:12257 ||| ,
but  ||| S:12257 E:12271 ||| CC
microextensions  ||| S:12271 E:12287 ||| NNS
were  ||| S:12287 E:12292 ||| VBD
lost  ||| S:12292 E:12297 ||| VBN
( ||| S:12297 E:12298 ||| -LRB-
Figure  ||| S:12298 E:12305 ||| NNP
3Aand  ||| S:12305 E:12311 ||| NNP
3B ||| S:12311 E:12313 ||| NNP
) ||| S:12313 E:12314 ||| -RRB-
.  ||| S:12314 E:12316 ||| .
The  ||| S:12316 E:12320 ||| DT
SEM  ||| S:12320 E:12334 ||| NNP
observation  ||| S:12334 E:12346 ||| NN
before  ||| S:12346 E:12353 ||| IN
and  ||| S:12353 E:12357 ||| CC
after  ||| S:12357 E:12363 ||| IN
preparation  ||| S:12363 E:12375 ||| NN
for  ||| S:12375 E:12379 ||| IN
fluorescence  ||| S:12379 E:12402 ||| JJ
microscopy  ||| S:12402 E:12413 ||| NNS
( ||| S:12413 E:12414 ||| -LRB-
washing  ||| S:12414 E:12422 ||| NN
and  ||| S:12422 E:12426 ||| CC
incubation  ||| S:12426 E:12437 ||| NN
with  ||| S:12437 E:12442 ||| IN
probes ||| S:12442 E:12448 ||| NNS
)  ||| S:12448 E:12450 ||| -RRB-
indicated  ||| S:12450 E:12470 ||| VBD
that  ||| S:12470 E:12475 ||| DT
microextensions  ||| S:12475 E:12491 ||| NN
were  ||| S:12491 E:12496 ||| VBD
lost  ||| S:12496 E:12501 ||| VBN
during  ||| S:12501 E:12508 ||| IN
these  ||| S:12508 E:12514 ||| DT
steps  ||| S:12514 E:12520 ||| NNS
of  ||| S:12520 E:12523 ||| IN
the  ||| S:12523 E:12537 ||| DT
procedure ||| S:12537 E:12546 ||| NN
.  ||| S:12546 E:12548 ||| .
On  ||| S:12548 E:12551 ||| IN
the  ||| S:12551 E:12555 ||| DT
other  ||| S:12555 E:12561 ||| JJ
hand ||| S:12561 E:12565 ||| NN
,  ||| S:12565 E:12567 ||| ,
microextensions  ||| S:12567 E:12583 ||| VBG
of  ||| S:12583 E:12586 ||| IN
cells  ||| S:12586 E:12602 ||| NNS
prefixed  ||| S:12602 E:12611 ||| VBN
with  ||| S:12611 E:12616 ||| IN
glutaraldehyde  ||| S:12616 E:12631 ||| NN
or  ||| S:12631 E:12634 ||| CC
DSP  ||| S:12634 E:12638 ||| NNP
prior  ||| S:12638 E:12644 ||| RB
to  ||| S:12644 E:12647 ||| TO
extraction  ||| S:12647 E:12668 ||| NNS
were  ||| S:12668 E:12673 ||| VBD
very  ||| S:12673 E:12678 ||| RB
well  ||| S:12678 E:12683 ||| RB
preserved  ||| S:12683 E:12693 ||| VBN
indeed  ||| S:12693 E:12700 ||| RB
( ||| S:12700 E:12701 ||| -LRB-
Figure  ||| S:12701 E:12708 ||| NNP
3Eand  ||| S:12708 E:12714 ||| NNP
3I ||| S:12714 E:12716 ||| NNP
) ||| S:12716 E:12717 ||| -RRB-
.  ||| S:12717 E:12729 ||| .
However ||| S:12729 E:12736 ||| RB
,  ||| S:12736 E:12738 ||| ,
the  ||| S:12738 E:12742 ||| DT
cytoskeleton  ||| S:12742 E:12755 ||| NN
of  ||| S:12755 E:12758 ||| IN
glutaraldehyde-fixed  ||| S:12758 E:12779 ||| JJ
cells  ||| S:12779 E:12795 ||| NNS
could  ||| S:12795 E:12801 ||| MD
not  ||| S:12801 E:12805 ||| RB
be  ||| S:12805 E:12808 ||| VB
exposed  ||| S:12808 E:12816 ||| VBN
by  ||| S:12816 E:12819 ||| IN
the  ||| S:12819 E:12823 ||| DT
detergent  ||| S:12823 E:12833 ||| NN
and  ||| S:12833 E:12837 ||| CC
some  ||| S:12837 E:12842 ||| DT
structures  ||| S:12842 E:12863 ||| NNS
apparently  ||| S:12863 E:12874 ||| RB
were  ||| S:12874 E:12879 ||| VBD
lost  ||| S:12879 E:12884 ||| VBN
in  ||| S:12884 E:12887 ||| IN
DSP-Tsb-fixed  ||| S:12887 E:12901 ||| JJ
cells  ||| S:12901 E:12907 ||| NNS
when  ||| S:12907 E:12912 ||| WRB
analysed  ||| S:12912 E:12931 ||| NNS
by  ||| S:12931 E:12934 ||| IN
SEM  ||| S:12934 E:12938 ||| NNP
( ||| S:12938 E:12939 ||| -LRB-
data  ||| S:12939 E:12944 ||| NNS
not  ||| S:12944 E:12948 ||| RB
shown ||| S:12948 E:12953 ||| VBN
) ||| S:12953 E:12954 ||| -RRB-
.  ||| S:12954 E:12956 ||| .
Quick  ||| S:12956 E:12962 ||| JJ
extraction  ||| S:12962 E:12973 ||| NN
with  ||| S:12973 E:12978 ||| IN
0.2 ||| S:12978 E:12981 ||| CD
%  ||| S:12981 E:12993 ||| NN
Triton  ||| S:12993 E:13000 ||| NNP
X-100  ||| S:13000 E:13006 ||| NNP
in  ||| S:13006 E:13009 ||| IN
MTSB  ||| S:13009 E:13014 ||| NNP
( ||| S:13014 E:13015 ||| -LRB-
30  ||| S:13015 E:13018 ||| CD
seconds ||| S:13018 E:13025 ||| NNS
,  ||| S:13025 E:13027 ||| ,
2  ||| S:13027 E:13029 ||| CD
times ||| S:13029 E:13034 ||| NNS
) ||| S:13034 E:13035 ||| -RRB-
,  ||| S:13035 E:13037 ||| ,
followed  ||| S:13037 E:13046 ||| VBN
by  ||| S:13046 E:13059 ||| IN
fixation  ||| S:13059 E:13068 ||| NN
with  ||| S:13068 E:13073 ||| IN
1 ||| S:13073 E:13074 ||| CD
%  ||| S:13074 E:13076 ||| NN
glutaraldehyde  ||| S:13076 E:13091 ||| VBZ
also  ||| S:13091 E:13096 ||| RB
preserved  ||| S:13096 E:13116 ||| VBN
microextensions  ||| S:13116 E:13132 ||| VBN
well  ||| S:13132 E:13137 ||| RB
indicating  ||| S:13137 E:13148 ||| VBG
that  ||| S:13148 E:13153 ||| DT
fragmentation  ||| S:13153 E:13167 ||| NN
or  ||| S:13167 E:13180 ||| CC
removal  ||| S:13180 E:13188 ||| NN
of  ||| S:13188 E:13191 ||| IN
microextensions  ||| S:13191 E:13207 ||| NN
by  ||| S:13207 E:13210 ||| IN
extraction  ||| S:13210 E:13221 ||| NN
with  ||| S:13221 E:13226 ||| IN
0.2 ||| S:13226 E:13229 ||| CD
%  ||| S:13229 E:13231 ||| NN
Triton  ||| S:13231 E:13248 ||| NNP
X-100  ||| S:13248 E:13254 ||| NNP
does  ||| S:13254 E:13259 ||| VBZ
not  ||| S:13259 E:13263 ||| RB
occur  ||| S:13263 E:13269 ||| VB
within  ||| S:13269 E:13276 ||| IN
1  ||| S:13276 E:13278 ||| CD
min ||| S:13278 E:13281 ||| NNS
.  ||| S:13281 E:13283 ||| .
The  ||| S:13283 E:13287 ||| DT
DOTMAC ||| S:13287 E:13293 ||| NNP
/ ||| S:13293 E:13294 ||| NNP
PFA  ||| S:13294 E:13298 ||| NNP
method  ||| S:13298 E:13315 ||| NN
provided  ||| S:13315 E:13324 ||| VBD
excellent  ||| S:13324 E:13334 ||| JJ
morphological  ||| S:13334 E:13348 ||| JJ
preservation  ||| S:13348 E:13361 ||| NN
and  ||| S:13361 E:13375 ||| CC
immunolabeling  ||| S:13375 E:13390 ||| NN
with  ||| S:13390 E:13395 ||| IN
high  ||| S:13395 E:13400 ||| JJ
fluorescence  ||| S:13400 E:13413 ||| JJ
intensity  ||| S:13413 E:13423 ||| NN
of  ||| S:13423 E:13426 ||| IN
actin  ||| S:13426 E:13442 ||| JJ
stress  ||| S:13442 E:13449 ||| NN
fibers  ||| S:13449 E:13456 ||| NNS
and  ||| S:13456 E:13460 ||| CC
microextensions  ||| S:13460 E:13476 ||| NNS
( ||| S:13476 E:13477 ||| -LRB-
Figure  ||| S:13477 E:13484 ||| NNP
3Qand  ||| S:13484 E:13490 ||| NNP
3S ||| S:13490 E:13492 ||| NNP
) ||| S:13492 E:13493 ||| -RRB-
.  ||| S:13493 E:13505 ||| .
Although  ||| S:13505 E:13514 ||| IN
phalloidin  ||| S:13514 E:13525 ||| JJ
staining  ||| S:13525 E:13534 ||| NN
and  ||| S:13534 E:13538 ||| CC
immunolabeling  ||| S:13538 E:13553 ||| NN
of  ||| S:13553 E:13566 ||| IN
tubulin  ||| S:13566 E:13574 ||| NN
were  ||| S:13574 E:13579 ||| VBD
poor  ||| S:13579 E:13584 ||| JJ
in  ||| S:13584 E:13587 ||| IN
cells  ||| S:13587 E:13593 ||| NNS
prepared  ||| S:13593 E:13602 ||| VBN
by  ||| S:13602 E:13605 ||| IN
the  ||| S:13605 E:13609 ||| DT
DOTMAC ||| S:13609 E:13615 ||| NNP
/ ||| S:13615 E:13616 ||| NNP
PFA  ||| S:13616 E:13630 ||| NNP
method  ||| S:13630 E:13637 ||| NN
( ||| S:13637 E:13638 ||| -LRB-
Figure  ||| S:13638 E:13645 ||| NNP
3Rand  ||| S:13645 E:13651 ||| NNP
3T ||| S:13651 E:13653 ||| NNP
) ||| S:13653 E:13654 ||| -RRB-
,  ||| S:13654 E:13656 ||| ,
this  ||| S:13656 E:13661 ||| DT
method  ||| S:13661 E:13668 ||| NN
provided  ||| S:13668 E:13677 ||| VBD
the  ||| S:13677 E:13681 ||| DT
widest  ||| S:13681 E:13698 ||| JJS
spectrum  ||| S:13698 E:13707 ||| NN
of  ||| S:13707 E:13710 ||| IN
reactivity  ||| S:13710 E:13721 ||| NN
with  ||| S:13721 E:13726 ||| IN
the  ||| S:13726 E:13730 ||| DT
probes  ||| S:13730 E:13737 ||| NNS
investigated  ||| S:13737 E:13750 ||| VBD
here  ||| S:13750 E:13765 ||| RB
( ||| S:13765 E:13766 ||| -LRB-
Figure  ||| S:13766 E:13773 ||| NNP
3and  ||| S:13773 E:13778 ||| NNP
Table  ||| S:13778 E:13784 ||| NNP
1 ||| S:13784 E:13785 ||| CD
) ||| S:13785 E:13786 ||| -RRB-
.  ||| S:13786 E:13788 ||| .
The  ||| S:13788 E:13792 ||| DT
monoclonal  ||| S:13792 E:13803 ||| JJ
antibody  ||| S:13803 E:13812 ||| NN
reagent  ||| S:13812 E:13830 ||| VBZ
specific  ||| S:13830 E:13839 ||| JJ
for  ||| S:13839 E:13843 ||| IN
β-actin  ||| S:13843 E:13851 ||| NNP
worked  ||| S:13851 E:13858 ||| VBD
only  ||| S:13858 E:13863 ||| RB
in  ||| S:13863 E:13866 ||| IN
TCA  ||| S:13866 E:13870 ||| NNP
or  ||| S:13870 E:13883 ||| CC
DOTMAC ||| S:13883 E:13889 ||| NNP
/ ||| S:13889 E:13890 ||| NNP
PFA-treated  ||| S:13890 E:13902 ||| JJ
cells  ||| S:13902 E:13908 ||| NNS
( ||| S:13908 E:13909 ||| -LRB-
Figure  ||| S:13909 E:13916 ||| NNP
3Oand  ||| S:13916 E:13922 ||| NNP
3S ||| S:13922 E:13924 ||| NNP
) ||| S:13924 E:13925 ||| -RRB-
.  ||| S:13925 E:13937 ||| .
Next ||| S:13937 E:13941 ||| JJ
,  ||| S:13941 E:13943 ||| ,
we  ||| S:13943 E:13946 ||| PRP
compared  ||| S:13946 E:13955 ||| VBD
the  ||| S:13955 E:13959 ||| DT
staining  ||| S:13959 E:13968 ||| JJ
patterns  ||| S:13968 E:13977 ||| NNS
of  ||| S:13977 E:13980 ||| IN
two  ||| S:13980 E:13994 ||| CD
well-characterized  ||| S:13994 E:14013 ||| JJ
cytoskeletal  ||| S:14013 E:14026 ||| JJ
proteins ||| S:14026 E:14034 ||| NNS
,  ||| S:14034 E:14036 ||| ,
vinculin  ||| S:14036 E:14045 ||| NN
and  ||| S:14045 E:14059 ||| CC
moesin ||| S:14059 E:14065 ||| NN
,  ||| S:14065 E:14067 ||| ,
in  ||| S:14067 E:14070 ||| IN
cells  ||| S:14070 E:14076 ||| NNS
prepared  ||| S:14076 E:14085 ||| VBN
by  ||| S:14085 E:14088 ||| IN
DOTMAC ||| S:14088 E:14094 ||| NNP
/ ||| S:14094 E:14095 ||| NNP
PFA  ||| S:14095 E:14099 ||| NNP
and  ||| S:14099 E:14103 ||| CC
other  ||| S:14103 E:14119 ||| JJ
conventional  ||| S:14119 E:14132 ||| JJ
fixation  ||| S:14132 E:14141 ||| NN
methods  ||| S:14141 E:14149 ||| NNS
( ||| S:14149 E:14150 ||| -LRB-
Figure  ||| S:14150 E:14157 ||| NNP
4 ||| S:14157 E:14158 ||| CD
) ||| S:14158 E:14159 ||| -RRB-
.  ||| S:14159 E:14161 ||| .
As  ||| S:14161 E:14164 ||| IN
expected.  ||| S:14164 E:14184 ||| NNP
vinculin  ||| S:14184 E:14193 ||| VBD
localized  ||| S:14193 E:14203 ||| VBN
at  ||| S:14203 E:14206 ||| IN
focal  ||| S:14206 E:14212 ||| JJ
contacts  ||| S:14212 E:14221 ||| NNS
in  ||| S:14221 E:14224 ||| IN
cells  ||| S:14224 E:14230 ||| NNS
prepared  ||| S:14230 E:14239 ||| VBN
by  ||| S:14239 E:14252 ||| IN
either  ||| S:14252 E:14259 ||| DT
PFA ||| S:14259 E:14262 ||| NNP
/ ||| S:14262 E:14263 ||| NNP
Triton  ||| S:14263 E:14270 ||| NNP
X-100  ||| S:14270 E:14276 ||| NNP
or  ||| S:14276 E:14279 ||| CC
by  ||| S:14279 E:14282 ||| IN
DOTMAC ||| S:14282 E:14288 ||| NNP
/ ||| S:14288 E:14289 ||| NNP
PFA  ||| S:14289 E:14293 ||| NNP
( ||| S:14293 E:14294 ||| -LRB-
Figure  ||| S:14294 E:14301 ||| NNP
4 ||| S:14301 E:14302 ||| CD
,  ||| S:14302 E:14304 ||| ,
B ||| S:14304 E:14305 ||| NNP
,  ||| S:14305 E:14307 ||| ,
J ||| S:14307 E:14308 ||| NNP
,  ||| S:14308 E:14320 ||| ,
and  ||| S:14320 E:14324 ||| CC
4M ||| S:14324 E:14326 ||| CD
) ||| S:14326 E:14327 ||| -RRB-
.  ||| S:14327 E:14329 ||| .
Moesin  ||| S:14329 E:14336 ||| JJ
staining ||| S:14336 E:14344 ||| NN
,  ||| S:14344 E:14346 ||| ,
on  ||| S:14346 E:14349 ||| IN
the  ||| S:14349 E:14353 ||| DT
other  ||| S:14353 E:14359 ||| JJ
hand ||| S:14359 E:14363 ||| NN
,  ||| S:14363 E:14365 ||| ,
was  ||| S:14365 E:14379 ||| VBD
primarily  ||| S:14379 E:14389 ||| RB
at  ||| S:14389 E:14392 ||| IN
the  ||| S:14392 E:14396 ||| DT
edge  ||| S:14396 E:14401 ||| NN
of  ||| S:14401 E:14404 ||| IN
cells  ||| S:14404 E:14410 ||| NNS
and  ||| S:14410 E:14414 ||| CC
in  ||| S:14414 E:14417 ||| IN
microextensions ||| S:14417 E:14432 ||| NN
,  ||| S:14432 E:14444 ||| ,
when  ||| S:14444 E:14449 ||| WRB
cells  ||| S:14449 E:14455 ||| NNS
were  ||| S:14455 E:14460 ||| VBD
fixed  ||| S:14460 E:14466 ||| VBN
with  ||| S:14466 E:14471 ||| IN
TCA  ||| S:14471 E:14475 ||| NNP
or  ||| S:14475 E:14478 ||| CC
DOTMAC ||| S:14478 E:14484 ||| NNP
/ ||| S:14484 E:14485 ||| NNP
PFA  ||| S:14485 E:14489 ||| NNP
( ||| S:14489 E:14490 ||| -LRB-
Figure  ||| S:14490 E:14507 ||| NNP
4Gand  ||| S:14507 E:14513 ||| NNP
4K ||| S:14513 E:14515 ||| NNP
) ||| S:14515 E:14516 ||| -RRB-
.  ||| S:14516 E:14518 ||| .
DOTMAC ||| S:14518 E:14524 ||| NNP
/ ||| S:14524 E:14525 ||| NNP
PFA  ||| S:14525 E:14529 ||| NNP
was  ||| S:14529 E:14533 ||| VBD
superior  ||| S:14533 E:14542 ||| JJ
to  ||| S:14542 E:14545 ||| TO
TCA  ||| S:14545 E:14549 ||| NNP
and  ||| S:14549 E:14553 ||| CC
the  ||| S:14553 E:14567 ||| DT
standard  ||| S:14567 E:14576 ||| JJ
Triton  ||| S:14576 E:14583 ||| NNP
X-100  ||| S:14583 E:14589 ||| NNP
permeabilization  ||| S:14589 E:14606 ||| JJ
procedure  ||| S:14606 E:14616 ||| NN
to  ||| S:14616 E:14629 ||| TO
preserve  ||| S:14629 E:14638 ||| VB
microextensions  ||| S:14638 E:14654 ||| NNS
and  ||| S:14654 E:14658 ||| CC
for  ||| S:14658 E:14662 ||| IN
moesin  ||| S:14662 E:14669 ||| JJ
staining  ||| S:14669 E:14678 ||| NNS
( ||| S:14678 E:14679 ||| -LRB-
Figure  ||| S:14679 E:14696 ||| NNP
4 ||| S:14696 E:14697 ||| CD
,  ||| S:14697 E:14699 ||| ,
G ||| S:14699 E:14700 ||| NNP
,  ||| S:14700 E:14702 ||| ,
K ||| S:14702 E:14703 ||| NNP
,  ||| S:14703 E:14705 ||| ,
and  ||| S:14705 E:14709 ||| CC
4N ||| S:14709 E:14711 ||| NNP
, ||| S:14711 E:14712 ||| ,
O ||| S:14712 E:14713 ||| NNP
, ||| S:14713 E:14714 ||| ,
P ||| S:14714 E:14715 ||| NN
) ||| S:14715 E:14716 ||| -RRB-
.  ||| S:14716 E:14728 ||| .
TCA  ||| S:14728 E:14732 ||| NNP
fixation  ||| S:14732 E:14741 ||| NN
was  ||| S:14741 E:14745 ||| VBD
reported  ||| S:14745 E:14754 ||| VBN
recently  ||| S:14754 E:14763 ||| RB
to  ||| S:14763 E:14766 ||| TO
be  ||| S:14766 E:14769 ||| VB
useful  ||| S:14769 E:14776 ||| JJ
for  ||| S:14776 E:14790 ||| IN
staining  ||| S:14790 E:14799 ||| NN
of  ||| S:14799 E:14802 ||| IN
phosphorylated  ||| S:14802 E:14817 ||| JJ
moesin  ||| S:14817 E:14824 ||| NNS
[  ||| S:14824 E:14826 ||| -LRB-
12 ||| S:14826 E:14828 ||| CD
] ||| S:14828 E:14829 ||| -RRB-
.  ||| S:14829 E:14831 ||| .
Therefore ||| S:14831 E:14840 ||| RB
,  ||| S:14840 E:14842 ||| ,
we  ||| S:14842 E:14855 ||| PRP
tested  ||| S:14855 E:14862 ||| VBD
our  ||| S:14862 E:14866 ||| PRP$
anti-phospho-moesin  ||| S:14866 E:14886 ||| JJ
antibodies  ||| S:14886 E:14897 ||| NNS
with  ||| S:14897 E:14902 ||| IN
this  ||| S:14902 E:14917 ||| DT
method  ||| S:14917 E:14924 ||| NN
and ||| S:14924 E:14927 ||| CC
,  ||| S:14927 E:14929 ||| ,
as  ||| S:14929 E:14932 ||| RB
shown  ||| S:14932 E:14938 ||| VBN
in  ||| S:14938 E:14941 ||| IN
Figure  ||| S:14941 E:14948 ||| NNP
4H ||| S:14948 E:14950 ||| NNP
,  ||| S:14950 E:14952 ||| ,
the  ||| S:14952 E:14956 ||| DT
fluorescence  ||| S:14956 E:14979 ||| JJ
intensity  ||| S:14979 E:14989 ||| NN
was  ||| S:14989 E:14993 ||| VBD
too  ||| S:14993 E:14997 ||| RB
low  ||| S:14997 E:15001 ||| JJ
to  ||| S:15001 E:15004 ||| TO
distinguish  ||| S:15004 E:15016 ||| VB
characteristic  ||| S:15016 E:15041 ||| JJ
structures  ||| S:15041 E:15052 ||| NNS
probably  ||| S:15052 E:15061 ||| RB
because  ||| S:15061 E:15069 ||| IN
the  ||| S:15069 E:15073 ||| DT
amount  ||| S:15073 E:15080 ||| NN
of  ||| S:15080 E:15083 ||| IN
phosphorylated  ||| S:15083 E:15108 ||| JJ
moesin  ||| S:15108 E:15115 ||| NN
is  ||| S:15115 E:15118 ||| VBZ
low  ||| S:15118 E:15122 ||| JJ
in  ||| S:15122 E:15125 ||| IN
unstimulated  ||| S:15125 E:15138 ||| CD
NIH3T3  ||| S:15138 E:15145 ||| CD
cells  ||| S:15145 E:15151 ||| NNS
( ||| S:15151 E:15152 ||| -LRB-
cf ||| S:15152 E:15154 ||| NN
.  ||| S:15154 E:15156 ||| .
Figure  ||| S:15156 E:15173 ||| NN
7 ||| S:15173 E:15174 ||| CD
) ||| S:15174 E:15175 ||| -RRB-
.  ||| S:15175 E:15177 ||| .
Figure  ||| S:15177 E:15184 ||| NN
5demonstrates  ||| S:15184 E:15198 ||| VBZ
another  ||| S:15198 E:15206 ||| DT
example  ||| S:15206 E:15214 ||| NN
of  ||| S:15214 E:15217 ||| IN
NIH3T3  ||| S:15217 E:15224 ||| CD
cells  ||| S:15224 E:15240 ||| NNS
stained  ||| S:15240 E:15248 ||| VBN
with  ||| S:15248 E:15253 ||| IN
actin  ||| S:15253 E:15259 ||| JJ
monoclonal  ||| S:15259 E:15270 ||| NN
and  ||| S:15270 E:15274 ||| CC
moesin  ||| S:15274 E:15281 ||| JJ
polyclonal  ||| S:15281 E:15302 ||| JJ
antibodies  ||| S:15302 E:15313 ||| NNS
after  ||| S:15313 E:15319 ||| IN
DOTMAC ||| S:15319 E:15325 ||| NNP
/ ||| S:15325 E:15326 ||| NNP
PFA  ||| S:15326 E:15330 ||| NNP
fixation ||| S:15330 E:15338 ||| NN
.  ||| S:15338 E:15340 ||| .
Many  ||| S:15340 E:15345 ||| JJ
branched  ||| S:15345 E:15364 ||| JJ
microextensions  ||| S:15364 E:15380 ||| NN
were  ||| S:15380 E:15385 ||| VBD
double-stained  ||| S:15385 E:15400 ||| JJ
with  ||| S:15400 E:15405 ||| IN
these  ||| S:15405 E:15421 ||| DT
antibodies ||| S:15421 E:15431 ||| NNS
,  ||| S:15431 E:15433 ||| ,
but  ||| S:15433 E:15437 ||| CC
occasionally ||| S:15437 E:15449 ||| RB
,  ||| S:15449 E:15451 ||| ,
part  ||| S:15451 E:15456 ||| NN
of  ||| S:15456 E:15459 ||| IN
a  ||| S:15459 E:15461 ||| DT
microextension  ||| S:15461 E:15476 ||| NN
or  ||| S:15476 E:15489 ||| CC
an  ||| S:15489 E:15492 ||| DT
entire  ||| S:15492 E:15499 ||| JJ
microextension  ||| S:15499 E:15514 ||| NNS
apparently  ||| S:15514 E:15525 ||| RB
lacked  ||| S:15525 E:15532 ||| VBD
actin  ||| S:15532 E:15538 ||| NNS
[  ||| S:15538 E:15540 ||| -LRB-
17 ||| S:15540 E:15542 ||| CD
,  ||| S:15542 E:15554 ||| ,
22 ||| S:15554 E:15556 ||| CD
] ||| S:15556 E:15557 ||| -RRB-
.  ||| S:15557 E:15587 ||| .
Evaluation  ||| S:15587 E:15598 ||| NN
of  ||| S:15598 E:15601 ||| IN
crosslinked  ||| S:15601 E:15613 ||| JJ
polypeptides  ||| S:15613 E:15626 ||| NN
after  ||| S:15626 E:15642 ||| IN
fixation  ||| S:15642 E:15651 ||| NN
and  ||| S:15651 E:15655 ||| CC
extraction  ||| S:15655 E:15676 ||| VB
Our  ||| S:15676 E:15680 ||| PRP$
results  ||| S:15680 E:15688 ||| NNS
suggested  ||| S:15688 E:15698 ||| VBD
that  ||| S:15698 E:15703 ||| IN
some  ||| S:15703 E:15708 ||| DT
of  ||| S:15708 E:15711 ||| IN
procedures  ||| S:15711 E:15722 ||| NNS
listed  ||| S:15722 E:15739 ||| VBN
in  ||| S:15739 E:15742 ||| IN
Table  ||| S:15742 E:15748 ||| NNP
1  ||| S:15748 E:15750 ||| CD
were  ||| S:15750 E:15755 ||| VBD
inadequate  ||| S:15755 E:15766 ||| JJ
for  ||| S:15766 E:15770 ||| IN
preserving  ||| S:15770 E:15781 ||| VBG
fine  ||| S:15781 E:15786 ||| JJ
structural  ||| S:15786 E:15807 ||| JJ
details ||| S:15807 E:15814 ||| NNS
.  ||| S:15814 E:15816 ||| .
Therefore ||| S:15816 E:15825 ||| RB
,  ||| S:15825 E:15827 ||| ,
we  ||| S:15827 E:15830 ||| PRP
re-evaluated  ||| S:15830 E:15843 ||| VBD
the  ||| S:15843 E:15847 ||| DT
extent  ||| S:15847 E:15854 ||| NN
of  ||| S:15854 E:15867 ||| IN
crosslinking  ||| S:15867 E:15880 ||| NN
of  ||| S:15880 E:15883 ||| IN
polypeptides  ||| S:15883 E:15896 ||| NN
by  ||| S:15896 E:15899 ||| IN
gel  ||| S:15899 E:15903 ||| JJ
electrophoresis  ||| S:15903 E:15919 ||| NN
and  ||| S:15919 E:15933 ||| CC
western  ||| S:15933 E:15941 ||| JJ
blotting ||| S:15941 E:15949 ||| NN
.  ||| S:15949 E:15951 ||| .
The  ||| S:15951 E:15955 ||| DT
polypeptide  ||| S:15955 E:15967 ||| JJ
banding  ||| S:15967 E:15975 ||| JJ
patterns  ||| S:15975 E:15984 ||| NNS
of  ||| S:15984 E:15997 ||| IN
extracts  ||| S:15997 E:16006 ||| NN
from  ||| S:16006 E:16011 ||| IN
unfixed  ||| S:16011 E:16019 ||| NN
and  ||| S:16019 E:16023 ||| CC
fixed  ||| S:16023 E:16029 ||| JJ
cells  ||| S:16029 E:16035 ||| NNS
with  ||| S:16035 E:16040 ||| IN
SDS  ||| S:16040 E:16044 ||| NNP
sample  ||| S:16044 E:16061 ||| NN
buffer  ||| S:16061 E:16068 ||| NNS
are  ||| S:16068 E:16072 ||| VBP
shown  ||| S:16072 E:16078 ||| VBN
in  ||| S:16078 E:16081 ||| IN
Figure  ||| S:16081 E:16088 ||| NNP
6 ||| S:16088 E:16089 ||| CD
.  ||| S:16089 E:16091 ||| .
Incubation  ||| S:16091 E:16102 ||| NNP
in  ||| S:16102 E:16105 ||| IN
0.5 ||| S:16105 E:16108 ||| CD
%  ||| S:16108 E:16110 ||| NN
Triton  ||| S:16110 E:16127 ||| NNP
X-100  ||| S:16127 E:16133 ||| NNP
in  ||| S:16133 E:16136 ||| IN
PBS  ||| S:16136 E:16140 ||| NNP
detached  ||| S:16140 E:16149 ||| NN
cells  ||| S:16149 E:16155 ||| NNS
from  ||| S:16155 E:16160 ||| IN
the  ||| S:16160 E:16164 ||| DT
dish  ||| S:16164 E:16169 ||| NN
( ||| S:16169 E:16170 ||| -LRB-
Figure  ||| S:16170 E:16177 ||| NNP
6A ||| S:16177 E:16179 ||| NNP
,  ||| S:16179 E:16191 ||| ,
lane  ||| S:16191 E:16196 ||| CD
2 ||| S:16196 E:16197 ||| CD
) ||| S:16197 E:16198 ||| -RRB-
,  ||| S:16198 E:16200 ||| ,
but  ||| S:16200 E:16204 ||| CC
addition  ||| S:16204 E:16213 ||| NN
of  ||| S:16213 E:16216 ||| IN
1  ||| S:16216 E:16218 ||| CD
mM  ||| S:16218 E:16221 ||| JJ
magnesium  ||| S:16221 E:16231 ||| NN
and  ||| S:16231 E:16235 ||| CC
1  ||| S:16235 E:16237 ||| CD
mM  ||| S:16237 E:16240 ||| JJ
calcium  ||| S:16240 E:16258 ||| NN
ions  ||| S:16258 E:16263 ||| NN
in  ||| S:16263 E:16266 ||| IN
PBS  ||| S:16266 E:16270 ||| NNP
prevented  ||| S:16270 E:16280 ||| VBD
detachment  ||| S:16280 E:16291 ||| VBN
to  ||| S:16291 E:16294 ||| TO
some  ||| S:16294 E:16299 ||| DT
extent  ||| S:16299 E:16306 ||| NN
( ||| S:16306 E:16307 ||| -LRB-
Figure  ||| S:16307 E:16324 ||| NNP
6A ||| S:16324 E:16326 ||| NNP
,  ||| S:16326 E:16328 ||| ,
lane  ||| S:16328 E:16333 ||| CD
3 ||| S:16333 E:16334 ||| CD
) ||| S:16334 E:16335 ||| -RRB-
.  ||| S:16335 E:16337 ||| .
Microtubule  ||| S:16337 E:16349 ||| RB
stabilizing  ||| S:16349 E:16361 ||| VBG
buffer  ||| S:16361 E:16368 ||| NN
also  ||| S:16368 E:16383 ||| RB
prevented  ||| S:16383 E:16393 ||| VBN
detachment  ||| S:16393 E:16404 ||| NNS
( ||| S:16404 E:16405 ||| -LRB-
Figure  ||| S:16405 E:16412 ||| NNP
6A ||| S:16412 E:16414 ||| NNP
,  ||| S:16414 E:16416 ||| ,
lane  ||| S:16416 E:16421 ||| CD
5 ||| S:16421 E:16422 ||| CD
) ||| S:16422 E:16423 ||| -RRB-
.  ||| S:16423 E:16425 ||| .
On  ||| S:16425 E:16428 ||| IN
the  ||| S:16428 E:16432 ||| DT
other  ||| S:16432 E:16448 ||| JJ
hand ||| S:16448 E:16452 ||| NN
,  ||| S:16452 E:16454 ||| ,
most  ||| S:16454 E:16459 ||| JJS
polypeptides  ||| S:16459 E:16472 ||| NN
were  ||| S:16472 E:16477 ||| VBD
retained  ||| S:16477 E:16486 ||| VBN
on  ||| S:16486 E:16489 ||| IN
the  ||| S:16489 E:16493 ||| DT
dish  ||| S:16493 E:16498 ||| NN
after  ||| S:16498 E:16514 ||| IN
DOTMAC  ||| S:16514 E:16521 ||| NNP
treatment  ||| S:16521 E:16531 ||| NN
( ||| S:16531 E:16532 ||| -LRB-
Figure  ||| S:16532 E:16539 ||| NNP
6A ||| S:16539 E:16541 ||| NNP
,  ||| S:16541 E:16543 ||| ,
lane  ||| S:16543 E:16548 ||| CD
6 ||| S:16548 E:16549 ||| CD
) ||| S:16549 E:16550 ||| -RRB-
.  ||| S:16550 E:16552 ||| .
Although  ||| S:16552 E:16561 ||| IN
most  ||| S:16561 E:16566 ||| JJS
of  ||| S:16566 E:16579 ||| IN
β-actin  ||| S:16579 E:16587 ||| NNP
was  ||| S:16587 E:16591 ||| VBD
retained  ||| S:16591 E:16600 ||| VBN
after  ||| S:16600 E:16606 ||| IN
0.5 ||| S:16606 E:16609 ||| CD
%  ||| S:16609 E:16611 ||| NN
detergent  ||| S:16611 E:16621 ||| NN
extraction ||| S:16621 E:16631 ||| NN
,  ||| S:16631 E:16643 ||| ,
moesin  ||| S:16643 E:16650 ||| NN
was  ||| S:16650 E:16654 ||| VBD
not  ||| S:16654 E:16658 ||| RB
unless  ||| S:16658 E:16665 ||| IN
1 ||| S:16665 E:16666 ||| CD
%  ||| S:16666 E:16668 ||| NN
paraformaldehyde  ||| S:16668 E:16685 ||| NNS
was  ||| S:16685 E:16689 ||| VBD
added  ||| S:16689 E:16705 ||| VBN
( ||| S:16705 E:16706 ||| -LRB-
Figure  ||| S:16706 E:16713 ||| NNP
6A ||| S:16713 E:16715 ||| NNP
,  ||| S:16715 E:16717 ||| ,
lanes  ||| S:16717 E:16723 ||| CD
4  ||| S:16723 E:16725 ||| CD
and  ||| S:16725 E:16729 ||| CC
7 ||| S:16729 E:16730 ||| CD
) ||| S:16730 E:16731 ||| -RRB-
.  ||| S:16731 E:16733 ||| .
Under  ||| S:16733 E:16739 ||| IN
these  ||| S:16739 E:16745 ||| DT
conditions ||| S:16745 E:16755 ||| NNS
,  ||| S:16755 E:16767 ||| ,
moesin  ||| S:16767 E:16774 ||| NN
and  ||| S:16774 E:16778 ||| CC
β-actin  ||| S:16778 E:16786 ||| JJ
migrated  ||| S:16786 E:16795 ||| JJ
predominantly  ||| S:16795 E:16809 ||| NN
as  ||| S:16809 E:16812 ||| IN
monomeric  ||| S:16812 E:16832 ||| JJ
polypeptides  ||| S:16832 E:16845 ||| NN
at  ||| S:16845 E:16848 ||| IN
45  ||| S:16848 E:16851 ||| CD
and  ||| S:16851 E:16855 ||| CC
78  ||| S:16855 E:16858 ||| CD
kDa  ||| S:16858 E:16862 ||| JJ
positions  ||| S:16862 E:16872 ||| NNS
on  ||| S:16872 E:16875 ||| IN
the  ||| S:16875 E:16879 ||| DT
SDS-PAGE  ||| S:16879 E:16898 ||| JJ
gels  ||| S:16898 E:16903 ||| NN
and  ||| S:16903 E:16907 ||| CC
only  ||| S:16907 E:16912 ||| RB
very  ||| S:16912 E:16917 ||| RB
small  ||| S:16917 E:16923 ||| JJ
amounts  ||| S:16923 E:16931 ||| NNS
of  ||| S:16931 E:16934 ||| IN
crosslinked  ||| S:16934 E:16946 ||| JJ
moesin  ||| S:16946 E:16963 ||| NN
and  ||| S:16963 E:16967 ||| CC
β-actin  ||| S:16967 E:16975 ||| NNP
were  ||| S:16975 E:16980 ||| VBD
detected  ||| S:16980 E:16989 ||| VBN
by  ||| S:16989 E:16992 ||| IN
western  ||| S:16992 E:17000 ||| JJ
blotting  ||| S:17000 E:17009 ||| NN
at  ||| S:17009 E:17012 ||| IN
higher  ||| S:17012 E:17029 ||| JJR
molecular  ||| S:17029 E:17039 ||| JJ
weight  ||| S:17039 E:17046 ||| NN
positions  ||| S:17046 E:17056 ||| NNS
( ||| S:17056 E:17057 ||| -LRB-
data  ||| S:17057 E:17062 ||| NNS
not  ||| S:17062 E:17066 ||| RB
shown ||| S:17066 E:17071 ||| VBN
) ||| S:17071 E:17072 ||| -RRB-
.  ||| S:17072 E:17084 ||| .
Crosslinking  ||| S:17084 E:17097 ||| NNP
of  ||| S:17097 E:17100 ||| IN
polypeptides  ||| S:17100 E:17113 ||| NN
was  ||| S:17113 E:17117 ||| VBD
also  ||| S:17117 E:17122 ||| RB
evaluated  ||| S:17122 E:17132 ||| VBN
after  ||| S:17132 E:17148 ||| IN
treatment  ||| S:17148 E:17158 ||| NN
with  ||| S:17158 E:17163 ||| IN
several  ||| S:17163 E:17171 ||| JJ
other  ||| S:17171 E:17177 ||| JJ
fixatives  ||| S:17177 E:17187 ||| NN
that  ||| S:17187 E:17192 ||| WDT
preserved  ||| S:17192 E:17212 ||| VBD
microextensions  ||| S:17212 E:17228 ||| VBN
well  ||| S:17228 E:17233 ||| RB
and  ||| S:17233 E:17237 ||| CC
that  ||| S:17237 E:17242 ||| WDT
were  ||| S:17242 E:17247 ||| VBD
found  ||| S:17247 E:17253 ||| VBN
to  ||| S:17253 E:17256 ||| TO
be  ||| S:17256 E:17259 ||| VB
useful  ||| S:17259 E:17276 ||| JJ
previously  ||| S:17276 E:17287 ||| RB
for  ||| S:17287 E:17291 ||| IN
moesin  ||| S:17291 E:17298 ||| JJ
staining  ||| S:17298 E:17307 ||| NNS
( ||| S:17307 E:17308 ||| -LRB-
Figure  ||| S:17308 E:17315 ||| NNP
6B ||| S:17315 E:17317 ||| NNP
) ||| S:17317 E:17318 ||| -RRB-
.  ||| S:17318 E:17320 ||| .
Only  ||| S:17320 E:17325 ||| RB
a  ||| S:17325 E:17327 ||| DT
small  ||| S:17327 E:17343 ||| JJ
amount  ||| S:17343 E:17350 ||| NN
of  ||| S:17350 E:17353 ||| IN
polypeptides  ||| S:17353 E:17366 ||| NN
was  ||| S:17366 E:17370 ||| VBD
extracted  ||| S:17370 E:17380 ||| VBN
when  ||| S:17380 E:17385 ||| WRB
cells  ||| S:17385 E:17391 ||| NNS
were  ||| S:17391 E:17406 ||| VBD
fixed  ||| S:17406 E:17412 ||| VBN
with  ||| S:17412 E:17417 ||| IN
glutaraldehyde  ||| S:17417 E:17432 ||| NN
or  ||| S:17432 E:17435 ||| CC
DSP-Tsb  ||| S:17435 E:17443 ||| NNP
( ||| S:17443 E:17444 ||| -LRB-
Figure  ||| S:17444 E:17451 ||| NNP
6B ||| S:17451 E:17453 ||| NNP
,  ||| S:17453 E:17455 ||| ,
lane  ||| S:17455 E:17460 ||| CD
2 ||| S:17460 E:17461 ||| CD
,  ||| S:17461 E:17473 ||| ,
3  ||| S:17473 E:17475 ||| CD
and  ||| S:17475 E:17479 ||| CC
6 ||| S:17479 E:17480 ||| CD
)  ||| S:17480 E:17482 ||| -RRB-
and  ||| S:17482 E:17486 ||| CC
the  ||| S:17486 E:17490 ||| DT
cells  ||| S:17490 E:17496 ||| NNS
were  ||| S:17496 E:17501 ||| VBD
morphologically  ||| S:17501 E:17517 ||| VBN
well  ||| S:17517 E:17532 ||| RB
preserved  ||| S:17532 E:17542 ||| VBN
by  ||| S:17542 E:17545 ||| IN
these  ||| S:17545 E:17551 ||| DT
fixatives  ||| S:17551 E:17561 ||| NN
as  ||| S:17561 E:17564 ||| IN
observed  ||| S:17564 E:17573 ||| VBN
by  ||| S:17573 E:17576 ||| IN
SEM ||| S:17576 E:17579 ||| NNP
,  ||| S:17579 E:17591 ||| ,
indicating  ||| S:17591 E:17602 ||| VBG
that  ||| S:17602 E:17607 ||| IN
most  ||| S:17607 E:17612 ||| JJS
proteins  ||| S:17612 E:17621 ||| NNS
were  ||| S:17621 E:17626 ||| VBD
irreversibly  ||| S:17626 E:17649 ||| JJ
crosslinked ||| S:17649 E:17660 ||| NN
.  ||| S:17660 E:17662 ||| .
On  ||| S:17662 E:17665 ||| IN
the  ||| S:17665 E:17669 ||| DT
other  ||| S:17669 E:17675 ||| JJ
hand ||| S:17675 E:17679 ||| NN
,  ||| S:17679 E:17681 ||| ,
when  ||| S:17681 E:17686 ||| WRB
cells  ||| S:17686 E:17692 ||| NNS
were  ||| S:17692 E:17697 ||| VBD
fixed  ||| S:17697 E:17713 ||| VBN
with  ||| S:17713 E:17718 ||| IN
PLP  ||| S:17718 E:17722 ||| NNP
or  ||| S:17722 E:17725 ||| CC
LP  ||| S:17725 E:17728 ||| NNP
and  ||| S:17728 E:17732 ||| CC
treated  ||| S:17732 E:17740 ||| VBN
with  ||| S:17740 E:17745 ||| IN
1 ||| S:17745 E:17746 ||| CD
%  ||| S:17746 E:17748 ||| NN
saponin  ||| S:17748 E:17756 ||| NN
in  ||| S:17756 E:17759 ||| IN
3 ||| S:17759 E:17760 ||| CD
%  ||| S:17760 E:17762 ||| NN
BSA  ||| S:17762 E:17766 ||| NN
for  ||| S:17766 E:17780 ||| IN
permeabilization ||| S:17780 E:17796 ||| NN
,  ||| S:17796 E:17798 ||| ,
most  ||| S:17798 E:17803 ||| JJS
of  ||| S:17803 E:17806 ||| IN
the  ||| S:17806 E:17810 ||| DT
polypeptides  ||| S:17810 E:17823 ||| NN
were  ||| S:17823 E:17828 ||| VBD
either  ||| S:17828 E:17845 ||| RB
not  ||| S:17845 E:17849 ||| RB
crosslinked  ||| S:17849 E:17861 ||| VBN
by  ||| S:17861 E:17864 ||| IN
these  ||| S:17864 E:17870 ||| DT
relatively  ||| S:17870 E:17881 ||| RB
mild  ||| S:17881 E:17886 ||| JJ
fixatives  ||| S:17886 E:17896 ||| NN
or  ||| S:17896 E:17909 ||| CC
crosslinks  ||| S:17909 E:17920 ||| NNS
were  ||| S:17920 E:17925 ||| VBD
reversed  ||| S:17925 E:17934 ||| VBN
by  ||| S:17934 E:17937 ||| IN
the  ||| S:17937 E:17941 ||| DT
addition  ||| S:17941 E:17950 ||| NN
of  ||| S:17950 E:17953 ||| IN
SDS  ||| S:17953 E:17957 ||| NNP
sample  ||| S:17957 E:17974 ||| NN
buffer  ||| S:17974 E:17981 ||| NN
( ||| S:17981 E:17982 ||| -LRB-
Figure  ||| S:17982 E:17989 ||| NNP
6B ||| S:17989 E:17991 ||| NNP
,  ||| S:17991 E:17993 ||| ,
lanes  ||| S:17993 E:17999 ||| CD
4  ||| S:17999 E:18001 ||| CD
and  ||| S:18001 E:18005 ||| CC
5 ||| S:18005 E:18006 ||| CD
) ||| S:18006 E:18007 ||| -RRB-
.  ||| S:18007 E:18009 ||| .
Similar  ||| S:18009 E:18017 ||| JJ
results  ||| S:18017 E:18025 ||| NNS
were  ||| S:18025 E:18040 ||| VBD
obtained  ||| S:18040 E:18049 ||| VBN
when  ||| S:18049 E:18054 ||| WRB
cells  ||| S:18054 E:18060 ||| NNS
were  ||| S:18060 E:18065 ||| VBD
fixed  ||| S:18065 E:18071 ||| VBN
with  ||| S:18071 E:18076 ||| IN
3.7 ||| S:18076 E:18079 ||| CD
%  ||| S:18079 E:18081 ||| NN
formalin  ||| S:18081 E:18090 ||| NNS
or  ||| S:18090 E:18093 ||| CC
4 ||| S:18093 E:18094 ||| CD
%  ||| S:18094 E:18106 ||| NN
PFA ||| S:18106 E:18109 ||| NNP
,  ||| S:18109 E:18111 ||| ,
followed  ||| S:18111 E:18120 ||| VBN
by  ||| S:18120 E:18123 ||| IN
permeabilization  ||| S:18123 E:18140 ||| NN
with  ||| S:18140 E:18145 ||| IN
0.1 ||| S:18145 E:18148 ||| CD
%  ||| S:18148 E:18150 ||| NN
Triton  ||| S:18150 E:18157 ||| NNP
X-100 ||| S:18157 E:18162 ||| NNP
.  ||| S:18162 E:18174 ||| .
Threonine558-phosphomoesin  ||| S:18174 E:18201 ||| NNP
was  ||| S:18201 E:18205 ||| VBD
not  ||| S:18205 E:18209 ||| RB
dephosphorylated  ||| S:18209 E:18226 ||| VBN
in  ||| S:18226 E:18239 ||| IN
these  ||| S:18239 E:18245 ||| DT
fixatives ||| S:18245 E:18254 ||| NN
,  ||| S:18254 E:18256 ||| ,
as  ||| S:18256 E:18259 ||| RB
determined  ||| S:18259 E:18270 ||| VBN
by  ||| S:18270 E:18273 ||| IN
western  ||| S:18273 E:18281 ||| JJ
blotting  ||| S:18281 E:18290 ||| NN
with  ||| S:18290 E:18305 ||| IN
specific  ||| S:18305 E:18314 ||| JJ
phosphomoesin  ||| S:18314 E:18328 ||| JJ
antibodies  ||| S:18328 E:18339 ||| NNS
( ||| S:18339 E:18340 ||| -LRB-
Figure  ||| S:18340 E:18347 ||| NNP
6B ||| S:18347 E:18349 ||| NNP
) ||| S:18349 E:18350 ||| -RRB-
.  ||| S:18350 E:18352 ||| .
We  ||| S:18352 E:18365 ||| PRP
examined  ||| S:18365 E:18374 ||| VBD
the  ||| S:18374 E:18378 ||| DT
effect  ||| S:18378 E:18385 ||| NN
of  ||| S:18385 E:18388 ||| IN
incubation  ||| S:18388 E:18399 ||| JJ
time  ||| S:18399 E:18404 ||| NN
and  ||| S:18404 E:18408 ||| CC
temperature  ||| S:18408 E:18430 ||| NN
during  ||| S:18430 E:18437 ||| IN
fixation  ||| S:18437 E:18446 ||| NN
with  ||| S:18446 E:18451 ||| IN
4 ||| S:18451 E:18452 ||| CD
%  ||| S:18452 E:18454 ||| NN
PFA  ||| S:18454 E:18458 ||| NN
in  ||| S:18458 E:18461 ||| IN
PBS ||| S:18461 E:18464 ||| NNP
( ||| S:18464 E:18465 ||| -LRB-
+ ||| S:18465 E:18466 ||| NNP
) ||| S:18466 E:18467 ||| -RRB-
,  ||| S:18467 E:18469 ||| ,
since  ||| S:18469 E:18475 ||| IN
conditions  ||| S:18475 E:18496 ||| NNS
for  ||| S:18496 E:18500 ||| IN
irreversible  ||| S:18500 E:18513 ||| JJ
crosslinking  ||| S:18513 E:18526 ||| NN
of  ||| S:18526 E:18529 ||| IN
polypeptides  ||| S:18529 E:18542 ||| NN
in  ||| S:18542 E:18545 ||| IN
cultured  ||| S:18545 E:18564 ||| JJ
cells  ||| S:18564 E:18570 ||| NNS
with  ||| S:18570 E:18575 ||| IN
formaldehyde  ||| S:18575 E:18588 ||| NNS
are  ||| S:18588 E:18592 ||| VBP
unknown ||| S:18592 E:18599 ||| JJ
.  ||| S:18599 E:18601 ||| .
As  ||| S:18601 E:18604 ||| RB
shown  ||| S:18604 E:18610 ||| VBN
in  ||| S:18610 E:18613 ||| IN
Figure  ||| S:18613 E:18630 ||| NNP
6C ||| S:18630 E:18632 ||| NNP
,  ||| S:18632 E:18634 ||| ,
fixation  ||| S:18634 E:18643 ||| NN
under  ||| S:18643 E:18649 ||| IN
the  ||| S:18649 E:18653 ||| DT
widely  ||| S:18653 E:18660 ||| RB
used  ||| S:18660 E:18665 ||| VBN
conditions  ||| S:18665 E:18676 ||| NNS
at  ||| S:18676 E:18679 ||| IN
room  ||| S:18679 E:18694 ||| NN
temperature  ||| S:18694 E:18706 ||| NN
( ||| S:18706 E:18707 ||| -LRB-
25°C ||| S:18707 E:18711 ||| NNP
)  ||| S:18711 E:18713 ||| -RRB-
for  ||| S:18713 E:18717 ||| IN
20  ||| S:18717 E:18720 ||| CD
min ||| S:18720 E:18723 ||| NN
,  ||| S:18723 E:18725 ||| ,
is  ||| S:18725 E:18728 ||| VBZ
not  ||| S:18728 E:18732 ||| RB
sufficient  ||| S:18732 E:18743 ||| JJ
to  ||| S:18743 E:18756 ||| TO
irreversibly  ||| S:18756 E:18769 ||| VB
crosslink  ||| S:18769 E:18779 ||| JJ
actin ||| S:18779 E:18784 ||| NN
,  ||| S:18784 E:18786 ||| ,
moesin  ||| S:18786 E:18793 ||| NN
and  ||| S:18793 E:18797 ||| CC
many  ||| S:18797 E:18802 ||| JJ
other  ||| S:18802 E:18818 ||| JJ
polypeptides ||| S:18818 E:18830 ||| NN
.  ||| S:18830 E:18832 ||| .
At  ||| S:18832 E:18835 ||| IN
37°C ||| S:18835 E:18839 ||| NNP
,  ||| S:18839 E:18841 ||| ,
the  ||| S:18841 E:18845 ||| DT
required  ||| S:18845 E:18854 ||| JJ
time  ||| S:18854 E:18859 ||| NN
for  ||| S:18859 E:18863 ||| IN
incubation  ||| S:18863 E:18884 ||| NNS
can  ||| S:18884 E:18888 ||| MD
be  ||| S:18888 E:18891 ||| VB
shortened ||| S:18891 E:18900 ||| VBN
,  ||| S:18900 E:18902 ||| ,
but  ||| S:18902 E:18906 ||| CC
most  ||| S:18906 E:18911 ||| JJS
of  ||| S:18911 E:18914 ||| IN
the  ||| S:18914 E:18918 ||| DT
actin  ||| S:18918 E:18924 ||| JJ
molecules  ||| S:18924 E:18934 ||| NNS
were  ||| S:18934 E:18949 ||| VBD
not  ||| S:18949 E:18953 ||| RB
irreversibly  ||| S:18953 E:18966 ||| JJ
crosslinked  ||| S:18966 E:18978 ||| NNS
even  ||| S:18978 E:18983 ||| RB
after  ||| S:18983 E:18989 ||| IN
30  ||| S:18989 E:18992 ||| CD
min ||| S:18992 E:18995 ||| NNS
.  ||| S:18995 E:19007 ||| .
Incubation  ||| S:19007 E:19018 ||| NNP
with  ||| S:19018 E:19023 ||| IN
sodium  ||| S:19023 E:19030 ||| JJ
borohydride  ||| S:19030 E:19042 ||| NN
after  ||| S:19042 E:19048 ||| IN
fixation  ||| S:19048 E:19057 ||| NN
in  ||| S:19057 E:19060 ||| IN
PFA  ||| S:19060 E:19074 ||| NNP
had  ||| S:19074 E:19078 ||| VBD
no  ||| S:19078 E:19081 ||| DT
effect  ||| S:19081 E:19088 ||| NN
either  ||| S:19088 E:19095 ||| CC
( ||| S:19095 E:19096 ||| -LRB-
data  ||| S:19096 E:19101 ||| NNS
not  ||| S:19101 E:19105 ||| RB
shown ||| S:19105 E:19110 ||| VBN
)  ||| S:19110 E:19112 ||| -RRB-
suggesting  ||| S:19112 E:19123 ||| VBG
that  ||| S:19123 E:19138 ||| IN
reversible  ||| S:19138 E:19149 ||| JJ
bridges  ||| S:19149 E:19157 ||| NNS
may  ||| S:19157 E:19161 ||| MD
have  ||| S:19161 E:19166 ||| VB
formed  ||| S:19166 E:19173 ||| VBN
that  ||| S:19173 E:19178 ||| WDT
could  ||| S:19178 E:19184 ||| MD
not  ||| S:19184 E:19188 ||| RB
be  ||| S:19188 E:19201 ||| VB
reduced ||| S:19201 E:19208 ||| VBN
.  ||| S:19208 E:19238 ||| .
Biochemical  ||| S:19238 E:19250 ||| JJ
analysis  ||| S:19250 E:19259 ||| NN
of  ||| S:19259 E:19262 ||| IN
DOTMAC-insoluble  ||| S:19262 E:19279 ||| JJ
materials  ||| S:19279 E:19299 ||| NNS
of  ||| S:19299 E:19302 ||| IN
NIH3T3  ||| S:19302 E:19309 ||| CD
cells  ||| S:19309 E:19325 ||| CD
NIH3T3  ||| S:19325 E:19332 ||| CD
cells  ||| S:19332 E:19338 ||| NNS
suspended  ||| S:19338 E:19348 ||| VBN
in  ||| S:19348 E:19351 ||| IN
PBS  ||| S:19351 E:19355 ||| NNP
were  ||| S:19355 E:19360 ||| VBD
treated  ||| S:19360 E:19368 ||| VBN
with  ||| S:19368 E:19373 ||| IN
1  ||| S:19373 E:19375 ||| CD
μM  ||| S:19375 E:19388 ||| JJ
staurosporine ||| S:19388 E:19401 ||| NN
,  ||| S:19401 E:19403 ||| ,
1  ||| S:19403 E:19405 ||| CD
μM  ||| S:19405 E:19408 ||| JJ
calyculin  ||| S:19408 E:19418 ||| JJ
A  ||| S:19418 E:19420 ||| NN
or  ||| S:19420 E:19423 ||| CC
100  ||| S:19423 E:19427 ||| CD
μM  ||| S:19427 E:19430 ||| JJ
pervanadate  ||| S:19430 E:19442 ||| NN
and  ||| S:19442 E:19456 ||| CC
fractionated  ||| S:19456 E:19469 ||| NN
with  ||| S:19469 E:19474 ||| IN
0.5 ||| S:19474 E:19477 ||| CD
%  ||| S:19477 E:19479 ||| NN
Triton  ||| S:19479 E:19486 ||| NNP
X-100  ||| S:19486 E:19492 ||| NNP
or  ||| S:19492 E:19495 ||| CC
DOTMAC ||| S:19495 E:19501 ||| NNP
.  ||| S:19501 E:19503 ||| .
Similar  ||| S:19503 E:19511 ||| JJ
to  ||| S:19511 E:19524 ||| TO
results  ||| S:19524 E:19532 ||| NNS
in  ||| S:19532 E:19535 ||| IN
platelets  ||| S:19535 E:19545 ||| NNS
[  ||| S:19545 E:19547 ||| -LRB-
19 ||| S:19547 E:19549 ||| CD
] ||| S:19549 E:19550 ||| -RRB-
,  ||| S:19550 E:19552 ||| ,
the  ||| S:19552 E:19556 ||| DT
polypeptide  ||| S:19556 E:19568 ||| JJ
patterns  ||| S:19568 E:19577 ||| NNS
on  ||| S:19577 E:19590 ||| IN
SDS-PAGE  ||| S:19590 E:19599 ||| JJ
gels  ||| S:19599 E:19604 ||| JJ
differed  ||| S:19604 E:19613 ||| NN
for  ||| S:19613 E:19617 ||| IN
DOTMAC-  ||| S:19617 E:19625 ||| JJ
and  ||| S:19625 E:19629 ||| CC
Triton  ||| S:19629 E:19646 ||| NNP
X-100-extracted  ||| S:19646 E:19662 ||| NNP
cells  ||| S:19662 E:19668 ||| NNS
and  ||| S:19668 E:19672 ||| CC
more  ||| S:19672 E:19677 ||| JJR
polypeptides  ||| S:19677 E:19690 ||| NNS
were  ||| S:19690 E:19705 ||| VBD
recovered  ||| S:19705 E:19715 ||| VBN
in  ||| S:19715 E:19718 ||| IN
the  ||| S:19718 E:19722 ||| DT
DOTMAC-  ||| S:19722 E:19730 ||| JJ
as  ||| S:19730 E:19733 ||| IN
compared  ||| S:19733 E:19742 ||| VBN
to  ||| S:19742 E:19745 ||| TO
the  ||| S:19745 E:19749 ||| DT
Triton  ||| S:19749 E:19766 ||| NNP
X-100-insoluble  ||| S:19766 E:19782 ||| NNP
fraction  ||| S:19782 E:19791 ||| NN
( ||| S:19791 E:19792 ||| -LRB-
Figure  ||| S:19792 E:19799 ||| NNP
7 ||| S:19799 E:19800 ||| CD
) ||| S:19800 E:19801 ||| -RRB-
.  ||| S:19801 E:19803 ||| .
Many  ||| S:19803 E:19808 ||| JJ
signaling  ||| S:19808 E:19828 ||| JJ
molecules  ||| S:19828 E:19838 ||| NNS
are  ||| S:19838 E:19842 ||| VBP
known  ||| S:19842 E:19848 ||| VBN
to  ||| S:19848 E:19851 ||| TO
be  ||| S:19851 E:19854 ||| VB
sequestered  ||| S:19854 E:19866 ||| VBN
into  ||| S:19866 E:19871 ||| IN
the  ||| S:19871 E:19875 ||| DT
Triton  ||| S:19875 E:19892 ||| NNP
X-100-insoluble  ||| S:19892 E:19908 ||| NNP
fraction  ||| S:19908 E:19917 ||| NN
during  ||| S:19917 E:19924 ||| IN
activation  ||| S:19924 E:19935 ||| NN
and ||| S:19935 E:19938 ||| CC
/ ||| S:19938 E:19939 ||| NNP
or  ||| S:19939 E:19952 ||| CC
aggregation  ||| S:19952 E:19964 ||| NN
of  ||| S:19964 E:19967 ||| IN
human  ||| S:19967 E:19973 ||| JJ
platelets ||| S:19973 E:19982 ||| NN
,  ||| S:19982 E:19984 ||| ,
and  ||| S:19984 E:19988 ||| CC
cytoskeletal  ||| S:19988 E:20011 ||| JJ
association  ||| S:20011 E:20023 ||| NN
has  ||| S:20023 E:20027 ||| VBZ
been  ||| S:20027 E:20032 ||| VBN
inferred  ||| S:20032 E:20041 ||| VBN
from  ||| S:20041 E:20046 ||| IN
this  ||| S:20046 E:20051 ||| DT
result ||| S:20051 E:20057 ||| NN
.  ||| S:20057 E:20059 ||| .
While  ||| S:20059 E:20075 ||| IN
this  ||| S:20075 E:20080 ||| DT
may  ||| S:20080 E:20084 ||| MD
be  ||| S:20084 E:20087 ||| VB
true  ||| S:20087 E:20092 ||| JJ
for  ||| S:20092 E:20096 ||| IN
some  ||| S:20096 E:20101 ||| DT
proteins ||| S:20101 E:20109 ||| NNS
,  ||| S:20109 E:20111 ||| ,
the  ||| S:20111 E:20115 ||| DT
postulated  ||| S:20115 E:20136 ||| JJ
cytoskeletal  ||| S:20136 E:20149 ||| JJ
association  ||| S:20149 E:20161 ||| NN
of  ||| S:20161 E:20164 ||| IN
threonine558-phosphorylated  ||| S:20164 E:20202 ||| CD
moesin  ||| S:20202 E:20209 ||| NNS
was  ||| S:20209 E:20213 ||| VBD
maintained  ||| S:20213 E:20224 ||| VBN
only  ||| S:20224 E:20229 ||| RB
when  ||| S:20229 E:20234 ||| WRB
platelets  ||| S:20234 E:20244 ||| NNS
were  ||| S:20244 E:20249 ||| VBD
extracted  ||| S:20249 E:20269 ||| VBN
with  ||| S:20269 E:20274 ||| IN
DOTMAC ||| S:20274 E:20280 ||| NNP
,  ||| S:20280 E:20282 ||| ,
but  ||| S:20282 E:20286 ||| CC
not  ||| S:20286 E:20290 ||| RB
with  ||| S:20290 E:20295 ||| IN
Triton  ||| S:20295 E:20302 ||| NNP
X-100  ||| S:20302 E:20308 ||| NNP
[  ||| S:20308 E:20310 ||| -LRB-
19 ||| S:20310 E:20312 ||| CD
] ||| S:20312 E:20313 ||| -RRB-
.  ||| S:20313 E:20315 ||| .
By  ||| S:20315 E:20328 ||| IN
contrast ||| S:20328 E:20336 ||| NN
,  ||| S:20336 E:20338 ||| ,
phosphorylated  ||| S:20338 E:20353 ||| JJ
moesin  ||| S:20353 E:20360 ||| NN
was  ||| S:20360 E:20364 ||| VBD
found  ||| S:20364 E:20370 ||| VBN
in  ||| S:20370 E:20373 ||| IN
the  ||| S:20373 E:20387 ||| DT
insoluble  ||| S:20387 E:20397 ||| JJ
material  ||| S:20397 E:20406 ||| NN
of  ||| S:20406 E:20409 ||| IN
NIH3T3  ||| S:20409 E:20416 ||| CD
cells  ||| S:20416 E:20422 ||| NNS
after  ||| S:20422 E:20428 ||| IN
extraction  ||| S:20428 E:20439 ||| NN
with  ||| S:20439 E:20454 ||| IN
both  ||| S:20454 E:20459 ||| DT
types  ||| S:20459 E:20465 ||| NNS
of  ||| S:20465 E:20468 ||| IN
detergent  ||| S:20468 E:20478 ||| NN
( ||| S:20478 E:20479 ||| -LRB-
Figure  ||| S:20479 E:20486 ||| NNP
7 ||| S:20486 E:20487 ||| CD
) ||| S:20487 E:20488 ||| -RRB-
.  ||| S:20488 E:20490 ||| .
When  ||| S:20490 E:20495 ||| WRB
extracted  ||| S:20495 E:20505 ||| VBN
with  ||| S:20505 E:20520 ||| IN
0.5 ||| S:20520 E:20523 ||| CD
%  ||| S:20523 E:20525 ||| NN
detergent ||| S:20525 E:20534 ||| NN
,  ||| S:20534 E:20536 ||| ,
a  ||| S:20536 E:20538 ||| DT
larger  ||| S:20538 E:20545 ||| JJR
amount  ||| S:20545 E:20552 ||| NN
of  ||| S:20552 E:20555 ||| IN
insoluble  ||| S:20555 E:20575 ||| JJ
phosphomoesin  ||| S:20575 E:20589 ||| NN
was  ||| S:20589 E:20593 ||| VBD
detected  ||| S:20593 E:20602 ||| VBN
with  ||| S:20602 E:20607 ||| IN
Triton  ||| S:20607 E:20614 ||| NNP
X-100  ||| S:20614 E:20620 ||| NNP
as  ||| S:20620 E:20623 ||| RB
compared  ||| S:20623 E:20642 ||| VBN
to  ||| S:20642 E:20645 ||| TO
DOTMAC ||| S:20645 E:20651 ||| NNP
.  ||| S:20651 E:20653 ||| .
Different  ||| S:20653 E:20663 ||| JJ
concentrations  ||| S:20663 E:20678 ||| NNS
of  ||| S:20678 E:20681 ||| IN
detergents  ||| S:20681 E:20692 ||| NNS
( ||| S:20692 E:20693 ||| -LRB-
0.1 ||| S:20693 E:20696 ||| CD
% ||| S:20696 E:20697 ||| NN
,  ||| S:20697 E:20709 ||| ,
1 ||| S:20709 E:20710 ||| CD
%  ||| S:20710 E:20712 ||| NN
and  ||| S:20712 E:20716 ||| CC
2 ||| S:20716 E:20717 ||| CD
% ||| S:20717 E:20718 ||| NN
)  ||| S:20718 E:20720 ||| -RRB-
were  ||| S:20720 E:20725 ||| VBD
tested  ||| S:20725 E:20732 ||| VBN
and  ||| S:20732 E:20736 ||| CC
correlated  ||| S:20736 E:20747 ||| NN
with  ||| S:20747 E:20752 ||| IN
the  ||| S:20752 E:20756 ||| DT
amount  ||| S:20756 E:20763 ||| NN
of  ||| S:20763 E:20776 ||| IN
moesin  ||| S:20776 E:20783 ||| VBG
released  ||| S:20783 E:20792 ||| VBN
from  ||| S:20792 E:20797 ||| IN
NIH3T3  ||| S:20797 E:20804 ||| CD
cells ||| S:20804 E:20809 ||| NNS
,  ||| S:20809 E:20811 ||| ,
but  ||| S:20811 E:20815 ||| CC
the  ||| S:20815 E:20819 ||| DT
insoluble  ||| S:20819 E:20839 ||| JJ
fraction  ||| S:20839 E:20848 ||| NN
of  ||| S:20848 E:20851 ||| IN
moesin  ||| S:20851 E:20858 ||| NN
was  ||| S:20858 E:20862 ||| VBD
always  ||| S:20862 E:20869 ||| RB
higher  ||| S:20869 E:20876 ||| JJR
with  ||| S:20876 E:20881 ||| IN
Triton  ||| S:20881 E:20888 ||| NNP
X-100  ||| S:20888 E:20904 ||| NNP
than  ||| S:20904 E:20909 ||| IN
with  ||| S:20909 E:20914 ||| IN
DOTMAC  ||| S:20914 E:20921 ||| NNP
( ||| S:20921 E:20922 ||| -LRB-
data  ||| S:20922 E:20927 ||| NNS
not  ||| S:20927 E:20931 ||| RB
shown ||| S:20931 E:20936 ||| VBN
) ||| S:20936 E:20937 ||| -RRB-
.  ||| S:20937 E:20949 ||| .
We  ||| S:20949 E:20952 ||| PRP
also  ||| S:20952 E:20957 ||| RB
analysed  ||| S:20957 E:20966 ||| VBN
for  ||| S:20966 E:20970 ||| IN
tyrosine-phosphorylated  ||| S:20970 E:20994 ||| JJ
proteins  ||| S:20994 E:21013 ||| NNS
in  ||| S:21013 E:21016 ||| IN
the  ||| S:21016 E:21020 ||| DT
insoluble  ||| S:21020 E:21030 ||| JJ
fraction  ||| S:21030 E:21039 ||| NN
of  ||| S:21039 E:21042 ||| IN
cells  ||| S:21042 E:21048 ||| NNS
treated  ||| S:21048 E:21056 ||| VBN
with  ||| S:21056 E:21071 ||| IN
pervanadate  ||| S:21071 E:21083 ||| NNS
( ||| S:21083 E:21084 ||| -LRB-
PV ||| S:21084 E:21086 ||| NNP
) ||| S:21086 E:21087 ||| -RRB-
,  ||| S:21087 E:21089 ||| ,
a  ||| S:21089 E:21091 ||| DT
potent  ||| S:21091 E:21098 ||| JJ
inhibitor  ||| S:21098 E:21108 ||| NN
of  ||| S:21108 E:21111 ||| IN
tyrosine  ||| S:21111 E:21130 ||| JJ
phosphatases ||| S:21130 E:21142 ||| NN
,  ||| S:21142 E:21144 ||| ,
extracted  ||| S:21144 E:21154 ||| VBN
with  ||| S:21154 E:21159 ||| IN
0.5 ||| S:21159 E:21162 ||| CD
%  ||| S:21162 E:21164 ||| NN
detergent ||| S:21164 E:21173 ||| NN
.  ||| S:21173 E:21175 ||| .
A  ||| S:21175 E:21177 ||| DT
larger  ||| S:21177 E:21194 ||| JJR
fraction  ||| S:21194 E:21203 ||| NN
of  ||| S:21203 E:21206 ||| IN
tyrosine-phosphorylated  ||| S:21206 E:21230 ||| JJ
proteins  ||| S:21230 E:21239 ||| NNS
were  ||| S:21239 E:21254 ||| VBD
recovered  ||| S:21254 E:21264 ||| VBN
in  ||| S:21264 E:21267 ||| IN
the  ||| S:21267 E:21271 ||| DT
DOTMAC-insoluble  ||| S:21271 E:21288 ||| JJ
pellet  ||| S:21288 E:21295 ||| NNS
( ||| S:21295 E:21296 ||| -LRB-
unpublished  ||| S:21296 E:21318 ||| JJ
observation ||| S:21318 E:21329 ||| NN
)  ||| S:21329 E:21359 ||| -RRB-
DOTMAC  ||| S:21359 E:21366 ||| NNP
induces  ||| S:21366 E:21374 ||| VBZ
bundling  ||| S:21374 E:21383 ||| VBG
of  ||| S:21383 E:21386 ||| IN
actin  ||| S:21386 E:21392 ||| JJ
filaments  ||| S:21392 E:21402 ||| NN
and  ||| S:21402 E:21416 ||| CC
microtubules  ||| S:21416 E:21439 ||| VBG
The  ||| S:21439 E:21443 ||| DT
excellent  ||| S:21443 E:21453 ||| JJ
preservation  ||| S:21453 E:21466 ||| NN
of  ||| S:21466 E:21469 ||| IN
the  ||| S:21469 E:21473 ||| DT
cytoskeleton  ||| S:21473 E:21486 ||| NN
in  ||| S:21486 E:21499 ||| IN
microextensions  ||| S:21499 E:21515 ||| NN
of  ||| S:21515 E:21518 ||| IN
cells  ||| S:21518 E:21524 ||| NNS
fixed  ||| S:21524 E:21530 ||| VBN
with  ||| S:21530 E:21535 ||| IN
PFA ||| S:21535 E:21538 ||| NNP
/ ||| S:21538 E:21539 ||| NNP
DOTMAC  ||| S:21539 E:21546 ||| NNP
could  ||| S:21546 E:21552 ||| MD
be  ||| S:21552 E:21565 ||| VB
due  ||| S:21565 E:21569 ||| JJ
to  ||| S:21569 E:21572 ||| TO
stabilization  ||| S:21572 E:21586 ||| VB
of  ||| S:21586 E:21589 ||| IN
the  ||| S:21589 E:21593 ||| DT
cytoskeleton  ||| S:21593 E:21606 ||| NN
in  ||| S:21606 E:21609 ||| IN
general  ||| S:21609 E:21617 ||| JJ
or  ||| S:21617 E:21620 ||| CC
of  ||| S:21620 E:21633 ||| IN
actin  ||| S:21633 E:21639 ||| JJ
filaments  ||| S:21639 E:21649 ||| JJ
selectively ||| S:21649 E:21660 ||| NN
.  ||| S:21660 E:21662 ||| .
We ||| S:21662 E:21664 ||| PRP
,  ||| S:21664 E:21666 ||| ,
therefore ||| S:21666 E:21675 ||| RB
,  ||| S:21675 E:21677 ||| ,
explored  ||| S:21677 E:21696 ||| VBG
whether  ||| S:21696 E:21704 ||| IN
DOTMAC  ||| S:21704 E:21711 ||| NNP
has  ||| S:21711 E:21715 ||| VBZ
a  ||| S:21715 E:21717 ||| DT
direct  ||| S:21717 E:21724 ||| JJ
effect  ||| S:21724 E:21731 ||| NN
in  ||| S:21731 E:21734 ||| IN
vitro  ||| S:21734 E:21740 ||| NN
on  ||| S:21740 E:21743 ||| IN
actin  ||| S:21743 E:21759 ||| NNS
filaments  ||| S:21759 E:21769 ||| VBP
prepared  ||| S:21769 E:21778 ||| VBN
from  ||| S:21778 E:21783 ||| IN
purified  ||| S:21783 E:21792 ||| JJ
actin ||| S:21792 E:21797 ||| NN
.  ||| S:21797 E:21799 ||| .
As  ||| S:21799 E:21802 ||| RB
shown  ||| S:21802 E:21808 ||| VBN
in  ||| S:21808 E:21821 ||| IN
Figure  ||| S:21821 E:21828 ||| NNP
8 ||| S:21828 E:21829 ||| CD
,  ||| S:21829 E:21831 ||| ,
actin  ||| S:21831 E:21837 ||| NNS
filaments  ||| S:21837 E:21847 ||| VBP
bundled  ||| S:21847 E:21855 ||| VBN
in  ||| S:21855 E:21858 ||| IN
the  ||| S:21858 E:21862 ||| DT
presence  ||| S:21862 E:21871 ||| NN
of  ||| S:21871 E:21884 ||| IN
DOTMAC  ||| S:21884 E:21891 ||| NNP
( ||| S:21891 E:21892 ||| -LRB-
Figure  ||| S:21892 E:21899 ||| NNP
8B ||| S:21899 E:21901 ||| NNP
)  ||| S:21901 E:21903 ||| -RRB-
suggesting  ||| S:21903 E:21914 ||| VBG
that  ||| S:21914 E:21919 ||| IN
this  ||| S:21919 E:21924 ||| DT
might  ||| S:21924 E:21930 ||| MD
contribute  ||| S:21930 E:21951 ||| VB
to  ||| S:21951 E:21954 ||| TO
the  ||| S:21954 E:21958 ||| DT
greater  ||| S:21958 E:21966 ||| JJR
stability  ||| S:21966 E:21976 ||| NN
of  ||| S:21976 E:21979 ||| IN
the  ||| S:21979 E:21983 ||| DT
actin  ||| S:21983 E:21989 ||| JJ
cytoskeleton  ||| S:21989 E:22002 ||| NN
that  ||| S:22002 E:22017 ||| IN
we  ||| S:22017 E:22020 ||| PRP
have  ||| S:22020 E:22025 ||| VBP
observed  ||| S:22025 E:22034 ||| VBN
in  ||| S:22034 E:22037 ||| IN
cells  ||| S:22037 E:22043 ||| NNS
extracted  ||| S:22043 E:22053 ||| VBN
with  ||| S:22053 E:22058 ||| IN
this  ||| S:22058 E:22063 ||| DT
detergent ||| S:22063 E:22072 ||| NN
.  ||| S:22072 E:22084 ||| .
This  ||| S:22084 E:22089 ||| DT
effect  ||| S:22089 E:22096 ||| NN
is  ||| S:22096 E:22099 ||| VBZ
relatively  ||| S:22099 E:22110 ||| RB
specific  ||| S:22110 E:22119 ||| JJ
since  ||| S:22119 E:22125 ||| IN
DOTMAC  ||| S:22125 E:22132 ||| NNP
disrupted  ||| S:22132 E:22152 ||| VBD
microtubules  ||| S:22152 E:22165 ||| JJ
and  ||| S:22165 E:22169 ||| CC
they  ||| S:22169 E:22174 ||| PRP
appeared  ||| S:22174 E:22183 ||| VBD
as  ||| S:22183 E:22186 ||| IN
amorphous  ||| S:22186 E:22196 ||| JJ
filaments  ||| S:22196 E:22216 ||| NNS
( ||| S:22216 E:22217 ||| -LRB-
Figure  ||| S:22217 E:22224 ||| NNP
8D ||| S:22224 E:22226 ||| NNP
) ||| S:22226 E:22227 ||| -RRB-
.  ||| S:22227 E:22260 ||| .
Discussion  ||| S:22260 E:22290 ||| NNP
Detection  ||| S:22290 E:22300 ||| NNP
and  ||| S:22300 E:22304 ||| CC
definition  ||| S:22304 E:22315 ||| NN
of  ||| S:22315 E:22318 ||| IN
micropodia  ||| S:22318 E:22329 ||| NN
and  ||| S:22329 E:22343 ||| CC
ultramicroextensions  ||| S:22343 E:22374 ||| JJ
Extensions  ||| S:22374 E:22385 ||| NNS
of  ||| S:22385 E:22388 ||| IN
the  ||| S:22388 E:22392 ||| DT
cell  ||| S:22392 E:22397 ||| NN
surface  ||| S:22397 E:22405 ||| NN
were  ||| S:22405 E:22410 ||| VBD
first  ||| S:22410 E:22416 ||| RB
described  ||| S:22416 E:22426 ||| VBN
as  ||| S:22426 E:22439 ||| IN
fibrous  ||| S:22439 E:22447 ||| JJ
projections  ||| S:22447 E:22459 ||| NNS
of  ||| S:22459 E:22462 ||| IN
tissue  ||| S:22462 E:22469 ||| NN
culture  ||| S:22469 E:22477 ||| NN
cells  ||| S:22477 E:22483 ||| NNS
by  ||| S:22483 E:22486 ||| IN
electron  ||| S:22486 E:22505 ||| JJ
microscopy  ||| S:22505 E:22516 ||| NN
in  ||| S:22516 E:22519 ||| IN
1945  ||| S:22519 E:22524 ||| CD
[  ||| S:22524 E:22526 ||| -LRB-
23 ||| S:22526 E:22528 ||| CD
] ||| S:22528 E:22529 ||| -RRB-
.  ||| S:22529 E:22531 ||| .
Since  ||| S:22531 E:22537 ||| IN
then ||| S:22537 E:22541 ||| RB
,  ||| S:22541 E:22543 ||| ,
the  ||| S:22543 E:22547 ||| DT
terminology  ||| S:22547 E:22559 ||| NN
has  ||| S:22559 E:22573 ||| VBZ
varied  ||| S:22573 E:22580 ||| VBN
in  ||| S:22580 E:22583 ||| IN
the  ||| S:22583 E:22587 ||| DT
literature  ||| S:22587 E:22598 ||| NN
and  ||| S:22598 E:22602 ||| CC
extensions  ||| S:22602 E:22613 ||| NNS
have  ||| S:22613 E:22618 ||| VBP
been  ||| S:22618 E:22633 ||| VBN
designated  ||| S:22633 E:22644 ||| VBN
as  ||| S:22644 E:22647 ||| IN
pseudopodia  ||| S:22647 E:22659 ||| NNS
[  ||| S:22659 E:22661 ||| -LRB-
24 ||| S:22661 E:22663 ||| CD
] ||| S:22663 E:22664 ||| -RRB-
,  ||| S:22664 E:22666 ||| ,
microextensions  ||| S:22666 E:22682 ||| NNS
[  ||| S:22682 E:22684 ||| -LRB-
25 ||| S:22684 E:22686 ||| CD
] ||| S:22686 E:22687 ||| -RRB-
,  ||| S:22687 E:22699 ||| ,
retraction  ||| S:22699 E:22710 ||| JJ
fibers  ||| S:22710 E:22717 ||| NNS
[  ||| S:22717 E:22719 ||| -LRB-
25 ||| S:22719 E:22721 ||| CD
] ||| S:22721 E:22722 ||| -RRB-
,  ||| S:22722 E:22724 ||| ,
microspikes  ||| S:22724 E:22736 ||| NNS
[  ||| S:22736 E:22738 ||| -LRB-
26 ||| S:22738 E:22740 ||| CD
] ||| S:22740 E:22741 ||| -RRB-
,  ||| S:22741 E:22743 ||| ,
filopodia  ||| S:22743 E:22753 ||| NNS
[  ||| S:22753 E:22765 ||| -LRB-
24 ||| S:22765 E:22767 ||| CD
,  ||| S:22767 E:22769 ||| ,
27 ||| S:22769 E:22771 ||| CD
,  ||| S:22771 E:22773 ||| ,
28 ||| S:22773 E:22775 ||| CD
] ||| S:22775 E:22776 ||| -RRB-
,  ||| S:22776 E:22778 ||| ,
often  ||| S:22778 E:22784 ||| RB
without  ||| S:22784 E:22792 ||| IN
a  ||| S:22792 E:22794 ||| DT
clear  ||| S:22794 E:22800 ||| JJ
definition  ||| S:22800 E:22811 ||| NN
of  ||| S:22811 E:22814 ||| IN
these  ||| S:22814 E:22830 ||| DT
terms ||| S:22830 E:22835 ||| NNS
.  ||| S:22835 E:22837 ||| .
Microvilli  ||| S:22837 E:22848 ||| NNS
are  ||| S:22848 E:22852 ||| VBP
light  ||| S:22852 E:22858 ||| JJ
microscopically  ||| S:22858 E:22874 ||| JJ
distinct  ||| S:22874 E:22883 ||| NN
from  ||| S:22883 E:22898 ||| IN
filopodia  ||| S:22898 E:22908 ||| NN
and  ||| S:22908 E:22912 ||| CC
retraction  ||| S:22912 E:22923 ||| JJ
fibers  ||| S:22923 E:22930 ||| NNS
[  ||| S:22930 E:22932 ||| -LRB-
29 ||| S:22932 E:22934 ||| CD
] ||| S:22934 E:22935 ||| -RRB-
.  ||| S:22935 E:22937 ||| .
Filopodia  ||| S:22937 E:22947 ||| NNP
or  ||| S:22947 E:22960 ||| CC
microspikes  ||| S:22960 E:22972 ||| NNS
extend  ||| S:22972 E:22979 ||| VBP
actively  ||| S:22979 E:22988 ||| RB
from  ||| S:22988 E:22993 ||| IN
the  ||| S:22993 E:22997 ||| DT
cell  ||| S:22997 E:23002 ||| NN
surface ||| S:23002 E:23009 ||| NN
,  ||| S:23009 E:23021 ||| ,
whereas  ||| S:23021 E:23029 ||| IN
retraction  ||| S:23029 E:23040 ||| JJ
fibers  ||| S:23040 E:23047 ||| NNS
are  ||| S:23047 E:23051 ||| VBP
extensions  ||| S:23051 E:23062 ||| NNS
that  ||| S:23062 E:23067 ||| WDT
have  ||| S:23067 E:23072 ||| VBP
been  ||| S:23072 E:23087 ||| VBN
left  ||| S:23087 E:23092 ||| VBN
behind  ||| S:23092 E:23099 ||| RP
by  ||| S:23099 E:23102 ||| IN
a  ||| S:23102 E:23104 ||| DT
retracting  ||| S:23104 E:23115 ||| JJ
lamellipodium  ||| S:23115 E:23129 ||| NN
or  ||| S:23129 E:23132 ||| CC
that  ||| S:23132 E:23137 ||| WDT
are  ||| S:23137 E:23151 ||| VBP
derived  ||| S:23151 E:23159 ||| VBN
from  ||| S:23159 E:23164 ||| IN
an  ||| S:23164 E:23167 ||| DT
attached  ||| S:23167 E:23176 ||| JJ
filopodium ||| S:23176 E:23186 ||| NN
.  ||| S:23186 E:23188 ||| .
We  ||| S:23188 E:23191 ||| PRP
use  ||| S:23191 E:23195 ||| VBP
the  ||| S:23195 E:23199 ||| DT
term  ||| S:23199 E:23214 ||| NN
"micropodia ||| S:23214 E:23225 ||| VBZ
"  ||| S:23225 E:23227 ||| ``
here  ||| S:23227 E:23232 ||| RB
for  ||| S:23232 E:23236 ||| IN
morphologically  ||| S:23236 E:23252 ||| JJ
describing  ||| S:23252 E:23273 ||| JJ
filopodia ||| S:23273 E:23282 ||| NN
,  ||| S:23282 E:23284 ||| ,
microspikes ||| S:23284 E:23295 ||| NN
,  ||| S:23295 E:23297 ||| ,
and  ||| S:23297 E:23301 ||| CC
retraction  ||| S:23301 E:23312 ||| JJ
fibers ||| S:23312 E:23318 ||| NNS
,  ||| S:23318 E:23320 ||| ,
and  ||| S:23320 E:23324 ||| CC
to  ||| S:23324 E:23337 ||| TO
differentiate  ||| S:23337 E:23351 ||| VB
these  ||| S:23351 E:23357 ||| DT
structures  ||| S:23357 E:23368 ||| NNS
from  ||| S:23368 E:23373 ||| IN
lamellipodia ||| S:23373 E:23385 ||| NN
.  ||| S:23385 E:23387 ||| .
While  ||| S:23387 E:23403 ||| IN
the  ||| S:23403 E:23407 ||| DT
transiently  ||| S:23407 E:23419 ||| NN
occurring  ||| S:23419 E:23429 ||| VBG
filopodia  ||| S:23429 E:23439 ||| NNS
and  ||| S:23439 E:23443 ||| CC
retraction  ||| S:23443 E:23454 ||| JJ
fibers  ||| S:23454 E:23471 ||| NNS
can  ||| S:23471 E:23475 ||| MD
largely  ||| S:23475 E:23483 ||| RB
be  ||| S:23483 E:23486 ||| VB
distinguished  ||| S:23486 E:23500 ||| VBN
only  ||| S:23500 E:23505 ||| RB
by  ||| S:23505 E:23508 ||| IN
time-lapse  ||| S:23508 E:23519 ||| JJ
video  ||| S:23519 E:23535 ||| NN
microscopy  ||| S:23535 E:23546 ||| NNS
[  ||| S:23546 E:23548 ||| -LRB-
22 ||| S:23548 E:23550 ||| CD
] ||| S:23550 E:23551 ||| -RRB-
,  ||| S:23551 E:23553 ||| ,
both ||| S:23553 E:23557 ||| DT
,  ||| S:23557 E:23559 ||| ,
micropodia  ||| S:23559 E:23570 ||| NN
and  ||| S:23570 E:23574 ||| CC
lamellipodia ||| S:23574 E:23586 ||| NN
,  ||| S:23586 E:23588 ||| ,
are  ||| S:23588 E:23602 ||| VBP
functionally  ||| S:23602 E:23615 ||| VBN
related  ||| S:23615 E:23623 ||| VBN
to  ||| S:23623 E:23626 ||| TO
movement  ||| S:23626 E:23635 ||| NN
of  ||| S:23635 E:23638 ||| IN
cells ||| S:23638 E:23643 ||| NNS
.  ||| S:23643 E:23645 ||| .
Micropodia  ||| S:23645 E:23666 ||| NNP
were  ||| S:23666 E:23671 ||| VBD
reported  ||| S:23671 E:23680 ||| VBN
to  ||| S:23680 E:23683 ||| TO
have  ||| S:23683 E:23688 ||| VB
diameters  ||| S:23688 E:23698 ||| VBN
of  ||| S:23698 E:23701 ||| IN
about  ||| S:23701 E:23707 ||| IN
0.2  ||| S:23707 E:23711 ||| CD
μm  ||| S:23711 E:23714 ||| NNS
[  ||| S:23714 E:23716 ||| -LRB-
29 ||| S:23716 E:23718 ||| CD
]  ||| S:23718 E:23720 ||| -RRB-
or  ||| S:23720 E:23733 ||| CC
0.08∼  ||| S:23733 E:23739 ||| CD
0.16  ||| S:23739 E:23744 ||| CD
μm  ||| S:23744 E:23747 ||| NNS
[  ||| S:23747 E:23749 ||| -LRB-
20 ||| S:23749 E:23751 ||| CD
]  ||| S:23751 E:23753 ||| -RRB-
and  ||| S:23753 E:23757 ||| CC
lengths  ||| S:23757 E:23765 ||| NNS
ranging  ||| S:23765 E:23773 ||| VBG
from  ||| S:23773 E:23778 ||| IN
5  ||| S:23778 E:23780 ||| CD
to  ||| S:23780 E:23783 ||| TO
30  ||| S:23783 E:23786 ||| CD
μm  ||| S:23786 E:23789 ||| NNS
[  ||| S:23789 E:23801 ||| -LRB-
29 ||| S:23801 E:23803 ||| CD
] ||| S:23803 E:23804 ||| -RRB-
.  ||| S:23804 E:23806 ||| .
On  ||| S:23806 E:23809 ||| IN
the  ||| S:23809 E:23813 ||| DT
other  ||| S:23813 E:23819 ||| JJ
hand ||| S:23819 E:23823 ||| NN
,  ||| S:23823 E:23825 ||| ,
microvilli  ||| S:23825 E:23836 ||| NNS
are  ||| S:23836 E:23840 ||| VBP
more  ||| S:23840 E:23845 ||| RBR
permanent  ||| S:23845 E:23865 ||| JJ
discrete  ||| S:23865 E:23874 ||| JJ
cylindrical  ||| S:23874 E:23886 ||| JJ
projections  ||| S:23886 E:23898 ||| NNS
about  ||| S:23898 E:23904 ||| IN
0.1  ||| S:23904 E:23908 ||| CD
μm  ||| S:23908 E:23911 ||| NN
in  ||| S:23911 E:23914 ||| IN
diameter  ||| S:23914 E:23933 ||| NN
and  ||| S:23933 E:23937 ||| CC
up  ||| S:23937 E:23940 ||| RB
to  ||| S:23940 E:23943 ||| TO
2  ||| S:23943 E:23945 ||| CD
μm  ||| S:23945 E:23948 ||| NN
in  ||| S:23948 E:23951 ||| IN
length  ||| S:23951 E:23958 ||| NN
[  ||| S:23958 E:23960 ||| -LRB-
29 ||| S:23960 E:23962 ||| CD
]  ||| S:23962 E:23964 ||| -RRB-
that  ||| S:23964 E:23969 ||| WDT
may  ||| S:23969 E:23973 ||| MD
serve  ||| S:23973 E:23979 ||| VB
different  ||| S:23979 E:23999 ||| JJ
purposes ||| S:23999 E:24007 ||| NNS
,  ||| S:24007 E:24009 ||| ,
such  ||| S:24009 E:24014 ||| JJ
as  ||| S:24014 E:24017 ||| IN
in  ||| S:24017 E:24020 ||| IN
brushborder  ||| S:24020 E:24032 ||| JJ
membranes  ||| S:24032 E:24042 ||| NN
of  ||| S:24042 E:24045 ||| IN
the  ||| S:24045 E:24059 ||| DT
intestinal  ||| S:24059 E:24070 ||| JJ
epithelium  ||| S:24070 E:24081 ||| NN
or  ||| S:24081 E:24084 ||| CC
in  ||| S:24084 E:24087 ||| IN
lymphocytes ||| S:24087 E:24098 ||| NN
.  ||| S:24098 E:24100 ||| .
Numerous  ||| S:24100 E:24109 ||| JJ
slender  ||| S:24109 E:24127 ||| JJ
extensions  ||| S:24127 E:24138 ||| NNS
running  ||| S:24138 E:24146 ||| VBG
in  ||| S:24146 E:24149 ||| IN
parallel  ||| S:24149 E:24158 ||| NN
were  ||| S:24158 E:24163 ||| VBD
observed  ||| S:24163 E:24172 ||| VBN
previously ||| S:24172 E:24182 ||| RB
,  ||| S:24182 E:24194 ||| ,
when  ||| S:24194 E:24199 ||| WRB
rat  ||| S:24199 E:24203 ||| JJ
epithelial  ||| S:24203 E:24214 ||| NNS
( ||| S:24214 E:24215 ||| -LRB-
parenchymal ||| S:24215 E:24226 ||| LS
)  ||| S:24226 E:24228 ||| -RRB-
cells  ||| S:24228 E:24234 ||| NNS
adhere  ||| S:24234 E:24241 ||| VBP
to  ||| S:24241 E:24244 ||| TO
each  ||| S:24244 E:24259 ||| DT
other  ||| S:24259 E:24265 ||| JJ
[  ||| S:24265 E:24267 ||| -LRB-
30 ||| S:24267 E:24269 ||| CD
] ||| S:24269 E:24270 ||| -RRB-
.  ||| S:24270 E:24272 ||| .
Similar  ||| S:24272 E:24280 ||| JJ
structures  ||| S:24280 E:24291 ||| NNS
also  ||| S:24291 E:24296 ||| RB
occur  ||| S:24296 E:24302 ||| VB
in  ||| S:24302 E:24305 ||| IN
primary  ||| S:24305 E:24323 ||| JJ
keratinocytes  ||| S:24323 E:24337 ||| FW
mediating  ||| S:24337 E:24347 ||| FW
intercellular  ||| S:24347 E:24361 ||| FW
adhesion  ||| S:24361 E:24370 ||| FW
[  ||| S:24370 E:24372 ||| -LRB-
31 ||| S:24372 E:24374 ||| CD
] ||| S:24374 E:24375 ||| -RRB-
.  ||| S:24375 E:24387 ||| .
However ||| S:24387 E:24394 ||| RB
,  ||| S:24394 E:24396 ||| ,
these  ||| S:24396 E:24402 ||| DT
extensions  ||| S:24402 E:24413 ||| NNS
appeared  ||| S:24413 E:24422 ||| VBD
to  ||| S:24422 E:24425 ||| TO
be  ||| S:24425 E:24428 ||| VB
thicker  ||| S:24428 E:24446 ||| JJR
( ||| S:24446 E:24447 ||| -LRB-
estimated  ||| S:24447 E:24457 ||| VBN
as  ||| S:24457 E:24460 ||| IN
0.1μm  ||| S:24460 E:24466 ||| CD
in  ||| S:24466 E:24469 ||| IN
diameter ||| S:24469 E:24477 ||| NN
,  ||| S:24477 E:24479 ||| ,
although  ||| S:24479 E:24488 ||| IN
their  ||| S:24488 E:24494 ||| PRP$
apparent  ||| S:24494 E:24513 ||| JJ
diameter  ||| S:24513 E:24522 ||| NN
depended  ||| S:24522 E:24531 ||| VBD
on  ||| S:24531 E:24534 ||| IN
conditions  ||| S:24534 E:24545 ||| NNS
of  ||| S:24545 E:24548 ||| IN
coating  ||| S:24548 E:24556 ||| NN
with  ||| S:24556 E:24571 ||| IN
metals ||| S:24571 E:24577 ||| NNS
) ||| S:24577 E:24578 ||| -RRB-
.  ||| S:24578 E:24590 ||| .
Our  ||| S:24590 E:24594 ||| PRP$
experiments  ||| S:24594 E:24606 ||| NNS
were  ||| S:24606 E:24611 ||| VBD
focused  ||| S:24611 E:24619 ||| VBN
on  ||| S:24619 E:24622 ||| IN
the  ||| S:24622 E:24626 ||| DT
analysis  ||| S:24626 E:24635 ||| NN
of  ||| S:24635 E:24648 ||| IN
microextensions  ||| S:24648 E:24664 ||| NN
and  ||| S:24664 E:24668 ||| CC
their  ||| S:24668 E:24674 ||| PRP$
cytoskeletal  ||| S:24674 E:24687 ||| JJ
core  ||| S:24687 E:24692 ||| NN
by  ||| S:24692 E:24695 ||| IN
SEM  ||| S:24695 E:24699 ||| NNP
and  ||| S:24699 E:24713 ||| CC
confocal  ||| S:24713 E:24722 ||| JJ
laser  ||| S:24722 E:24728 ||| NN
scanning  ||| S:24728 E:24737 ||| NN
microscopy  ||| S:24737 E:24748 ||| NN
by  ||| S:24748 E:24751 ||| IN
searching  ||| S:24751 E:24761 ||| VBG
for  ||| S:24761 E:24765 ||| IN
a  ||| S:24765 E:24767 ||| DT
new  ||| S:24767 E:24781 ||| JJ
fixation  ||| S:24781 E:24790 ||| JJ
protocol ||| S:24790 E:24798 ||| NN
.  ||| S:24798 E:24800 ||| .
Here ||| S:24800 E:24804 ||| RB
,  ||| S:24804 E:24806 ||| ,
we  ||| S:24806 E:24809 ||| PRP
clearly  ||| S:24809 E:24817 ||| RB
show  ||| S:24817 E:24822 ||| VB
that  ||| S:24822 E:24827 ||| IN
NIH3T3  ||| S:24827 E:24844 ||| CD
cells  ||| S:24844 E:24850 ||| NNS
not  ||| S:24850 E:24854 ||| RB
only  ||| S:24854 E:24859 ||| RB
extend  ||| S:24859 E:24866 ||| VB
microextensions  ||| S:24866 E:24882 ||| VBN
of  ||| S:24882 E:24885 ||| IN
0.1∼  ||| S:24885 E:24890 ||| CD
0.2  ||| S:24890 E:24894 ||| CD
μm  ||| S:24894 E:24897 ||| NN
in  ||| S:24897 E:24910 ||| IN
diameter  ||| S:24910 E:24919 ||| NN
and  ||| S:24919 E:24923 ||| CC
of  ||| S:24923 E:24926 ||| IN
up  ||| S:24926 E:24929 ||| RB
to  ||| S:24929 E:24932 ||| TO
∼  ||| S:24932 E:24934 ||| CD
40  ||| S:24934 E:24937 ||| CD
μm  ||| S:24937 E:24940 ||| NN
in  ||| S:24940 E:24943 ||| IN
length ||| S:24943 E:24949 ||| NN
,  ||| S:24949 E:24951 ||| ,
but  ||| S:24951 E:24955 ||| CC
also  ||| S:24955 E:24960 ||| RB
slender  ||| S:24960 E:24978 ||| JJ
structures  ||| S:24978 E:24989 ||| NNS
of  ||| S:24989 E:24992 ||| IN
less  ||| S:24992 E:24997 ||| JJR
than  ||| S:24997 E:25002 ||| IN
0.05  ||| S:25002 E:25007 ||| CD
μm  ||| S:25007 E:25010 ||| JJ
diameter ||| S:25010 E:25018 ||| NN
.  ||| S:25018 E:25020 ||| .
The  ||| S:25020 E:25024 ||| DT
latter  ||| S:25024 E:25031 ||| NN
were  ||| S:25031 E:25046 ||| VBD
previously  ||| S:25046 E:25057 ||| RB
described  ||| S:25057 E:25067 ||| VBN
in  ||| S:25067 E:25070 ||| IN
the  ||| S:25070 E:25074 ||| DT
tumor  ||| S:25074 E:25080 ||| NN
cell  ||| S:25080 E:25085 ||| NN
lines  ||| S:25085 E:25091 ||| NNS
K-A31  ||| S:25091 E:25107 ||| VBP
( ||| S:25107 E:25108 ||| -LRB-
Balb ||| S:25108 E:25112 ||| FW
/ ||| S:25112 E:25113 ||| FW
3T3  ||| S:25113 E:25117 ||| FW
clone  ||| S:25117 E:25123 ||| FW
A31  ||| S:25123 E:25127 ||| FW
transformed  ||| S:25127 E:25139 ||| FW
by  ||| S:25139 E:25142 ||| IN
murine  ||| S:25142 E:25149 ||| JJ
sarcoma  ||| S:25149 E:25157 ||| JJ
virus ||| S:25157 E:25162 ||| NN
,  ||| S:25162 E:25174 ||| ,
[  ||| S:25174 E:25176 ||| -LRB-
32 ||| S:25176 E:25178 ||| CD
] ||| S:25178 E:25179 ||| CD
) ||| S:25179 E:25180 ||| -RRB-
,  ||| S:25180 E:25182 ||| ,
and  ||| S:25182 E:25186 ||| CC
in  ||| S:25186 E:25189 ||| IN
A875 ||| S:25189 E:25193 ||| NNP
,  ||| S:25193 E:25195 ||| ,
a  ||| S:25195 E:25197 ||| DT
malignant  ||| S:25197 E:25207 ||| JJ
human  ||| S:25207 E:25213 ||| JJ
lung  ||| S:25213 E:25218 ||| NN
melanoma  ||| S:25218 E:25227 ||| NN
line  ||| S:25227 E:25242 ||| NN
[  ||| S:25242 E:25244 ||| -LRB-
33 ||| S:25244 E:25246 ||| CD
] ||| S:25246 E:25247 ||| -RRB-
.  ||| S:25247 E:25249 ||| .
In  ||| S:25249 E:25252 ||| IN
K-A31  ||| S:25252 E:25258 ||| CD
cells ||| S:25258 E:25263 ||| NNS
,  ||| S:25263 E:25265 ||| ,
membranous  ||| S:25265 E:25276 ||| JJ
strands  ||| S:25276 E:25284 ||| NN
with  ||| S:25284 E:25289 ||| IN
diameters  ||| S:25289 E:25309 ||| NN
of  ||| S:25309 E:25312 ||| IN
less  ||| S:25312 E:25317 ||| JJR
than  ||| S:25317 E:25322 ||| IN
0.1  ||| S:25322 E:25326 ||| CD
μm  ||| S:25326 E:25329 ||| NNS
extended  ||| S:25329 E:25338 ||| VBD
away  ||| S:25338 E:25343 ||| RP
from  ||| S:25343 E:25348 ||| IN
and  ||| S:25348 E:25352 ||| CC
between  ||| S:25352 E:25360 ||| IN
cells  ||| S:25360 E:25376 ||| NNS
over  ||| S:25376 E:25381 ||| IN
distances  ||| S:25381 E:25391 ||| NNS
of  ||| S:25391 E:25394 ||| IN
10-15  ||| S:25394 E:25400 ||| CD
μm ||| S:25400 E:25402 ||| NNS
.  ||| S:25402 E:25404 ||| .
In  ||| S:25404 E:25407 ||| IN
A875  ||| S:25407 E:25412 ||| CD
cells ||| S:25412 E:25417 ||| NNS
,  ||| S:25417 E:25419 ||| ,
"filopodia ||| S:25419 E:25429 ||| NNP
"  ||| S:25429 E:25441 ||| ''
had  ||| S:25441 E:25445 ||| VBD
diameters  ||| S:25445 E:25455 ||| VBN
of  ||| S:25455 E:25458 ||| IN
0.05  ||| S:25458 E:25463 ||| CD
μm  ||| S:25463 E:25466 ||| NNS
or  ||| S:25466 E:25469 ||| CC
less  ||| S:25469 E:25474 ||| JJR
and  ||| S:25474 E:25478 ||| CC
were  ||| S:25478 E:25483 ||| VBD
often  ||| S:25483 E:25489 ||| RB
branched ||| S:25489 E:25497 ||| VBN
.  ||| S:25497 E:25509 ||| .
However ||| S:25509 E:25516 ||| RB
,  ||| S:25516 E:25518 ||| ,
details  ||| S:25518 E:25526 ||| NNS
of  ||| S:25526 E:25529 ||| IN
these  ||| S:25529 E:25535 ||| DT
structures  ||| S:25535 E:25546 ||| NNS
were  ||| S:25546 E:25551 ||| VBD
not  ||| S:25551 E:25555 ||| RB
given  ||| S:25555 E:25561 ||| VBN
and  ||| S:25561 E:25575 ||| CC
not  ||| S:25575 E:25579 ||| RB
further  ||| S:25579 E:25587 ||| RB
discussed ||| S:25587 E:25596 ||| VBN
.  ||| S:25596 E:25598 ||| .
In  ||| S:25598 E:25601 ||| IN
the  ||| S:25601 E:25605 ||| DT
literature ||| S:25605 E:25615 ||| NN
,  ||| S:25615 E:25617 ||| ,
terms  ||| S:25617 E:25623 ||| NNS
such  ||| S:25623 E:25628 ||| JJ
as  ||| S:25628 E:25641 ||| IN
slender  ||| S:25641 E:25649 ||| JJ
filopodia  ||| S:25649 E:25659 ||| NNS
[  ||| S:25659 E:25661 ||| -LRB-
34 ||| S:25661 E:25663 ||| CD
,  ||| S:25663 E:25665 ||| ,
35 ||| S:25665 E:25667 ||| CD
] ||| S:25667 E:25668 ||| -RRB-
,  ||| S:25668 E:25670 ||| ,
or  ||| S:25670 E:25673 ||| CC
slender  ||| S:25673 E:25681 ||| JJ
microvilli  ||| S:25681 E:25692 ||| NNS
[  ||| S:25692 E:25694 ||| -LRB-
36 ||| S:25694 E:25696 ||| CD
,  ||| S:25696 E:25708 ||| ,
37 ||| S:25708 E:25710 ||| CD
]  ||| S:25710 E:25712 ||| -RRB-
have  ||| S:25712 E:25717 ||| VBP
been  ||| S:25717 E:25722 ||| VBN
used ||| S:25722 E:25726 ||| VBN
.  ||| S:25726 E:25728 ||| .
All  ||| S:25728 E:25732 ||| DT
filopodia  ||| S:25732 E:25742 ||| NN
and  ||| S:25742 E:25746 ||| CC
microvilli  ||| S:25746 E:25757 ||| NNS
are  ||| S:25757 E:25771 ||| VBP
morphologically  ||| S:25771 E:25787 ||| JJ
slender  ||| S:25787 E:25795 ||| NN
and  ||| S:25795 E:25799 ||| CC
these  ||| S:25799 E:25805 ||| DT
descriptive  ||| S:25805 E:25817 ||| JJ
terms  ||| S:25817 E:25823 ||| NNS
in  ||| S:25823 E:25836 ||| IN
general  ||| S:25836 E:25844 ||| JJ
have  ||| S:25844 E:25849 ||| VBP
not  ||| S:25849 E:25853 ||| RB
been  ||| S:25853 E:25858 ||| VBN
used  ||| S:25858 E:25863 ||| VBN
to  ||| S:25863 E:25866 ||| TO
refer  ||| S:25866 E:25872 ||| VB
to  ||| S:25872 E:25875 ||| TO
microextensions  ||| S:25875 E:25901 ||| VB
having  ||| S:25901 E:25908 ||| VBG
a  ||| S:25908 E:25910 ||| DT
particular  ||| S:25910 E:25921 ||| JJ
dimension ||| S:25921 E:25930 ||| NN
.  ||| S:25930 E:25932 ||| .
In  ||| S:25932 E:25935 ||| IN
order  ||| S:25935 E:25941 ||| NN
to  ||| S:25941 E:25944 ||| TO
distinguish  ||| S:25944 E:25966 ||| VB
them  ||| S:25966 E:25971 ||| PRP
from  ||| S:25971 E:25976 ||| IN
others  ||| S:25976 E:25983 ||| NNS
and  ||| S:25983 E:25987 ||| CC
to  ||| S:25987 E:25990 ||| TO
avoid  ||| S:25990 E:25996 ||| VB
confusion ||| S:25996 E:26005 ||| NN
,  ||| S:26005 E:26007 ||| ,
we  ||| S:26007 E:26010 ||| PRP
propose  ||| S:26010 E:26018 ||| VBP
the  ||| S:26018 E:26032 ||| DT
term  ||| S:26032 E:26037 ||| NN
ultramicroextensions  ||| S:26037 E:26058 ||| NN
for  ||| S:26058 E:26062 ||| IN
discrete  ||| S:26062 E:26071 ||| JJ
cellular  ||| S:26071 E:26090 ||| JJ
extensions  ||| S:26090 E:26101 ||| NNS
that  ||| S:26101 E:26106 ||| WDT
are  ||| S:26106 E:26110 ||| VBP
less  ||| S:26110 E:26115 ||| JJR
than  ||| S:26115 E:26120 ||| IN
0.05  ||| S:26120 E:26125 ||| CD
μm  ||| S:26125 E:26128 ||| NN
in  ||| S:26128 E:26131 ||| IN
diameter ||| S:26131 E:26139 ||| NN
.  ||| S:26139 E:26151 ||| .
Ultramicroextensions  ||| S:26151 E:26172 ||| RB
extend  ||| S:26172 E:26179 ||| VB
like  ||| S:26179 E:26184 ||| IN
micropodia  ||| S:26184 E:26195 ||| NN
from  ||| S:26195 E:26200 ||| IN
the  ||| S:26200 E:26204 ||| DT
cell  ||| S:26204 E:26219 ||| NN
surface ||| S:26219 E:26226 ||| NN
,  ||| S:26226 E:26228 ||| ,
from  ||| S:26228 E:26233 ||| IN
the  ||| S:26233 E:26237 ||| DT
tips  ||| S:26237 E:26242 ||| NNS
of  ||| S:26242 E:26245 ||| IN
micropodia ||| S:26245 E:26255 ||| NN
,  ||| S:26255 E:26257 ||| ,
from  ||| S:26257 E:26262 ||| IN
microvilli ||| S:26262 E:26272 ||| NN
,  ||| S:26272 E:26274 ||| ,
or  ||| S:26274 E:26287 ||| CC
they  ||| S:26287 E:26292 ||| PRP
branch  ||| S:26292 E:26299 ||| VB
out  ||| S:26299 E:26303 ||| RP
from  ||| S:26303 E:26308 ||| IN
micropodia  ||| S:26308 E:26319 ||| NN
or  ||| S:26319 E:26322 ||| CC
other  ||| S:26322 E:26338 ||| JJ
ultramicroextensions ||| S:26338 E:26358 ||| NN
.  ||| S:26358 E:26360 ||| .
We  ||| S:26360 E:26363 ||| PRP
strongly  ||| S:26363 E:26372 ||| RB
believe  ||| S:26372 E:26380 ||| VB
that  ||| S:26380 E:26385 ||| IN
these  ||| S:26385 E:26391 ||| DT
are  ||| S:26391 E:26405 ||| VBP
unique  ||| S:26405 E:26412 ||| JJ
structures  ||| S:26412 E:26423 ||| NNS
and  ||| S:26423 E:26427 ||| CC
not  ||| S:26427 E:26431 ||| RB
artificially  ||| S:26431 E:26444 ||| RB
created  ||| S:26444 E:26452 ||| VBN
by  ||| S:26452 E:26455 ||| IN
our  ||| S:26455 E:26469 ||| PRP$
sample  ||| S:26469 E:26476 ||| NN
preparation  ||| S:26476 E:26488 ||| NN
technique ||| S:26488 E:26497 ||| NN
.  ||| S:26497 E:26499 ||| .
First ||| S:26499 E:26504 ||| NNP
,  ||| S:26504 E:26506 ||| ,
unless  ||| S:26506 E:26513 ||| IN
cells  ||| S:26513 E:26529 ||| NNS
contacted  ||| S:26529 E:26539 ||| VBN
each  ||| S:26539 E:26544 ||| DT
other ||| S:26544 E:26549 ||| JJ
,  ||| S:26549 E:26551 ||| ,
they  ||| S:26551 E:26556 ||| PRP
were  ||| S:26556 E:26561 ||| VBD
rarely  ||| S:26561 E:26568 ||| RB
seen  ||| S:26568 E:26573 ||| VBN
even  ||| S:26573 E:26578 ||| RB
after  ||| S:26578 E:26594 ||| IN
incubation  ||| S:26594 E:26605 ||| NN
for  ||| S:26605 E:26609 ||| IN
prolonged  ||| S:26609 E:26619 ||| JJ
periods ||| S:26619 E:26626 ||| NNS
,  ||| S:26626 E:26628 ||| ,
suggesting  ||| S:26628 E:26639 ||| VBG
that  ||| S:26639 E:26644 ||| IN
they  ||| S:26644 E:26659 ||| PRP
are  ||| S:26659 E:26663 ||| VBP
not  ||| S:26663 E:26667 ||| RB
simply  ||| S:26667 E:26674 ||| RB
created  ||| S:26674 E:26682 ||| VBN
by  ||| S:26682 E:26685 ||| IN
the  ||| S:26685 E:26689 ||| DT
collapse  ||| S:26689 E:26698 ||| NN
of  ||| S:26698 E:26701 ||| IN
parts  ||| S:26701 E:26707 ||| NNS
of  ||| S:26707 E:26710 ||| IN
the  ||| S:26710 E:26724 ||| DT
cell ||| S:26724 E:26728 ||| NN
.  ||| S:26728 E:26730 ||| .
Secondly ||| S:26730 E:26738 ||| RB
,  ||| S:26738 E:26740 ||| ,
their  ||| S:26740 E:26746 ||| PRP$
shape  ||| S:26746 E:26752 ||| NN
is  ||| S:26752 E:26755 ||| VBZ
rather  ||| S:26755 E:26762 ||| RB
similar  ||| S:26762 E:26770 ||| JJ
to  ||| S:26770 E:26773 ||| TO
the  ||| S:26773 E:26787 ||| DT
generally  ||| S:26787 E:26797 ||| RB
larger  ||| S:26797 E:26804 ||| JJR
microspikes  ||| S:26804 E:26816 ||| NNS
or  ||| S:26816 E:26819 ||| CC
microvilli ||| S:26819 E:26829 ||| NN
.  ||| S:26829 E:26831 ||| .
Future  ||| S:26831 E:26838 ||| JJ
work  ||| S:26838 E:26853 ||| NN
might  ||| S:26853 E:26859 ||| MD
show  ||| S:26859 E:26864 ||| VB
that  ||| S:26864 E:26869 ||| IN
they  ||| S:26869 E:26874 ||| PRP
can  ||| S:26874 E:26878 ||| MD
be  ||| S:26878 E:26881 ||| VB
detected  ||| S:26881 E:26890 ||| VBN
by  ||| S:26890 E:26893 ||| IN
differential  ||| S:26893 E:26916 ||| JJ
interference-contrast  ||| S:26916 E:26938 ||| JJ
microscopy  ||| S:26938 E:26949 ||| NN
and  ||| S:26949 E:26953 ||| CC
electronic  ||| S:26953 E:26964 ||| JJ
image  ||| S:26964 E:26980 ||| NN
processing  ||| S:26980 E:26991 ||| NN
or  ||| S:26991 E:26994 ||| CC
other  ||| S:26994 E:27000 ||| JJ
techniques ||| S:27000 E:27010 ||| NNS
,  ||| S:27010 E:27012 ||| ,
which  ||| S:27012 E:27018 ||| WDT
would  ||| S:27018 E:27024 ||| MD
greatly  ||| S:27024 E:27042 ||| RB
facilitate  ||| S:27042 E:27053 ||| VB
functional  ||| S:27053 E:27064 ||| JJ
studies ||| S:27064 E:27071 ||| NNS
.  ||| S:27071 E:27073 ||| .
Ultramicroextensions  ||| S:27073 E:27094 ||| NNP
may  ||| S:27094 E:27108 ||| MD
be  ||| S:27108 E:27111 ||| VB
difficult  ||| S:27111 E:27121 ||| JJ
to  ||| S:27121 E:27124 ||| TO
distinguish  ||| S:27124 E:27136 ||| VB
by  ||| S:27136 E:27139 ||| IN
immunofluorescence  ||| S:27139 E:27168 ||| JJ
microscopy  ||| S:27168 E:27179 ||| NN
from  ||| S:27179 E:27184 ||| IN
micropodia  ||| S:27184 E:27195 ||| NNS
that  ||| S:27195 E:27200 ||| WDT
also  ||| S:27200 E:27205 ||| RB
appear  ||| S:27205 E:27212 ||| VB
as  ||| S:27212 E:27215 ||| IN
small  ||| S:27215 E:27231 ||| JJ
fluorescent  ||| S:27231 E:27243 ||| JJ
dots  ||| S:27243 E:27248 ||| NN
on  ||| S:27248 E:27251 ||| IN
the  ||| S:27251 E:27255 ||| DT
cell  ||| S:27255 E:27260 ||| NN
body ||| S:27260 E:27264 ||| NN
,  ||| S:27264 E:27266 ||| ,
or  ||| S:27266 E:27269 ||| CC
they  ||| S:27269 E:27274 ||| PRP
may  ||| S:27274 E:27278 ||| MD
remain  ||| S:27278 E:27295 ||| VB
undetected  ||| S:27295 E:27306 ||| JJ
due  ||| S:27306 E:27310 ||| JJ
to  ||| S:27310 E:27313 ||| TO
low  ||| S:27313 E:27317 ||| JJ
fluorescence  ||| S:27317 E:27330 ||| NNS
signal  ||| S:27330 E:27337 ||| VBP
owing  ||| S:27337 E:27343 ||| VBG
to  ||| S:27343 E:27346 ||| TO
their  ||| S:27346 E:27362 ||| PRP$
small  ||| S:27362 E:27368 ||| JJ
size ||| S:27368 E:27372 ||| NN
.  ||| S:27372 E:27374 ||| .
The  ||| S:27374 E:27378 ||| DT
filopodia  ||| S:27378 E:27388 ||| NN
of  ||| S:27388 E:27391 ||| IN
spreading  ||| S:27391 E:27401 ||| VBG
3T3  ||| S:27401 E:27405 ||| CD
cells  ||| S:27405 E:27411 ||| NNS
were  ||| S:27411 E:27426 ||| VBD
extensively  ||| S:27426 E:27438 ||| RB
studied  ||| S:27438 E:27446 ||| VBN
by  ||| S:27446 E:27449 ||| IN
Albrecht-Buehler  ||| S:27449 E:27466 ||| FW
et  ||| S:27466 E:27469 ||| FW
al  ||| S:27469 E:27472 ||| FW
[  ||| S:27472 E:27474 ||| -LRB-
21 ||| S:27474 E:27476 ||| CD
,  ||| S:27476 E:27478 ||| ,
27 ||| S:27478 E:27480 ||| CD
,  ||| S:27480 E:27492 ||| ,
29 ||| S:27492 E:27494 ||| CD
] ||| S:27494 E:27495 ||| -RRB-
,  ||| S:27495 E:27497 ||| ,
but  ||| S:27497 E:27501 ||| CC
ultramicroextensions  ||| S:27501 E:27522 ||| NNS
were  ||| S:27522 E:27527 ||| VBD
not  ||| S:27527 E:27531 ||| RB
described  ||| S:27531 E:27551 ||| VBN
presumably  ||| S:27551 E:27562 ||| RB
because  ||| S:27562 E:27570 ||| IN
these  ||| S:27570 E:27576 ||| DT
studies  ||| S:27576 E:27584 ||| NNS
were  ||| S:27584 E:27589 ||| VBD
carried  ||| S:27589 E:27597 ||| VBN
out  ||| S:27597 E:27601 ||| RP
during  ||| S:27601 E:27618 ||| IN
early  ||| S:27618 E:27624 ||| JJ
spreading  ||| S:27624 E:27634 ||| NN
of  ||| S:27634 E:27637 ||| IN
3T3  ||| S:27637 E:27641 ||| CD
cells ||| S:27641 E:27646 ||| NNS
.  ||| S:27646 E:27648 ||| .
Cells  ||| S:27648 E:27654 ||| NNS
that  ||| S:27654 E:27659 ||| WDT
do  ||| S:27659 E:27662 ||| VBP
not  ||| S:27662 E:27666 ||| RB
touch  ||| S:27666 E:27682 ||| VB
other  ||| S:27682 E:27688 ||| JJ
cells  ||| S:27688 E:27694 ||| NNS
rarely  ||| S:27694 E:27701 ||| RB
display  ||| S:27701 E:27709 ||| VB
ultramicroextensions  ||| S:27709 E:27730 ||| VBN
even  ||| S:27730 E:27745 ||| RB
after  ||| S:27745 E:27751 ||| IN
long  ||| S:27751 E:27756 ||| JJ
periods  ||| S:27756 E:27764 ||| NNS
of  ||| S:27764 E:27767 ||| IN
incubation ||| S:27767 E:27777 ||| NN
.  ||| S:27777 E:27779 ||| .
Ultramicroextensions  ||| S:27779 E:27810 ||| NNP
were  ||| S:27810 E:27815 ||| VBD
quite  ||| S:27815 E:27821 ||| RB
frequent  ||| S:27821 E:27830 ||| JJ
between  ||| S:27830 E:27838 ||| IN
cells  ||| S:27838 E:27844 ||| NNS
and  ||| S:27844 E:27848 ||| CC
on  ||| S:27848 E:27851 ||| IN
the  ||| S:27851 E:27855 ||| DT
surface  ||| S:27855 E:27863 ||| NN
of  ||| S:27863 E:27876 ||| IN
cells  ||| S:27876 E:27882 ||| NNS
grown  ||| S:27882 E:27888 ||| VBN
at  ||| S:27888 E:27891 ||| IN
confluency ||| S:27891 E:27901 ||| NN
.  ||| S:27901 E:27903 ||| .
This  ||| S:27903 E:27908 ||| DT
suggests  ||| S:27908 E:27917 ||| VBZ
that  ||| S:27917 E:27922 ||| IN
their  ||| S:27922 E:27938 ||| PRP$
formation  ||| S:27938 E:27948 ||| NN
is  ||| S:27948 E:27951 ||| VBZ
triggered  ||| S:27951 E:27961 ||| VBN
by  ||| S:27961 E:27964 ||| IN
contact  ||| S:27964 E:27972 ||| NN
with  ||| S:27972 E:27977 ||| IN
other  ||| S:27977 E:27983 ||| JJ
cells  ||| S:27983 E:27989 ||| NNS
and  ||| S:27989 E:28003 ||| CC
that  ||| S:28003 E:28008 ||| IN
they  ||| S:28008 E:28013 ||| PRP
are  ||| S:28013 E:28017 ||| VBP
not  ||| S:28017 E:28021 ||| RB
primarily  ||| S:28021 E:28031 ||| RB
related  ||| S:28031 E:28039 ||| VBN
to  ||| S:28039 E:28042 ||| TO
cell  ||| S:28042 E:28047 ||| NN
movement ||| S:28047 E:28055 ||| NN
.  ||| S:28055 E:28085 ||| .
Preservation  ||| S:28085 E:28098 ||| NNP
and  ||| S:28098 E:28102 ||| CC
exposure  ||| S:28102 E:28111 ||| NN
of  ||| S:28111 E:28114 ||| IN
cytoskeleton  ||| S:28114 E:28127 ||| NN
in  ||| S:28127 E:28140 ||| IN
microextensions  ||| S:28140 E:28156 ||| NN
and  ||| S:28156 E:28160 ||| CC
ultramicroextensions  ||| S:28160 E:28191 ||| VBD
We  ||| S:28191 E:28194 ||| PRP
have  ||| S:28194 E:28199 ||| VBP
successfully  ||| S:28199 E:28212 ||| RB
exposed  ||| S:28212 E:28220 ||| VBN
the  ||| S:28220 E:28224 ||| DT
cytoskeleton  ||| S:28224 E:28237 ||| NN
of  ||| S:28237 E:28250 ||| IN
microextensions  ||| S:28250 E:28266 ||| NN
and  ||| S:28266 E:28270 ||| CC
ultramicroextensions  ||| S:28270 E:28291 ||| VBP
using  ||| S:28291 E:28297 ||| VBG
a  ||| S:28297 E:28299 ||| DT
newly  ||| S:28299 E:28315 ||| RB
developed  ||| S:28315 E:28325 ||| VBN
fixative  ||| S:28325 E:28334 ||| NNS
that  ||| S:28334 E:28339 ||| WDT
contains  ||| S:28339 E:28348 ||| VBZ
DOTMAC ||| S:28348 E:28354 ||| NNP
.  ||| S:28354 E:28356 ||| .
In  ||| S:28356 E:28359 ||| IN
order  ||| S:28359 E:28365 ||| NN
to  ||| S:28365 E:28378 ||| TO
study  ||| S:28378 E:28384 ||| VB
the  ||| S:28384 E:28388 ||| DT
structure  ||| S:28388 E:28398 ||| NN
of  ||| S:28398 E:28401 ||| IN
the  ||| S:28401 E:28405 ||| DT
cytoskeletal  ||| S:28405 E:28418 ||| JJ
network  ||| S:28418 E:28426 ||| NN
it  ||| S:28426 E:28429 ||| PRP
is  ||| S:28429 E:28442 ||| VBZ
necessary  ||| S:28442 E:28452 ||| JJ
to  ||| S:28452 E:28455 ||| TO
extract  ||| S:28455 E:28463 ||| VB
cells  ||| S:28463 E:28469 ||| NNS
with  ||| S:28469 E:28474 ||| IN
a  ||| S:28474 E:28476 ||| DT
detergent  ||| S:28476 E:28486 ||| NN
to  ||| S:28486 E:28489 ||| TO
expose  ||| S:28489 E:28506 ||| VB
cytoskeletal  ||| S:28506 E:28519 ||| JJ
filaments  ||| S:28519 E:28529 ||| NN
for  ||| S:28529 E:28533 ||| IN
electron  ||| S:28533 E:28542 ||| JJ
microscopic  ||| S:28542 E:28554 ||| JJ
imaging ||| S:28554 E:28561 ||| NN
.  ||| S:28561 E:28573 ||| .
Several  ||| S:28573 E:28581 ||| JJ
detergents  ||| S:28581 E:28592 ||| NNS
were  ||| S:28592 E:28597 ||| VBD
tested  ||| S:28597 E:28604 ||| VBN
for  ||| S:28604 E:28608 ||| IN
their  ||| S:28608 E:28614 ||| PRP$
effects  ||| S:28614 E:28622 ||| NNS
on  ||| S:28622 E:28635 ||| IN
cytoskeletal  ||| S:28635 E:28648 ||| JJ
structures  ||| S:28648 E:28659 ||| NNS
by  ||| S:28659 E:28662 ||| IN
Schliwa  ||| S:28662 E:28670 ||| NNP
et  ||| S:28670 E:28673 ||| FW
al.  ||| S:28673 E:28677 ||| FW
[  ||| S:28677 E:28679 ||| -LRB-
3 ||| S:28679 E:28680 ||| LS
] ||| S:28680 E:28681 ||| -RRB-
,  ||| S:28681 E:28683 ||| ,
but  ||| S:28683 E:28687 ||| CC
the  ||| S:28687 E:28701 ||| DT
cationic  ||| S:28701 E:28710 ||| JJ
detergent  ||| S:28710 E:28720 ||| NN
DOTMAC  ||| S:28720 E:28727 ||| NNP
was  ||| S:28727 E:28731 ||| VBD
not  ||| S:28731 E:28735 ||| RB
included ||| S:28735 E:28743 ||| VBD
.  ||| S:28743 E:28745 ||| .
In  ||| S:28745 E:28748 ||| IN
addition ||| S:28748 E:28756 ||| NN
,  ||| S:28756 E:28768 ||| ,
past  ||| S:28768 E:28773 ||| JJ
studies  ||| S:28773 E:28781 ||| NNS
on  ||| S:28781 E:28784 ||| IN
the  ||| S:28784 E:28788 ||| DT
cytoskeleton  ||| S:28788 E:28801 ||| NN
of  ||| S:28801 E:28804 ||| IN
detergent-extracted  ||| S:28804 E:28834 ||| JJ
cells  ||| S:28834 E:28840 ||| NNS
have  ||| S:28840 E:28845 ||| VBP
mainly  ||| S:28845 E:28852 ||| RB
focused  ||| S:28852 E:28860 ||| VBN
on  ||| S:28860 E:28863 ||| IN
the  ||| S:28863 E:28867 ||| DT
cell  ||| S:28867 E:28872 ||| NN
body  ||| S:28872 E:28877 ||| NN
and  ||| S:28877 E:28881 ||| CC
subcortex  ||| S:28881 E:28901 ||| NNS
[  ||| S:28901 E:28903 ||| -LRB-
3 ||| S:28903 E:28904 ||| LS
,  ||| S:28904 E:28906 ||| ,
8 ||| S:28906 E:28907 ||| CD
] ||| S:28907 E:28908 ||| -RRB-
,  ||| S:28908 E:28910 ||| ,
but  ||| S:28910 E:28914 ||| CC
not  ||| S:28914 E:28918 ||| RB
on  ||| S:28918 E:28921 ||| IN
microextensions ||| S:28921 E:28936 ||| NN
.  ||| S:28936 E:28938 ||| .
Although  ||| S:28938 E:28947 ||| IN
extraction  ||| S:28947 E:28968 ||| NN
can  ||| S:28968 E:28972 ||| MD
be  ||| S:28972 E:28975 ||| VB
done  ||| S:28975 E:28980 ||| VBN
before ||| S:28980 E:28986 ||| RB
,  ||| S:28986 E:28988 ||| ,
during ||| S:28988 E:28994 ||| IN
,  ||| S:28994 E:28996 ||| ,
or  ||| S:28996 E:28999 ||| CC
after  ||| S:28999 E:29005 ||| IN
fixation ||| S:29005 E:29013 ||| NN
,  ||| S:29013 E:29015 ||| ,
we  ||| S:29015 E:29018 ||| PRP
used  ||| S:29018 E:29033 ||| VBD
simultaneous  ||| S:29033 E:29046 ||| JJ
extraction  ||| S:29046 E:29057 ||| NN
and  ||| S:29057 E:29061 ||| CC
fixation ||| S:29061 E:29069 ||| NN
,  ||| S:29069 E:29071 ||| ,
because  ||| S:29071 E:29079 ||| IN
( ||| S:29079 E:29080 ||| -LRB-
i ||| S:29080 E:29081 ||| FW
)  ||| S:29081 E:29093 ||| -RRB-
cytoskeletal  ||| S:29093 E:29106 ||| JJ
molecules  ||| S:29106 E:29116 ||| NNS
may  ||| S:29116 E:29120 ||| MD
be  ||| S:29120 E:29123 ||| VB
rearranged  ||| S:29123 E:29134 ||| NNS
or  ||| S:29134 E:29137 ||| CC
altered  ||| S:29137 E:29155 ||| VBN
during  ||| S:29155 E:29162 ||| IN
fixation ||| S:29162 E:29170 ||| NN
,  ||| S:29170 E:29172 ||| ,
as  ||| S:29172 E:29175 ||| IN
irreversible  ||| S:29175 E:29188 ||| JJ
crosslinking  ||| S:29188 E:29201 ||| NN
of  ||| S:29201 E:29214 ||| IN
polypeptides  ||| S:29214 E:29227 ||| NN
is  ||| S:29227 E:29230 ||| VBZ
not  ||| S:29230 E:29234 ||| RB
complete  ||| S:29234 E:29243 ||| VB
even  ||| S:29243 E:29248 ||| RB
after  ||| S:29248 E:29254 ||| IN
15  ||| S:29254 E:29257 ||| CD
min  ||| S:29257 E:29261 ||| JJ
incubation  ||| S:29261 E:29282 ||| NN
with  ||| S:29282 E:29287 ||| IN
4 ||| S:29287 E:29288 ||| CD
%  ||| S:29288 E:29290 ||| NN
PFA  ||| S:29290 E:29294 ||| NN
at  ||| S:29294 E:29297 ||| IN
37°C ||| S:29297 E:29301 ||| CD
;  ||| S:29301 E:29303 ||| :
( ||| S:29303 E:29304 ||| -LRB-
ii ||| S:29304 E:29306 ||| LS
)  ||| S:29306 E:29308 ||| -RRB-
although  ||| S:29308 E:29317 ||| IN
actin  ||| S:29317 E:29323 ||| NN
was  ||| S:29323 E:29327 ||| VBD
more  ||| S:29327 E:29342 ||| RBR
difficult  ||| S:29342 E:29352 ||| JJ
to  ||| S:29352 E:29355 ||| TO
extract ||| S:29355 E:29362 ||| VB
,  ||| S:29362 E:29364 ||| ,
moesin  ||| S:29364 E:29371 ||| NN
and  ||| S:29371 E:29375 ||| CC
other  ||| S:29375 E:29381 ||| JJ
polypeptides  ||| S:29381 E:29394 ||| NN
were  ||| S:29394 E:29409 ||| VBD
removed  ||| S:29409 E:29417 ||| VBN
already  ||| S:29417 E:29425 ||| RB
with  ||| S:29425 E:29430 ||| IN
0.5 ||| S:29430 E:29433 ||| CD
%  ||| S:29433 E:29435 ||| NN
DOTMAC  ||| S:29435 E:29442 ||| NN
in  ||| S:29442 E:29445 ||| IN
the  ||| S:29445 E:29449 ||| DT
absence  ||| S:29449 E:29457 ||| NN
of  ||| S:29457 E:29460 ||| IN
PFA ||| S:29460 E:29463 ||| NNP
.  ||| S:29463 E:29475 ||| .
Addition  ||| S:29475 E:29484 ||| NN
of  ||| S:29484 E:29487 ||| IN
1 ||| S:29487 E:29488 ||| CD
%  ||| S:29488 E:29490 ||| NN
PFA  ||| S:29490 E:29494 ||| NNP
was  ||| S:29494 E:29498 ||| VBD
a  ||| S:29498 E:29500 ||| DT
necessary  ||| S:29500 E:29510 ||| JJ
compromise  ||| S:29510 E:29521 ||| NN
to  ||| S:29521 E:29534 ||| TO
visualize  ||| S:29534 E:29544 ||| VB
the  ||| S:29544 E:29548 ||| DT
cytoskeleton  ||| S:29548 E:29561 ||| NN
and  ||| S:29561 E:29565 ||| CC
its  ||| S:29565 E:29569 ||| PRP$
associated  ||| S:29569 E:29580 ||| JJ
molecules  ||| S:29580 E:29600 ||| NNS
no  ||| S:29600 E:29603 ||| DT
matter  ||| S:29603 E:29610 ||| NN
which  ||| S:29610 E:29616 ||| WDT
detergent  ||| S:29616 E:29626 ||| NN
was  ||| S:29626 E:29630 ||| VBD
being  ||| S:29630 E:29636 ||| VBG
used ||| S:29636 E:29640 ||| VBN
.  ||| S:29640 E:29652 ||| .
Although  ||| S:29652 E:29661 ||| IN
DOTMAC  ||| S:29661 E:29668 ||| NNP
induced  ||| S:29668 E:29676 ||| VBZ
bundling  ||| S:29676 E:29685 ||| VBG
of  ||| S:29685 E:29688 ||| IN
actin  ||| S:29688 E:29694 ||| JJ
filaments  ||| S:29694 E:29714 ||| NN
and  ||| S:29714 E:29718 ||| CC
microtubules ||| S:29718 E:29730 ||| NN
,  ||| S:29730 E:29732 ||| ,
which  ||| S:29732 E:29738 ||| WDT
could  ||| S:29738 E:29744 ||| MD
have  ||| S:29744 E:29749 ||| VB
affected  ||| S:29749 E:29768 ||| VBN
ultrastructural  ||| S:29768 E:29784 ||| JJ
features  ||| S:29784 E:29793 ||| NNS
of  ||| S:29793 E:29796 ||| IN
the  ||| S:29796 E:29800 ||| DT
cytoskeleton ||| S:29800 E:29812 ||| NN
,  ||| S:29812 E:29824 ||| ,
microextensions  ||| S:29824 E:29840 ||| VBG
of  ||| S:29840 E:29843 ||| IN
DOTMAC ||| S:29843 E:29849 ||| NNP
/ ||| S:29849 E:29850 ||| NNP
PFA-extracted  ||| S:29850 E:29864 ||| JJ
cells  ||| S:29864 E:29870 ||| NNS
did  ||| S:29870 E:29874 ||| VBD
not  ||| S:29874 E:29888 ||| RB
differ  ||| S:29888 E:29895 ||| VB
from  ||| S:29895 E:29900 ||| IN
those  ||| S:29900 E:29906 ||| DT
of  ||| S:29906 E:29909 ||| IN
non-treated  ||| S:29909 E:29921 ||| JJ
cells ||| S:29921 E:29926 ||| NNS
.  ||| S:29926 E:29928 ||| .
On  ||| S:29928 E:29931 ||| IN
the  ||| S:29931 E:29935 ||| DT
contrary ||| S:29935 E:29943 ||| NN
,  ||| S:29943 E:29955 ||| ,
bundling  ||| S:29955 E:29964 ||| VBG
of  ||| S:29964 E:29967 ||| IN
actin  ||| S:29967 E:29973 ||| JJ
filaments  ||| S:29973 E:29983 ||| NN
by  ||| S:29983 E:29986 ||| IN
DOTMAC  ||| S:29986 E:29993 ||| NNP
may  ||| S:29993 E:29997 ||| MD
have  ||| S:29997 E:30002 ||| VB
stabilized  ||| S:30002 E:30023 ||| VBN
these  ||| S:30023 E:30029 ||| DT
actin-containing  ||| S:30029 E:30046 ||| JJ
structures ||| S:30046 E:30056 ||| NNS
.  ||| S:30056 E:30058 ||| .
In  ||| S:30058 E:30061 ||| IN
SEM ||| S:30061 E:30064 ||| NNP
,  ||| S:30064 E:30066 ||| ,
micropodia ||| S:30066 E:30076 ||| NN
,  ||| S:30076 E:30088 ||| ,
ultramicroextensions  ||| S:30088 E:30109 ||| NN
and  ||| S:30109 E:30113 ||| CC
microvilli  ||| S:30113 E:30124 ||| NNS
were  ||| S:30124 E:30129 ||| VBD
well  ||| S:30129 E:30134 ||| RB
preserved ||| S:30134 E:30143 ||| VBN
,  ||| S:30143 E:30155 ||| ,
but  ||| S:30155 E:30159 ||| CC
their  ||| S:30159 E:30165 ||| PRP$
lipid  ||| S:30165 E:30171 ||| JJ
membranes  ||| S:30171 E:30181 ||| NNS
apparently  ||| S:30181 E:30192 ||| RB
were  ||| S:30192 E:30197 ||| VBD
lost ||| S:30197 E:30201 ||| VBN
.  ||| S:30201 E:30203 ||| .
This  ||| S:30203 E:30208 ||| DT
made  ||| S:30208 E:30223 ||| VBN
it  ||| S:30223 E:30226 ||| PRP
possible  ||| S:30226 E:30235 ||| JJ
to  ||| S:30235 E:30238 ||| TO
trace  ||| S:30238 E:30244 ||| VB
the  ||| S:30244 E:30248 ||| DT
origin  ||| S:30248 E:30255 ||| NN
of  ||| S:30255 E:30258 ||| IN
micropodia  ||| S:30258 E:30269 ||| NN
and  ||| S:30269 E:30283 ||| CC
ultramicroextensions ||| S:30283 E:30303 ||| NN
.  ||| S:30303 E:30305 ||| .
While  ||| S:30305 E:30311 ||| IN
the  ||| S:30311 E:30315 ||| DT
cytoskeleton  ||| S:30315 E:30328 ||| NN
of  ||| S:30328 E:30341 ||| IN
micropodia  ||| S:30341 E:30352 ||| NN
appeared  ||| S:30352 E:30361 ||| VBD
to  ||| S:30361 E:30364 ||| TO
connect  ||| S:30364 E:30372 ||| VB
to  ||| S:30372 E:30375 ||| TO
the  ||| S:30375 E:30379 ||| DT
cytoskeleton  ||| S:30379 E:30402 ||| NN
located  ||| S:30402 E:30410 ||| VBN
at  ||| S:30410 E:30413 ||| IN
the  ||| S:30413 E:30417 ||| DT
edge  ||| S:30417 E:30422 ||| NN
of  ||| S:30422 E:30425 ||| IN
the  ||| S:30425 E:30429 ||| DT
cells ||| S:30429 E:30434 ||| NNS
,  ||| S:30434 E:30436 ||| ,
by  ||| S:30436 E:30439 ||| IN
contrast ||| S:30439 E:30447 ||| NN
,  ||| S:30447 E:30449 ||| ,
filaments  ||| S:30449 E:30469 ||| VBG
of  ||| S:30469 E:30472 ||| IN
ultramicroextensions  ||| S:30472 E:30493 ||| NN
seemed  ||| S:30493 E:30500 ||| VBD
to  ||| S:30500 E:30503 ||| TO
extend  ||| S:30503 E:30510 ||| VB
from  ||| S:30510 E:30515 ||| IN
or  ||| S:30515 E:30518 ||| CC
connect  ||| S:30518 E:30536 ||| VB
to  ||| S:30536 E:30539 ||| TO
cytoplasmic ||| S:30539 E:30550 ||| VB
,  ||| S:30550 E:30552 ||| ,
rather  ||| S:30552 E:30559 ||| RB
than  ||| S:30559 E:30564 ||| IN
subcortical  ||| S:30564 E:30576 ||| JJ
structures ||| S:30576 E:30586 ||| NNS
.  ||| S:30586 E:30598 ||| .
Triton  ||| S:30598 E:30605 ||| NNP
X-100  ||| S:30605 E:30611 ||| NNP
is  ||| S:30611 E:30614 ||| VBZ
the  ||| S:30614 E:30618 ||| DT
most  ||| S:30618 E:30623 ||| RBS
widely  ||| S:30623 E:30630 ||| RB
used  ||| S:30630 E:30635 ||| VBN
detergent  ||| S:30635 E:30645 ||| NN
to  ||| S:30645 E:30658 ||| TO
expose  ||| S:30658 E:30665 ||| VB
the  ||| S:30665 E:30669 ||| DT
cytoskeleton  ||| S:30669 E:30682 ||| NN
for  ||| S:30682 E:30686 ||| IN
biochemical  ||| S:30686 E:30698 ||| NN
and  ||| S:30698 E:30712 ||| CC
immunohistological  ||| S:30712 E:30731 ||| JJ
studies ||| S:30731 E:30738 ||| NNS
,  ||| S:30738 E:30740 ||| ,
but  ||| S:30740 E:30744 ||| CC
without  ||| S:30744 E:30752 ||| IN
prefixation  ||| S:30752 E:30764 ||| VBG
it  ||| S:30764 E:30777 ||| PRP
caused  ||| S:30777 E:30784 ||| VBD
a  ||| S:30784 E:30786 ||| DT
marked  ||| S:30786 E:30793 ||| JJ
loss  ||| S:30793 E:30798 ||| NN
of  ||| S:30798 E:30801 ||| IN
cytoskeletal  ||| S:30801 E:30814 ||| JJ
material  ||| S:30814 E:30823 ||| NN
[  ||| S:30823 E:30825 ||| -LRB-
38 ||| S:30825 E:30827 ||| CD
,  ||| S:30827 E:30829 ||| ,
39 ||| S:30829 E:30831 ||| CD
] ||| S:30831 E:30832 ||| -RRB-
.  ||| S:30832 E:30844 ||| .
This  ||| S:30844 E:30849 ||| DT
method  ||| S:30849 E:30856 ||| NN
also  ||| S:30856 E:30861 ||| RB
has  ||| S:30861 E:30865 ||| VBZ
been  ||| S:30865 E:30870 ||| VBN
criticized  ||| S:30870 E:30881 ||| VBN
for  ||| S:30881 E:30885 ||| IN
loss  ||| S:30885 E:30890 ||| NN
of  ||| S:30890 E:30893 ||| IN
the  ||| S:30893 E:30907 ||| DT
microtrabecular  ||| S:30907 E:30923 ||| JJ
lattice  ||| S:30923 E:30931 ||| NNS
[  ||| S:30931 E:30933 ||| -LRB-
3 ||| S:30933 E:30934 ||| LS
,  ||| S:30934 E:30936 ||| ,
40 ||| S:30936 E:30938 ||| CD
] ||| S:30938 E:30939 ||| -RRB-
.  ||| S:30939 E:30941 ||| .
This  ||| S:30941 E:30946 ||| DT
loss  ||| S:30946 E:30951 ||| NN
is  ||| S:30951 E:30954 ||| VBZ
sometimes  ||| S:30954 E:30974 ||| RB
advantageous  ||| S:30974 E:30987 ||| VBN
to  ||| S:30987 E:30990 ||| TO
expose  ||| S:30990 E:30997 ||| VB
certain  ||| S:30997 E:31005 ||| JJ
types  ||| S:31005 E:31011 ||| NNS
of  ||| S:31011 E:31014 ||| IN
filaments  ||| S:31014 E:31024 ||| NNS
[  ||| S:31024 E:31026 ||| -LRB-
40 ||| S:31026 E:31028 ||| CD
] ||| S:31028 E:31029 ||| -RRB-
,  ||| S:31029 E:31041 ||| ,
but  ||| S:31041 E:31045 ||| CC
this  ||| S:31045 E:31050 ||| DT
was  ||| S:31050 E:31054 ||| VBD
not  ||| S:31054 E:31058 ||| RB
relevant  ||| S:31058 E:31067 ||| JJ
to  ||| S:31067 E:31070 ||| TO
our  ||| S:31070 E:31074 ||| PRP$
study ||| S:31074 E:31079 ||| NN
.  ||| S:31079 E:31081 ||| .
Triton  ||| S:31081 E:31088 ||| NNP
X-100  ||| S:31088 E:31094 ||| NNP
is  ||| S:31094 E:31107 ||| VBZ
not  ||| S:31107 E:31111 ||| RB
useful  ||| S:31111 E:31118 ||| JJ
and  ||| S:31118 E:31122 ||| CC
even  ||| S:31122 E:31127 ||| RB
inappropriate  ||| S:31127 E:31141 ||| JJ
for  ||| S:31141 E:31145 ||| IN
exposing  ||| S:31145 E:31154 ||| VBG
and  ||| S:31154 E:31168 ||| CC
maintaining  ||| S:31168 E:31180 ||| VBG
the  ||| S:31180 E:31184 ||| DT
cytoskeleton  ||| S:31184 E:31197 ||| NN
of  ||| S:31197 E:31200 ||| IN
microextensions ||| S:31200 E:31215 ||| NN
.  ||| S:31215 E:31217 ||| .
The  ||| S:31217 E:31231 ||| DT
fragmentation  ||| S:31231 E:31245 ||| NN
of  ||| S:31245 E:31248 ||| IN
microextensions  ||| S:31248 E:31264 ||| NN
and  ||| S:31264 E:31268 ||| CC
the  ||| S:31268 E:31272 ||| DT
amount  ||| S:31272 E:31279 ||| NN
of  ||| S:31279 E:31292 ||| IN
material  ||| S:31292 E:31301 ||| NN
lost  ||| S:31301 E:31306 ||| VBD
with  ||| S:31306 E:31311 ||| IN
this  ||| S:31311 E:31316 ||| DT
detergent  ||| S:31316 E:31326 ||| NN
were  ||| S:31326 E:31331 ||| VBD
time ||| S:31331 E:31335 ||| NN
,  ||| S:31335 E:31337 ||| ,
temperature  ||| S:31337 E:31359 ||| NN
and  ||| S:31359 E:31363 ||| CC
concentration  ||| S:31363 E:31377 ||| NN
dependent ||| S:31377 E:31386 ||| NN
.  ||| S:31386 E:31388 ||| .
The  ||| S:31388 E:31392 ||| DT
cytoskeleton  ||| S:31392 E:31405 ||| NN
tended  ||| S:31405 E:31412 ||| VBD
to  ||| S:31412 E:31425 ||| TO
be  ||| S:31425 E:31428 ||| VB
unmasked  ||| S:31428 E:31437 ||| VBN
at  ||| S:31437 E:31440 ||| IN
low  ||| S:31440 E:31444 ||| JJ
temperatures  ||| S:31444 E:31457 ||| NNS
and  ||| S:31457 E:31461 ||| CC
at  ||| S:31461 E:31464 ||| IN
low  ||| S:31464 E:31468 ||| JJ
concentrations  ||| S:31468 E:31493 ||| NNS
of  ||| S:31493 E:31496 ||| IN
Triton  ||| S:31496 E:31503 ||| NNP
X-100 ||| S:31503 E:31508 ||| NNP
,  ||| S:31508 E:31510 ||| ,
and  ||| S:31510 E:31514 ||| CC
the  ||| S:31514 E:31518 ||| DT
loss  ||| S:31518 E:31523 ||| NN
of  ||| S:31523 E:31526 ||| IN
material  ||| S:31526 E:31535 ||| NN
occurred  ||| S:31535 E:31554 ||| VBD
especially  ||| S:31554 E:31565 ||| RB
in  ||| S:31565 E:31568 ||| IN
lamellipodia  ||| S:31568 E:31581 ||| NNS
[  ||| S:31581 E:31583 ||| -LRB-
40 ||| S:31583 E:31585 ||| CD
] ||| S:31585 E:31586 ||| -RRB-
.  ||| S:31586 E:31588 ||| .
These  ||| S:31588 E:31594 ||| DT
earlier  ||| S:31594 E:31602 ||| JJR
data  ||| S:31602 E:31607 ||| NNS
are  ||| S:31607 E:31621 ||| VBP
consistent  ||| S:31621 E:31632 ||| JJ
with  ||| S:31632 E:31637 ||| IN
our  ||| S:31637 E:31641 ||| PRP$
results  ||| S:31641 E:31649 ||| NNS
concerning  ||| S:31649 E:31660 ||| VBG
lamellipodia ||| S:31660 E:31672 ||| NN
,  ||| S:31672 E:31674 ||| ,
but  ||| S:31674 E:31688 ||| CC
other  ||| S:31688 E:31694 ||| JJ
microextensions  ||| S:31694 E:31710 ||| NN
were  ||| S:31710 E:31715 ||| VBD
ignored ||| S:31715 E:31722 ||| VBN
.  ||| S:31722 E:31724 ||| .
Previous  ||| S:31724 E:31733 ||| JJ
authors  ||| S:31733 E:31751 ||| NNS
preferred  ||| S:31751 E:31761 ||| VBN
to  ||| S:31761 E:31764 ||| TO
use  ||| S:31764 E:31768 ||| VB
1 ||| S:31768 E:31769 ||| CD
%  ||| S:31769 E:31771 ||| NN
Triton  ||| S:31771 E:31778 ||| NNP
X-100 ||| S:31778 E:31783 ||| NNP
,  ||| S:31783 E:31785 ||| ,
a  ||| S:31785 E:31787 ||| DT
relatively  ||| S:31787 E:31798 ||| RB
high  ||| S:31798 E:31813 ||| JJ
concentration  ||| S:31813 E:31827 ||| NN
of  ||| S:31827 E:31830 ||| IN
detergent ||| S:31830 E:31839 ||| NN
,  ||| S:31839 E:31841 ||| ,
because  ||| S:31841 E:31849 ||| IN
it  ||| S:31849 E:31852 ||| PRP
is  ||| S:31852 E:31855 ||| VBZ
critical  ||| S:31855 E:31864 ||| JJ
for  ||| S:31864 E:31878 ||| IN
rapid  ||| S:31878 E:31884 ||| JJ
solubilization  ||| S:31884 E:31899 ||| NN
of  ||| S:31899 E:31902 ||| IN
the  ||| S:31902 E:31906 ||| DT
cell  ||| S:31906 E:31911 ||| NN
membrane  ||| S:31911 E:31920 ||| NNS
and  ||| S:31920 E:31924 ||| CC
cessation  ||| S:31924 E:31944 ||| NN
of  ||| S:31944 E:31947 ||| IN
cell  ||| S:31947 E:31952 ||| NN
activity ||| S:31952 E:31960 ||| NN
.  ||| S:31960 E:31962 ||| .
However ||| S:31962 E:31969 ||| RB
,  ||| S:31969 E:31971 ||| ,
1 ||| S:31971 E:31972 ||| CD
%  ||| S:31972 E:31974 ||| NN
Triton  ||| S:31974 E:31981 ||| NNP
X-100  ||| S:31981 E:31987 ||| NNP
destroyed  ||| S:31987 E:32007 ||| VBD
microextensions  ||| S:32007 E:32023 ||| VBN
even  ||| S:32023 E:32028 ||| RB
in  ||| S:32028 E:32031 ||| IN
PEM  ||| S:32031 E:32035 ||| NNP
buffer ||| S:32035 E:32041 ||| NN
.  ||| S:32041 E:32043 ||| .
Another  ||| S:32043 E:32051 ||| DT
problems  ||| S:32051 E:32060 ||| NNS
with  ||| S:32060 E:32075 ||| IN
Triton  ||| S:32075 E:32082 ||| NNP
X-100  ||| S:32082 E:32088 ||| NNP
is  ||| S:32088 E:32091 ||| VBZ
that  ||| S:32091 E:32096 ||| DT
most  ||| S:32096 E:32101 ||| JJS
of  ||| S:32101 E:32104 ||| IN
the  ||| S:32104 E:32108 ||| DT
cells  ||| S:32108 E:32114 ||| NNS
detached  ||| S:32114 E:32123 ||| VBN
from  ||| S:32123 E:32128 ||| IN
the  ||| S:32128 E:32142 ||| DT
substrate  ||| S:32142 E:32152 ||| NN
and  ||| S:32152 E:32156 ||| CC
the  ||| S:32156 E:32160 ||| DT
remaining  ||| S:32160 E:32170 ||| JJ
cells  ||| S:32170 E:32176 ||| NNS
are  ||| S:32176 E:32180 ||| VBP
usually  ||| S:32180 E:32188 ||| RB
quite  ||| S:32188 E:32204 ||| RB
distorted  ||| S:32204 E:32214 ||| VBN
in  ||| S:32214 E:32217 ||| IN
shape  ||| S:32217 E:32223 ||| NN
[  ||| S:32223 E:32225 ||| -LRB-
38 ||| S:32225 E:32227 ||| CD
] ||| S:32227 E:32228 ||| -RRB-
.  ||| S:32228 E:32230 ||| .
We  ||| S:32230 E:32233 ||| PRP
have  ||| S:32233 E:32238 ||| VBP
seen  ||| S:32238 E:32243 ||| VBN
similar  ||| S:32243 E:32251 ||| JJ
shape  ||| S:32251 E:32267 ||| NN
changes  ||| S:32267 E:32275 ||| NNS
with  ||| S:32275 E:32280 ||| IN
Triton  ||| S:32280 E:32287 ||| NNP
X-100-extracted  ||| S:32287 E:32303 ||| NNP
cells  ||| S:32303 E:32309 ||| NNS
after  ||| S:32309 E:32325 ||| IN
relatively  ||| S:32325 E:32336 ||| RB
short  ||| S:32336 E:32342 ||| JJ
prefixation  ||| S:32342 E:32354 ||| NN
with  ||| S:32354 E:32359 ||| IN
formaldehyde  ||| S:32359 E:32372 ||| NNS
( ||| S:32372 E:32373 ||| -LRB-
Table  ||| S:32373 E:32389 ||| NNP
2 ||| S:32389 E:32390 ||| CD
) ||| S:32390 E:32391 ||| -RRB-
.  ||| S:32391 E:32403 ||| .
The  ||| S:32403 E:32407 ||| DT
composition  ||| S:32407 E:32419 ||| NN
of  ||| S:32419 E:32422 ||| IN
the  ||| S:32422 E:32426 ||| DT
extraction  ||| S:32426 E:32437 ||| JJ
buffer  ||| S:32437 E:32444 ||| NN
is  ||| S:32444 E:32447 ||| VBZ
an  ||| S:32447 E:32460 ||| DT
important  ||| S:32460 E:32470 ||| JJ
factor  ||| S:32470 E:32477 ||| NN
[  ||| S:32477 E:32479 ||| -LRB-
15 ||| S:32479 E:32481 ||| CD
] ||| S:32481 E:32482 ||| -RRB-
.  ||| S:32482 E:32484 ||| .
Although  ||| S:32484 E:32493 ||| IN
MTSB ||| S:32493 E:32497 ||| NNP
,  ||| S:32497 E:32499 ||| ,
which  ||| S:32499 E:32505 ||| WDT
is  ||| S:32505 E:32518 ||| VBZ
essentially  ||| S:32518 E:32530 ||| RB
similar  ||| S:32530 E:32538 ||| JJ
to  ||| S:32538 E:32541 ||| TO
PHEM ||| S:32541 E:32545 ||| NNP
,  ||| S:32545 E:32547 ||| ,
PEM ||| S:32547 E:32550 ||| NNP
,  ||| S:32550 E:32552 ||| ,
or  ||| S:32552 E:32555 ||| CC
MTPB ||| S:32555 E:32559 ||| NNP
,  ||| S:32559 E:32561 ||| ,
was  ||| S:32561 E:32565 ||| VBD
shown  ||| S:32565 E:32571 ||| VBN
to  ||| S:32571 E:32584 ||| TO
give  ||| S:32584 E:32589 ||| VB
the  ||| S:32589 E:32593 ||| DT
best  ||| S:32593 E:32598 ||| JJS
preservation  ||| S:32598 E:32611 ||| NN
of  ||| S:32611 E:32614 ||| IN
the  ||| S:32614 E:32618 ||| DT
cytoskeleton ||| S:32618 E:32630 ||| NN
,  ||| S:32630 E:32632 ||| ,
no  ||| S:32632 E:32645 ||| DT
morphological  ||| S:32645 E:32659 ||| JJ
differences  ||| S:32659 E:32671 ||| NNS
were  ||| S:32671 E:32676 ||| VBD
seen  ||| S:32676 E:32681 ||| VBN
between  ||| S:32681 E:32689 ||| IN
these  ||| S:32689 E:32695 ||| DT
buffers  ||| S:32695 E:32713 ||| NN
and  ||| S:32713 E:32717 ||| CC
PBS ||| S:32717 E:32720 ||| NNP
( ||| S:32720 E:32721 ||| -LRB-
+ ||| S:32721 E:32722 ||| NNP
) ||| S:32722 E:32723 ||| -RRB-
,  ||| S:32723 E:32725 ||| ,
when  ||| S:32725 E:32730 ||| WRB
the  ||| S:32730 E:32734 ||| DT
cells  ||| S:32734 E:32740 ||| NNS
were  ||| S:32740 E:32745 ||| VBD
extracted  ||| S:32745 E:32755 ||| VBN
with  ||| S:32755 E:32760 ||| IN
DOTMAC  ||| S:32760 E:32777 ||| NNP
( ||| S:32777 E:32778 ||| -LRB-
data  ||| S:32778 E:32783 ||| NNS
not  ||| S:32783 E:32787 ||| RB
shown ||| S:32787 E:32792 ||| VBN
) ||| S:32792 E:32793 ||| -RRB-
.  ||| S:32793 E:32795 ||| .
Addition  ||| S:32795 E:32804 ||| NN
of  ||| S:32804 E:32807 ||| IN
phalloidin ||| S:32807 E:32817 ||| NN
,  ||| S:32817 E:32819 ||| ,
taxol ||| S:32819 E:32824 ||| NN
,  ||| S:32824 E:32826 ||| ,
or  ||| S:32826 E:32829 ||| CC
PEG  ||| S:32829 E:32843 ||| NNP
did  ||| S:32843 E:32847 ||| VBD
not  ||| S:32847 E:32851 ||| RB
make  ||| S:32851 E:32856 ||| VB
a  ||| S:32856 E:32858 ||| DT
difference  ||| S:32858 E:32869 ||| NN
either  ||| S:32869 E:32876 ||| CC
( ||| S:32876 E:32877 ||| -LRB-
data  ||| S:32877 E:32882 ||| NNS
not  ||| S:32882 E:32886 ||| RB
shown ||| S:32886 E:32891 ||| VBN
) ||| S:32891 E:32892 ||| -RRB-
.  ||| S:32892 E:32894 ||| .
In  ||| S:32894 E:32897 ||| IN
our  ||| S:32897 E:32911 ||| PRP$
experience ||| S:32911 E:32921 ||| NN
,  ||| S:32921 E:32923 ||| ,
the  ||| S:32923 E:32927 ||| DT
divalent  ||| S:32927 E:32936 ||| JJ
cations  ||| S:32936 E:32944 ||| NN
in  ||| S:32944 E:32947 ||| IN
PBS ||| S:32947 E:32950 ||| NNP
( ||| S:32950 E:32951 ||| -LRB-
+ ||| S:32951 E:32952 ||| NNP
)  ||| S:32952 E:32954 ||| -RRB-
prevented  ||| S:32954 E:32964 ||| VBD
the  ||| S:32964 E:32978 ||| DT
cellular  ||| S:32978 E:32987 ||| JJ
retraction  ||| S:32987 E:32998 ||| NNS
seen  ||| S:32998 E:33003 ||| VBN
within  ||| S:33003 E:33010 ||| IN
a  ||| S:33010 E:33012 ||| DT
few  ||| S:33012 E:33016 ||| JJ
minutes  ||| S:33016 E:33024 ||| NNS
with  ||| S:33024 E:33029 ||| IN
PBS  ||| S:33029 E:33043 ||| NNP
and  ||| S:33043 E:33047 ||| CC
are  ||| S:33047 E:33051 ||| VBP
necessary  ||| S:33051 E:33061 ||| JJ
to  ||| S:33061 E:33064 ||| TO
maintain  ||| S:33064 E:33073 ||| VB
interactions  ||| S:33073 E:33086 ||| VBN
between  ||| S:33086 E:33104 ||| IN
DOTMAC-resistant  ||| S:33104 E:33121 ||| JJ
components  ||| S:33121 E:33132 ||| NNS
and  ||| S:33132 E:33136 ||| CC
the  ||| S:33136 E:33140 ||| DT
substrate  ||| S:33140 E:33150 ||| NN
( ||| S:33150 E:33151 ||| -LRB-
data  ||| S:33151 E:33156 ||| NNS
not  ||| S:33156 E:33170 ||| RB
shown ||| S:33170 E:33175 ||| VBN
) ||| S:33175 E:33176 ||| -RRB-
.  ||| S:33176 E:33178 ||| .
DOTMAC ||| S:33178 E:33184 ||| NNP
,  ||| S:33184 E:33186 ||| ,
on  ||| S:33186 E:33189 ||| IN
the  ||| S:33189 E:33193 ||| DT
other  ||| S:33193 E:33199 ||| JJ
hand ||| S:33199 E:33203 ||| NN
,  ||| S:33203 E:33205 ||| ,
caused  ||| S:33205 E:33212 ||| VBD
rapid  ||| S:33212 E:33218 ||| JJ
cessation  ||| S:33218 E:33238 ||| NN
of  ||| S:33238 E:33241 ||| IN
all  ||| S:33241 E:33245 ||| DT
cell  ||| S:33245 E:33250 ||| NN
activity ||| S:33250 E:33258 ||| NN
.  ||| S:33258 E:33270 ||| .
The  ||| S:33270 E:33274 ||| DT
type  ||| S:33274 E:33279 ||| NN
of  ||| S:33279 E:33282 ||| IN
fixative  ||| S:33282 E:33291 ||| NN
is  ||| S:33291 E:33294 ||| VBZ
another  ||| S:33294 E:33302 ||| DT
important  ||| S:33302 E:33312 ||| JJ
determinant  ||| S:33312 E:33334 ||| NN
for  ||| S:33334 E:33338 ||| IN
the  ||| S:33338 E:33342 ||| DT
analysis  ||| S:33342 E:33351 ||| NN
of  ||| S:33351 E:33354 ||| IN
cell  ||| S:33354 E:33359 ||| NN
shape  ||| S:33359 E:33365 ||| NN
and  ||| S:33365 E:33369 ||| CC
structural  ||| S:33369 E:33380 ||| JJ
integrity  ||| S:33380 E:33400 ||| NN
of  ||| S:33400 E:33403 ||| IN
the  ||| S:33403 E:33407 ||| DT
cytoskeleton ||| S:33407 E:33419 ||| NN
.  ||| S:33419 E:33421 ||| .
Glutaraldehyde  ||| S:33421 E:33436 ||| NNP
is  ||| S:33436 E:33439 ||| VBZ
considered  ||| S:33439 E:33450 ||| VBN
the  ||| S:33450 E:33464 ||| DT
best  ||| S:33464 E:33469 ||| JJS
fixative  ||| S:33469 E:33478 ||| NN
to  ||| S:33478 E:33481 ||| TO
preserve  ||| S:33481 E:33490 ||| VB
these  ||| S:33490 E:33496 ||| DT
structures ||| S:33496 E:33506 ||| NNS
,  ||| S:33506 E:33508 ||| ,
but  ||| S:33508 E:33512 ||| CC
there  ||| S:33512 E:33518 ||| EX
are  ||| S:33518 E:33532 ||| VBP
associated  ||| S:33532 E:33543 ||| VBN
disadvantages ||| S:33543 E:33556 ||| NNS
.  ||| S:33556 E:33558 ||| .
Prefixation  ||| S:33558 E:33570 ||| NNP
and  ||| S:33570 E:33574 ||| CC
postfixation  ||| S:33574 E:33597 ||| NN
with  ||| S:33597 E:33602 ||| IN
glutaraldehyde  ||| S:33602 E:33617 ||| JJ
precludes  ||| S:33617 E:33627 ||| JJ
exposure  ||| S:33627 E:33636 ||| NN
of  ||| S:33636 E:33639 ||| IN
the  ||| S:33639 E:33653 ||| DT
cytoskeleton  ||| S:33653 E:33666 ||| NN
and ||| S:33666 E:33669 ||| CC
,  ||| S:33669 E:33671 ||| ,
also  ||| S:33671 E:33676 ||| RB
quite  ||| S:33676 E:33682 ||| RB
frequently ||| S:33682 E:33692 ||| RB
,  ||| S:33692 E:33694 ||| ,
the  ||| S:33694 E:33698 ||| DT
binding  ||| S:33698 E:33706 ||| NN
of  ||| S:33706 E:33719 ||| IN
antibody  ||| S:33719 E:33728 ||| NN
probes ||| S:33728 E:33734 ||| NNS
.  ||| S:33734 E:33736 ||| .
On  ||| S:33736 E:33739 ||| IN
the  ||| S:33739 E:33743 ||| DT
other  ||| S:33743 E:33749 ||| JJ
hand ||| S:33749 E:33753 ||| NN
,  ||| S:33753 E:33755 ||| ,
formaldehyde  ||| S:33755 E:33768 ||| NN
is  ||| S:33768 E:33771 ||| VBZ
a  ||| S:33771 E:33783 ||| DT
rather  ||| S:33783 E:33790 ||| RB
weak  ||| S:33790 E:33795 ||| JJ
crosslinker ||| S:33795 E:33806 ||| NN
.  ||| S:33806 E:33808 ||| .
A  ||| S:33808 E:33810 ||| DT
crosslink  ||| S:33810 E:33820 ||| NN
formed  ||| S:33820 E:33827 ||| VBN
by  ||| S:33827 E:33840 ||| IN
formaldehyde  ||| S:33840 E:33853 ||| NN
between  ||| S:33853 E:33861 ||| IN
two  ||| S:33861 E:33865 ||| CD
functional  ||| S:33865 E:33876 ||| CD
groups  ||| S:33876 E:33883 ||| NNS
is  ||| S:33883 E:33896 ||| VBZ
theoretically  ||| S:33896 E:33910 ||| VBN
and  ||| S:33910 E:33914 ||| CC
experimentally  ||| S:33914 E:33929 ||| RB
a  ||| S:33929 E:33931 ||| DT
non-reducible  ||| S:33931 E:33955 ||| JJ
methylene  ||| S:33955 E:33965 ||| JJ
bridge ||| S:33965 E:33971 ||| NN
.  ||| S:33971 E:33973 ||| .
Such  ||| S:33973 E:33978 ||| JJ
bridges  ||| S:33978 E:33986 ||| NNS
are  ||| S:33986 E:33990 ||| VBP
readily  ||| S:33990 E:33998 ||| RB
hydrolysed  ||| S:33998 E:34019 ||| VBN
during  ||| S:34019 E:34026 ||| IN
washing ||| S:34026 E:34033 ||| NN
.  ||| S:34033 E:34035 ||| .
The  ||| S:34035 E:34039 ||| DT
only  ||| S:34039 E:34044 ||| JJ
irreversible  ||| S:34044 E:34057 ||| JJ
reaction  ||| S:34057 E:34066 ||| NN
would  ||| S:34066 E:34072 ||| MD
be  ||| S:34072 E:34085 ||| VB
one  ||| S:34085 E:34089 ||| CD
that  ||| S:34089 E:34094 ||| WDT
takes  ||| S:34094 E:34100 ||| VBZ
place  ||| S:34100 E:34106 ||| NN
slowly  ||| S:34106 E:34113 ||| RB
with  ||| S:34113 E:34118 ||| IN
the  ||| S:34118 E:34122 ||| DT
aromatic  ||| S:34122 E:34131 ||| JJ
hydrogen  ||| S:34131 E:34140 ||| NN
[  ||| S:34140 E:34152 ||| -LRB-
41 ||| S:34152 E:34154 ||| CD
] ||| S:34154 E:34155 ||| -RRB-
.  ||| S:34155 E:34157 ||| .
Our  ||| S:34157 E:34161 ||| PRP$
studies  ||| S:34161 E:34169 ||| NNS
provide  ||| S:34169 E:34177 ||| VBP
first  ||| S:34177 E:34183 ||| JJ
systematic  ||| S:34183 E:34194 ||| JJ
data  ||| S:34194 E:34199 ||| NNS
that  ||| S:34199 E:34204 ||| IN
cells  ||| S:34204 E:34220 ||| NNS
should  ||| S:34220 E:34227 ||| MD
be  ||| S:34227 E:34230 ||| VB
kept  ||| S:34230 E:34235 ||| VBN
in  ||| S:34235 E:34238 ||| IN
4 ||| S:34238 E:34239 ||| CD
%  ||| S:34239 E:34241 ||| NN
PFA  ||| S:34241 E:34245 ||| NN
for  ||| S:34245 E:34249 ||| IN
at  ||| S:34249 E:34252 ||| IN
least  ||| S:34252 E:34258 ||| JJS
60  ||| S:34258 E:34261 ||| CD
min  ||| S:34261 E:34265 ||| NN
at  ||| S:34265 E:34268 ||| IN
room  ||| S:34268 E:34283 ||| NN
temperature  ||| S:34283 E:34295 ||| NN
or  ||| S:34295 E:34298 ||| CC
for  ||| S:34298 E:34302 ||| IN
20  ||| S:34302 E:34305 ||| CD
min  ||| S:34305 E:34309 ||| NN
at  ||| S:34309 E:34312 ||| IN
37°C  ||| S:34312 E:34317 ||| CD
to  ||| S:34317 E:34320 ||| TO
irreversibly  ||| S:34320 E:34343 ||| VB
crosslink  ||| S:34343 E:34353 ||| JJ
most  ||| S:34353 E:34358 ||| JJS
of  ||| S:34358 E:34361 ||| IN
the  ||| S:34361 E:34365 ||| DT
polypeptides  ||| S:34365 E:34378 ||| NN
( ||| S:34378 E:34379 ||| -LRB-
Figure  ||| S:34379 E:34386 ||| NNP
6 ||| S:34386 E:34387 ||| CD
) ||| S:34387 E:34388 ||| -RRB-
.  ||| S:34388 E:34390 ||| .
Thus ||| S:34390 E:34394 ||| RB
,  ||| S:34394 E:34406 ||| ,
enzymatic  ||| S:34406 E:34416 ||| JJ
reactions  ||| S:34416 E:34426 ||| NNS
or  ||| S:34426 E:34429 ||| CC
rearrangement  ||| S:34429 E:34443 ||| NN
of  ||| S:34443 E:34446 ||| IN
components  ||| S:34446 E:34457 ||| NNS
in  ||| S:34457 E:34460 ||| IN
the  ||| S:34460 E:34474 ||| DT
cytosol  ||| S:34474 E:34482 ||| NN
could  ||| S:34482 E:34488 ||| MD
occur  ||| S:34488 E:34494 ||| VB
for  ||| S:34494 E:34498 ||| IN
some  ||| S:34498 E:34503 ||| DT
time  ||| S:34503 E:34508 ||| NN
during  ||| S:34508 E:34515 ||| IN
fixation ||| S:34515 E:34523 ||| NN
.  ||| S:34523 E:34525 ||| .
In  ||| S:34525 E:34538 ||| IN
fact ||| S:34538 E:34542 ||| NN
,  ||| S:34542 E:34544 ||| ,
dephosphorylation  ||| S:34544 E:34562 ||| VBG
of  ||| S:34562 E:34565 ||| IN
moesin  ||| S:34565 E:34572 ||| NN
occurred  ||| S:34572 E:34581 ||| VBD
in  ||| S:34581 E:34584 ||| IN
mouse  ||| S:34584 E:34600 ||| NN
epithelial  ||| S:34600 E:34611 ||| VBD
MTD-1  ||| S:34611 E:34617 ||| CD
cells  ||| S:34617 E:34623 ||| NNS
during  ||| S:34623 E:34630 ||| IN
fixation  ||| S:34630 E:34639 ||| NN
in  ||| S:34639 E:34642 ||| IN
1 ||| S:34642 E:34643 ||| CD
%  ||| S:34643 E:34645 ||| NN
or  ||| S:34645 E:34648 ||| CC
4 ||| S:34648 E:34649 ||| CD
%  ||| S:34649 E:34661 ||| NN
paraformaldehyde  ||| S:34661 E:34678 ||| NN
at  ||| S:34678 E:34681 ||| IN
room  ||| S:34681 E:34686 ||| NN
temperature  ||| S:34686 E:34698 ||| NN
for  ||| S:34698 E:34702 ||| IN
15  ||| S:34702 E:34705 ||| CD
min  ||| S:34705 E:34709 ||| NNS
[  ||| S:34709 E:34711 ||| -LRB-
12 ||| S:34711 E:34713 ||| CD
] ||| S:34713 E:34714 ||| -RRB-
.  ||| S:34714 E:34716 ||| .
As  ||| S:34716 E:34729 ||| RB
shown  ||| S:34729 E:34735 ||| VBN
here ||| S:34735 E:34739 ||| RB
,  ||| S:34739 E:34741 ||| ,
however ||| S:34741 E:34748 ||| RB
,  ||| S:34748 E:34750 ||| ,
moesin  ||| S:34750 E:34757 ||| VBD
apparently  ||| S:34757 E:34768 ||| RB
was  ||| S:34768 E:34772 ||| VBD
not  ||| S:34772 E:34786 ||| RB
dephosphorylated  ||| S:34786 E:34803 ||| VBN
in  ||| S:34803 E:34806 ||| IN
PFA-based  ||| S:34806 E:34816 ||| JJ
fixatives  ||| S:34816 E:34826 ||| NN
in  ||| S:34826 E:34829 ||| IN
NIH3T3  ||| S:34829 E:34836 ||| CD
cells ||| S:34836 E:34841 ||| NNS
.  ||| S:34841 E:34853 ||| .
These  ||| S:34853 E:34859 ||| DT
conflicting  ||| S:34859 E:34871 ||| JJ
results  ||| S:34871 E:34879 ||| NNS
could  ||| S:34879 E:34885 ||| MD
be  ||| S:34885 E:34888 ||| VB
due  ||| S:34888 E:34892 ||| JJ
to  ||| S:34892 E:34895 ||| TO
differences  ||| S:34895 E:34907 ||| NNS
of  ||| S:34907 E:34920 ||| IN
cell  ||| S:34920 E:34925 ||| NN
type  ||| S:34925 E:34930 ||| NN
and ||| S:34930 E:34933 ||| CC
/ ||| S:34933 E:34934 ||| NNP
or  ||| S:34934 E:34937 ||| CC
antibody  ||| S:34937 E:34946 ||| NN
reactivity ||| S:34946 E:34956 ||| NN
.  ||| S:34956 E:34958 ||| .
We  ||| S:34958 E:34961 ||| PRP
have  ||| S:34961 E:34966 ||| VBP
prepared  ||| S:34966 E:34985 ||| VBN
the  ||| S:34985 E:34989 ||| DT
formaldehyde  ||| S:34989 E:35002 ||| JJ
solution  ||| S:35002 E:35011 ||| NN
by  ||| S:35011 E:35014 ||| IN
dissolving  ||| S:35014 E:35025 ||| JJ
PFA  ||| S:35025 E:35029 ||| NN
in  ||| S:35029 E:35032 ||| IN
water ||| S:35032 E:35037 ||| NN
,  ||| S:35037 E:35049 ||| ,
because  ||| S:35049 E:35057 ||| IN
it  ||| S:35057 E:35060 ||| PRP
was  ||| S:35060 E:35064 ||| VBD
pointed  ||| S:35064 E:35072 ||| VBN
out  ||| S:35072 E:35076 ||| RP
that  ||| S:35076 E:35081 ||| DT
methanol  ||| S:35081 E:35090 ||| NN
included  ||| S:35090 E:35099 ||| VBD
in  ||| S:35099 E:35112 ||| IN
commercial  ||| S:35112 E:35123 ||| JJ
formaldehyde  ||| S:35123 E:35136 ||| NN
as  ||| S:35136 E:35139 ||| IN
a  ||| S:35139 E:35141 ||| DT
preservative ||| S:35141 E:35153 ||| NN
,  ||| S:35153 E:35155 ||| ,
is  ||| S:35155 E:35158 ||| VBZ
enough  ||| S:35158 E:35165 ||| RB
to  ||| S:35165 E:35178 ||| TO
cause  ||| S:35178 E:35184 ||| VB
retraction  ||| S:35184 E:35195 ||| VBN
of  ||| S:35195 E:35198 ||| IN
ruffles  ||| S:35198 E:35206 ||| NN
and  ||| S:35206 E:35210 ||| CC
lamellipodia  ||| S:35210 E:35223 ||| NNS
[  ||| S:35223 E:35225 ||| -LRB-
15 ||| S:35225 E:35227 ||| CD
] ||| S:35227 E:35228 ||| -RRB-
.  ||| S:35228 E:35240 ||| .
However ||| S:35240 E:35247 ||| RB
,  ||| S:35247 E:35249 ||| ,
no  ||| S:35249 E:35252 ||| DT
morphological  ||| S:35252 E:35266 ||| JJ
difference  ||| S:35266 E:35277 ||| NN
between  ||| S:35277 E:35285 ||| IN
PFA  ||| S:35285 E:35289 ||| NNP
and  ||| S:35289 E:35303 ||| CC
formaldehyde  ||| S:35303 E:35316 ||| NN
was  ||| S:35316 E:35320 ||| VBD
apparent  ||| S:35320 E:35329 ||| JJ
when  ||| S:35329 E:35334 ||| WRB
cells  ||| S:35334 E:35340 ||| NNS
were  ||| S:35340 E:35345 ||| VBD
extracted  ||| S:35345 E:35355 ||| VBN
with  ||| S:35355 E:35370 ||| IN
DOTMAC  ||| S:35370 E:35377 ||| NNP
( ||| S:35377 E:35378 ||| -LRB-
data  ||| S:35378 E:35383 ||| NNS
not  ||| S:35383 E:35387 ||| RB
shown ||| S:35387 E:35392 ||| VBN
) ||| S:35392 E:35393 ||| -RRB-
.  ||| S:35393 E:35423 ||| .
Evaluation  ||| S:35423 E:35434 ||| NN
of  ||| S:35434 E:35437 ||| IN
DOTMAC ||| S:35437 E:35443 ||| NNP
/ ||| S:35443 E:35444 ||| NNP
PFA  ||| S:35444 E:35448 ||| NNP
method  ||| S:35448 E:35455 ||| NN
by  ||| S:35455 E:35458 ||| IN
fluorescent  ||| S:35458 E:35480 ||| FW
microscopy  ||| S:35480 E:35501 ||| FW
Amieva  ||| S:35501 E:35508 ||| FW
et  ||| S:35508 E:35511 ||| FW
al.  ||| S:35511 E:35515 ||| FW
[  ||| S:35515 E:35517 ||| -LRB-
22 ||| S:35517 E:35519 ||| CD
]  ||| S:35519 E:35521 ||| -RRB-
pointed  ||| S:35521 E:35529 ||| VBD
out  ||| S:35529 E:35533 ||| RP
that  ||| S:35533 E:35538 ||| IN
some  ||| S:35538 E:35553 ||| DT
microextensions  ||| S:35553 E:35569 ||| NN
may  ||| S:35569 E:35573 ||| MD
be  ||| S:35573 E:35576 ||| VB
lost  ||| S:35576 E:35581 ||| VBN
during  ||| S:35581 E:35588 ||| IN
fixation  ||| S:35588 E:35597 ||| NN
and  ||| S:35597 E:35601 ||| CC
washing  ||| S:35601 E:35619 ||| JJ
steps ||| S:35619 E:35624 ||| NNS
,  ||| S:35624 E:35626 ||| ,
and  ||| S:35626 E:35630 ||| CC
Nobes  ||| S:35630 E:35636 ||| NNP
and  ||| S:35636 E:35640 ||| CC
Hall  ||| S:35640 E:35645 ||| NNP
[  ||| S:35645 E:35647 ||| -LRB-
16 ||| S:35647 E:35649 ||| CD
]  ||| S:35649 E:35651 ||| -RRB-
added  ||| S:35651 E:35657 ||| VBD
glutaraldehyde  ||| S:35657 E:35672 ||| VBN
to  ||| S:35672 E:35685 ||| TO
the  ||| S:35685 E:35689 ||| DT
fixative  ||| S:35689 E:35698 ||| NN
in  ||| S:35698 E:35701 ||| IN
order  ||| S:35701 E:35707 ||| NN
to  ||| S:35707 E:35710 ||| TO
stain  ||| S:35710 E:35716 ||| VB
these  ||| S:35716 E:35722 ||| DT
delicate  ||| S:35722 E:35731 ||| JJ
structures  ||| S:35731 E:35752 ||| NNS
with  ||| S:35752 E:35757 ||| IN
phalloidin ||| S:35757 E:35767 ||| NN
,  ||| S:35767 E:35769 ||| ,
but  ||| S:35769 E:35773 ||| CC
glutaraldehyde  ||| S:35773 E:35788 ||| NNS
had  ||| S:35788 E:35792 ||| VBD
to  ||| S:35792 E:35795 ||| TO
be  ||| S:35795 E:35798 ||| VB
omitted  ||| S:35798 E:35806 ||| VBN
for  ||| S:35806 E:35820 ||| IN
immunostaining ||| S:35820 E:35834 ||| NN
.  ||| S:35834 E:35836 ||| .
Because  ||| S:35836 E:35844 ||| IN
the  ||| S:35844 E:35848 ||| DT
procedure  ||| S:35848 E:35858 ||| NN
developed  ||| S:35858 E:35868 ||| VBD
here  ||| S:35868 E:35883 ||| RB
resulted  ||| S:35883 E:35892 ||| VBN
in  ||| S:35892 E:35895 ||| IN
a  ||| S:35895 E:35897 ||| DT
comparable  ||| S:35897 E:35908 ||| JJ
preservation  ||| S:35908 E:35921 ||| NN
of  ||| S:35921 E:35924 ||| IN
microextensions ||| S:35924 E:35939 ||| NN
,  ||| S:35939 E:35951 ||| ,
we  ||| S:35951 E:35954 ||| PRP
systematically  ||| S:35954 E:35969 ||| VBP
analysed  ||| S:35969 E:35978 ||| VBG
these  ||| S:35978 E:35984 ||| DT
structures  ||| S:35984 E:35995 ||| NNS
with  ||| S:35995 E:36000 ||| IN
various  ||| S:36000 E:36018 ||| JJ
probes  ||| S:36018 E:36025 ||| NNS
by  ||| S:36025 E:36028 ||| IN
immunofluorescence  ||| S:36028 E:36047 ||| JJ
microscopy ||| S:36047 E:36057 ||| NN
.  ||| S:36057 E:36059 ||| .
The  ||| S:36059 E:36063 ||| DT
DOTMAC ||| S:36063 E:36069 ||| NNP
/ ||| S:36069 E:36070 ||| NNP
PFA  ||| S:36070 E:36084 ||| NNP
method  ||| S:36084 E:36091 ||| NN
provided  ||| S:36091 E:36100 ||| VBD
excellent  ||| S:36100 E:36110 ||| JJ
morphological  ||| S:36110 E:36124 ||| JJ
preservation  ||| S:36124 E:36137 ||| NN
of  ||| S:36137 E:36150 ||| IN
actin  ||| S:36150 E:36156 ||| JJ
stress  ||| S:36156 E:36163 ||| NN
fibers  ||| S:36163 E:36170 ||| NNS
and  ||| S:36170 E:36174 ||| CC
microextensions  ||| S:36174 E:36190 ||| NNS
and  ||| S:36190 E:36194 ||| CC
high  ||| S:36194 E:36209 ||| JJ
intensity  ||| S:36209 E:36219 ||| NN
immunolabeling  ||| S:36219 E:36234 ||| NN
of  ||| S:36234 E:36237 ||| IN
actin ||| S:36237 E:36242 ||| NN
,  ||| S:36242 E:36244 ||| ,
while  ||| S:36244 E:36250 ||| IN
phalloidin  ||| S:36250 E:36271 ||| JJ
staining  ||| S:36271 E:36280 ||| NN
was  ||| S:36280 E:36284 ||| VBD
poor  ||| S:36284 E:36289 ||| JJ
probably  ||| S:36289 E:36298 ||| RB
owing  ||| S:36298 E:36304 ||| VBG
to  ||| S:36304 E:36307 ||| TO
partial  ||| S:36307 E:36315 ||| JJ
denaturation  ||| S:36315 E:36338 ||| NN
of  ||| S:36338 E:36341 ||| IN
actin  ||| S:36341 E:36347 ||| JJ
filaments ||| S:36347 E:36356 ||| NN
.  ||| S:36356 E:36358 ||| .
The  ||| S:36358 E:36362 ||| DT
DOTMAC ||| S:36362 E:36368 ||| NNP
/ ||| S:36368 E:36369 ||| NNP
PFA  ||| S:36369 E:36373 ||| NNP
method  ||| S:36373 E:36380 ||| NN
thus  ||| S:36380 E:36385 ||| RB
should  ||| S:36385 E:36392 ||| MD
be  ||| S:36392 E:36405 ||| VB
considered  ||| S:36405 E:36416 ||| VBN
the  ||| S:36416 E:36420 ||| DT
method  ||| S:36420 E:36427 ||| NN
of  ||| S:36427 E:36430 ||| IN
choice  ||| S:36430 E:36437 ||| NN
for  ||| S:36437 E:36441 ||| IN
the  ||| S:36441 E:36445 ||| DT
preservation  ||| S:36445 E:36458 ||| NN
and  ||| S:36458 E:36472 ||| CC
immunostaining  ||| S:36472 E:36487 ||| NN
of  ||| S:36487 E:36490 ||| IN
microextensions  ||| S:36490 E:36506 ||| NN
or  ||| S:36506 E:36509 ||| CC
when  ||| S:36509 E:36514 ||| WRB
cells  ||| S:36514 E:36520 ||| NNS
fixed  ||| S:36520 E:36526 ||| VBN
by  ||| S:36526 E:36539 ||| IN
other  ||| S:36539 E:36545 ||| JJ
methods  ||| S:36545 E:36553 ||| NNS
cannot  ||| S:36553 E:36560 ||| RB
be  ||| S:36560 E:36563 ||| VB
stained  ||| S:36563 E:36571 ||| VBN
with  ||| S:36571 E:36576 ||| IN
certain  ||| S:36576 E:36594 ||| JJ
antisera ||| S:36594 E:36602 ||| NN
.  ||| S:36602 E:36632 ||| .
Functional  ||| S:36632 E:36643 ||| JJ
significance  ||| S:36643 E:36656 ||| NN
of  ||| S:36656 E:36659 ||| IN
fractionation  ||| S:36659 E:36673 ||| NN
of  ||| S:36673 E:36686 ||| IN
polypeptides  ||| S:36686 E:36699 ||| NN
into  ||| S:36699 E:36704 ||| IN
DOTMAC-resistant  ||| S:36704 E:36721 ||| JJ
components  ||| S:36721 E:36732 ||| NNS
in  ||| S:36732 E:36735 ||| IN
NIH3T3  ||| S:36735 E:36752 ||| CD
cells  ||| S:36752 E:36768 ||| NNS
We  ||| S:36768 E:36771 ||| PRP
have  ||| S:36771 E:36776 ||| VBP
previously  ||| S:36776 E:36787 ||| RB
shown  ||| S:36787 E:36793 ||| VBN
that  ||| S:36793 E:36798 ||| IN
purified  ||| S:36798 E:36817 ||| NNS
threonine558-phosphomoesin  ||| S:36817 E:36844 ||| VBP
selectively  ||| S:36844 E:36856 ||| RB
co-sedimented  ||| S:36856 E:36870 ||| JJ
with  ||| S:36870 E:36885 ||| IN
actin  ||| S:36885 E:36891 ||| JJ
filaments  ||| S:36891 E:36901 ||| NN
in  ||| S:36901 E:36904 ||| IN
the  ||| S:36904 E:36908 ||| DT
presence  ||| S:36908 E:36917 ||| NN
of  ||| S:36917 E:36920 ||| IN
DOTMAC  ||| S:36920 E:36927 ||| NNP
or  ||| S:36927 E:36930 ||| CC
PIPs ||| S:36930 E:36934 ||| JJ
,  ||| S:36934 E:36936 ||| ,
but  ||| S:36936 E:36950 ||| CC
excess  ||| S:36950 E:36957 ||| JJ
Triton  ||| S:36957 E:36964 ||| NNP
X-100  ||| S:36964 E:36970 ||| NNP
disrupted  ||| S:36970 E:36980 ||| VBD
the  ||| S:36980 E:36984 ||| DT
interaction  ||| S:36984 E:36996 ||| NN
of  ||| S:36996 E:36999 ||| IN
moesin  ||| S:36999 E:37016 ||| NN
with  ||| S:37016 E:37021 ||| IN
PIPs  ||| S:37021 E:37026 ||| NNP
[  ||| S:37026 E:37028 ||| -LRB-
19 ||| S:37028 E:37030 ||| CD
] ||| S:37030 E:37031 ||| -RRB-
.  ||| S:37031 E:37033 ||| .
Furthermore ||| S:37033 E:37044 ||| RB
,  ||| S:37044 E:37046 ||| ,
the  ||| S:37046 E:37050 ||| DT
cytoskeletal  ||| S:37050 E:37073 ||| JJ
association  ||| S:37073 E:37085 ||| NN
of  ||| S:37085 E:37088 ||| IN
threonine558-phosphomoesin  ||| S:37088 E:37115 ||| NNP
was  ||| S:37115 E:37119 ||| VBD
maintained  ||| S:37119 E:37140 ||| VBN
when  ||| S:37140 E:37145 ||| WRB
platelets  ||| S:37145 E:37155 ||| NNS
were  ||| S:37155 E:37160 ||| VBD
extracted  ||| S:37160 E:37170 ||| VBN
with  ||| S:37170 E:37175 ||| IN
DOTMAC ||| S:37175 E:37181 ||| NNP
,  ||| S:37181 E:37183 ||| ,
but  ||| S:37183 E:37187 ||| CC
not  ||| S:37187 E:37191 ||| RB
with  ||| S:37191 E:37206 ||| IN
Triton  ||| S:37206 E:37213 ||| NNP
X-100 ||| S:37213 E:37218 ||| NNP
.  ||| S:37218 E:37220 ||| .
These  ||| S:37220 E:37226 ||| DT
results  ||| S:37226 E:37234 ||| NNS
were  ||| S:37234 E:37239 ||| VBD
consistent  ||| S:37239 E:37250 ||| JJ
with  ||| S:37250 E:37255 ||| IN
a  ||| S:37255 E:37257 ||| DT
model  ||| S:37257 E:37273 ||| NN
of  ||| S:37273 E:37276 ||| IN
an  ||| S:37276 E:37279 ||| DT
allosteric  ||| S:37279 E:37290 ||| JJ
change  ||| S:37290 E:37297 ||| NN
induced  ||| S:37297 E:37305 ||| NN
by  ||| S:37305 E:37308 ||| IN
PIPs  ||| S:37308 E:37313 ||| NNP
( ||| S:37313 E:37314 ||| -LRB-
or  ||| S:37314 E:37317 ||| CC
DOTMAC ||| S:37317 E:37323 ||| NNP
)  ||| S:37323 E:37325 ||| -RRB-
that  ||| S:37325 E:37340 ||| IN
exposed  ||| S:37340 E:37348 ||| VBN
and  ||| S:37348 E:37352 ||| CC
maintained  ||| S:37352 E:37363 ||| VBD
a  ||| S:37363 E:37365 ||| DT
cytoskeleton-binding  ||| S:37365 E:37386 ||| JJ
site  ||| S:37386 E:37391 ||| NN
of  ||| S:37391 E:37404 ||| IN
moesin ||| S:37404 E:37410 ||| NN
.  ||| S:37410 E:37412 ||| .
In  ||| S:37412 E:37415 ||| IN
NIH3T3  ||| S:37415 E:37422 ||| CD
cells ||| S:37422 E:37427 ||| NNS
,  ||| S:37427 E:37429 ||| ,
however ||| S:37429 E:37436 ||| RB
,  ||| S:37436 E:37438 ||| ,
unlike  ||| S:37438 E:37445 ||| IN
in  ||| S:37445 E:37448 ||| IN
platelets ||| S:37448 E:37457 ||| NN
,  ||| S:37457 E:37469 ||| ,
most  ||| S:37469 E:37474 ||| JJS
of  ||| S:37474 E:37477 ||| IN
threonine558-phosphomoesin  ||| S:37477 E:37504 ||| NNP
was  ||| S:37504 E:37508 ||| VBD
retained  ||| S:37508 E:37517 ||| VBN
in  ||| S:37517 E:37520 ||| IN
the  ||| S:37520 E:37534 ||| DT
Triton  ||| S:37534 E:37541 ||| NNP
X-100-insoluble ||| S:37541 E:37556 ||| NNP
,  ||| S:37556 E:37558 ||| ,
but  ||| S:37558 E:37562 ||| CC
only  ||| S:37562 E:37567 ||| RB
∼  ||| S:37567 E:37569 ||| CD
20 ||| S:37569 E:37571 ||| CD
%  ||| S:37571 E:37573 ||| NN
in  ||| S:37573 E:37576 ||| IN
the  ||| S:37576 E:37590 ||| DT
DOTMAC-insoluble  ||| S:37590 E:37607 ||| JJ
fraction ||| S:37607 E:37615 ||| NN
.  ||| S:37615 E:37617 ||| .
How  ||| S:37617 E:37621 ||| WRB
can  ||| S:37621 E:37625 ||| MD
this  ||| S:37625 E:37630 ||| DT
difference  ||| S:37630 E:37641 ||| NN
be  ||| S:37641 E:37654 ||| VB
reconciled ||| S:37654 E:37664 ||| NNS
?  ||| S:37664 E:37666 ||| .
One  ||| S:37666 E:37670 ||| CD
possibility  ||| S:37670 E:37682 ||| NN
is  ||| S:37682 E:37685 ||| VBZ
that  ||| S:37685 E:37690 ||| DT
moesin  ||| S:37690 E:37697 ||| NN
in  ||| S:37697 E:37700 ||| IN
NIH3T3  ||| S:37700 E:37717 ||| CD
cells  ||| S:37717 E:37723 ||| NNS
is  ||| S:37723 E:37726 ||| VBZ
modified  ||| S:37726 E:37735 ||| VBN
differently ||| S:37735 E:37746 ||| RB
.  ||| S:37746 E:37748 ||| .
For  ||| S:37748 E:37752 ||| IN
example ||| S:37752 E:37759 ||| NN
,  ||| S:37759 E:37761 ||| ,
moesin  ||| S:37761 E:37768 ||| NN
is  ||| S:37768 E:37781 ||| VBZ
tyrosine  ||| S:37781 E:37790 ||| JJ
phosphorylated  ||| S:37790 E:37805 ||| NN
in  ||| S:37805 E:37808 ||| IN
v-src-transfected  ||| S:37808 E:37826 ||| NNP
MDCK  ||| S:37826 E:37831 ||| NNP
cells  ||| S:37831 E:37837 ||| NNS
[  ||| S:37837 E:37849 ||| -LRB-
42 ||| S:37849 E:37851 ||| CD
] ||| S:37851 E:37852 ||| -RRB-
.  ||| S:37852 E:37854 ||| .
A  ||| S:37854 E:37856 ||| DT
second  ||| S:37856 E:37863 ||| JJ
possibility  ||| S:37863 E:37875 ||| NN
is  ||| S:37875 E:37878 ||| VBZ
that  ||| S:37878 E:37893 ||| IN
threonine558-phosphomoesin  ||| S:37893 E:37920 ||| CD
interacts  ||| S:37920 E:37930 ||| NN
with  ||| S:37930 E:37935 ||| IN
non-extractable  ||| S:37935 E:37961 ||| JJ
membrane  ||| S:37961 E:37970 ||| JJ
constituents  ||| S:37970 E:37983 ||| NNS
besides  ||| S:37983 E:37991 ||| IN
actin  ||| S:37991 E:37997 ||| JJ
filaments  ||| S:37997 E:38007 ||| NN
in  ||| S:38007 E:38010 ||| IN
cells  ||| S:38010 E:38026 ||| NNS
other  ||| S:38026 E:38032 ||| JJ
than  ||| S:38032 E:38037 ||| IN
platelets ||| S:38037 E:38046 ||| NN
.  ||| S:38046 E:38048 ||| .
For  ||| S:38048 E:38052 ||| IN
example ||| S:38052 E:38059 ||| NN
,  ||| S:38059 E:38061 ||| ,
the  ||| S:38061 E:38065 ||| DT
N-terminal  ||| S:38065 E:38076 ||| JJ
domain  ||| S:38076 E:38093 ||| NN
of  ||| S:38093 E:38096 ||| IN
moesin  ||| S:38096 E:38103 ||| NNS
lacking  ||| S:38103 E:38111 ||| VBG
the  ||| S:38111 E:38115 ||| DT
C-terminal  ||| S:38115 E:38126 ||| JJ
F-actin  ||| S:38126 E:38134 ||| JJ
binding  ||| S:38134 E:38142 ||| JJ
domain  ||| S:38142 E:38159 ||| NN
remained  ||| S:38159 E:38168 ||| VBD
strongly  ||| S:38168 E:38177 ||| RB
associated  ||| S:38177 E:38188 ||| VBN
with  ||| S:38188 E:38193 ||| IN
the  ||| S:38193 E:38197 ||| DT
NP-40-insoluble  ||| S:38197 E:38223 ||| JJ
material  ||| S:38223 E:38232 ||| NN
of  ||| S:38232 E:38235 ||| IN
NIH3T3  ||| S:38235 E:38242 ||| CD
cells  ||| S:38242 E:38248 ||| NNS
[  ||| S:38248 E:38250 ||| -LRB-
22 ||| S:38250 E:38252 ||| CD
] ||| S:38252 E:38253 ||| -RRB-
.  ||| S:38253 E:38255 ||| .
While  ||| S:38255 E:38261 ||| IN
this  ||| S:38261 E:38266 ||| DT
issue  ||| S:38266 E:38272 ||| NN
needs  ||| S:38272 E:38288 ||| VBZ
further  ||| S:38288 E:38296 ||| JJ
work ||| S:38296 E:38300 ||| NN
,  ||| S:38300 E:38302 ||| ,
it  ||| S:38302 E:38305 ||| PRP
is  ||| S:38305 E:38308 ||| VBZ
clear  ||| S:38308 E:38314 ||| JJ
that  ||| S:38314 E:38319 ||| IN
detergent  ||| S:38319 E:38329 ||| NN
extraction  ||| S:38329 E:38340 ||| VBZ
alone  ||| S:38340 E:38356 ||| RB
cannot  ||| S:38356 E:38363 ||| RB
be  ||| S:38363 E:38366 ||| VB
used  ||| S:38366 E:38371 ||| VBN
as  ||| S:38371 E:38374 ||| IN
the  ||| S:38374 E:38378 ||| DT
sole  ||| S:38378 E:38383 ||| JJ
criterion  ||| S:38383 E:38393 ||| NN
for  ||| S:38393 E:38397 ||| IN
cytoskeletal  ||| S:38397 E:38420 ||| JJ
association  ||| S:38420 E:38432 ||| NN
of  ||| S:38432 E:38435 ||| IN
proteins  ||| S:38435 E:38444 ||| NNS
such  ||| S:38444 E:38449 ||| JJ
as  ||| S:38449 E:38452 ||| IN
moesin  ||| S:38452 E:38459 ||| VBG
as  ||| S:38459 E:38462 ||| RB
stated  ||| S:38462 E:38479 ||| VBN
frequently  ||| S:38479 E:38490 ||| RB
in  ||| S:38490 E:38493 ||| IN
the  ||| S:38493 E:38497 ||| DT
recent  ||| S:38497 E:38504 ||| JJ
literature ||| S:38504 E:38514 ||| NN
.  ||| S:38514 E:38547 ||| .
Materials  ||| S:38547 E:38557 ||| NNS
and  ||| S:38557 E:38561 ||| CC
Methods  ||| S:38561 E:38588 ||| NNP
Chemicals  ||| S:38588 E:38598 ||| NNPS
and  ||| S:38598 E:38602 ||| CC
antibodies  ||| S:38602 E:38623 ||| JJ
DME  ||| S:38623 E:38627 ||| NNP
medium  ||| S:38627 E:38634 ||| NN
was  ||| S:38634 E:38638 ||| VBD
obtained  ||| S:38638 E:38647 ||| VBN
from  ||| S:38647 E:38652 ||| IN
Nissui  ||| S:38652 E:38659 ||| NNP
( ||| S:38659 E:38660 ||| -LRB-
Tokyo ||| S:38660 E:38665 ||| NNP
,  ||| S:38665 E:38667 ||| ,
Japan ||| S:38667 E:38672 ||| NNP
)  ||| S:38672 E:38674 ||| -RRB-
or  ||| S:38674 E:38687 ||| CC
Sigma  ||| S:38687 E:38693 ||| NNP
( ||| S:38693 E:38694 ||| -LRB-
St.  ||| S:38694 E:38698 ||| NNP
Louis ||| S:38698 E:38703 ||| NNP
,  ||| S:38703 E:38705 ||| ,
MO ||| S:38705 E:38707 ||| NNP
) ||| S:38707 E:38708 ||| -RRB-
.  ||| S:38708 E:38710 ||| .
FCS  ||| S:38710 E:38714 ||| NNP
was  ||| S:38714 E:38718 ||| VBD
purchased  ||| S:38718 E:38728 ||| VBN
from  ||| S:38728 E:38733 ||| IN
GIBCO  ||| S:38733 E:38739 ||| NNP
BRL  ||| S:38739 E:38753 ||| NNP
Life  ||| S:38753 E:38758 ||| NNP
Technologies  ||| S:38758 E:38771 ||| NNPS
( ||| S:38771 E:38772 ||| -LRB-
Paisley ||| S:38772 E:38779 ||| NNP
,  ||| S:38779 E:38781 ||| ,
Scotland ||| S:38781 E:38789 ||| NNP
)  ||| S:38789 E:38791 ||| -RRB-
or  ||| S:38791 E:38794 ||| CC
Sigma ||| S:38794 E:38799 ||| NNP
.  ||| S:38799 E:38801 ||| .
Other  ||| S:38801 E:38817 ||| JJ
tissue  ||| S:38817 E:38824 ||| NN
culture  ||| S:38824 E:38832 ||| NN
reagents  ||| S:38832 E:38841 ||| NNS
were  ||| S:38841 E:38846 ||| VBD
purchased  ||| S:38846 E:38856 ||| VBN
from  ||| S:38856 E:38861 ||| IN
GIBCO ||| S:38861 E:38866 ||| NNP
.  ||| S:38866 E:38868 ||| .
All  ||| S:38868 E:38882 ||| DT
lipids  ||| S:38882 E:38889 ||| NN
were  ||| S:38889 E:38894 ||| VBD
from  ||| S:38894 E:38899 ||| IN
Sigma ||| S:38899 E:38904 ||| NNP
.  ||| S:38904 E:38906 ||| .
Glutaraldehyde  ||| S:38906 E:38921 ||| NNP
( ||| S:38921 E:38922 ||| -LRB-
70 ||| S:38922 E:38924 ||| CD
%  ||| S:38924 E:38926 ||| NN
stock  ||| S:38926 E:38932 ||| NN
in  ||| S:38932 E:38945 ||| IN
water ||| S:38945 E:38950 ||| NN
,  ||| S:38950 E:38952 ||| ,
EM  ||| S:38952 E:38955 ||| NNP
grade ||| S:38955 E:38960 ||| NN
) ||| S:38960 E:38961 ||| -RRB-
,  ||| S:38961 E:38963 ||| ,
paraformaldehyde  ||| S:38963 E:38980 ||| NNS
( ||| S:38980 E:38981 ||| -LRB-
PFA ||| S:38981 E:38984 ||| NNP
) ||| S:38984 E:38985 ||| -RRB-
,  ||| S:38985 E:38987 ||| ,
and  ||| S:38987 E:38991 ||| CC
organic  ||| S:38991 E:39009 ||| JJ
solvents  ||| S:39009 E:39018 ||| NNS
were  ||| S:39018 E:39023 ||| VBD
purchased  ||| S:39023 E:39033 ||| VBN
from  ||| S:39033 E:39038 ||| IN
Nacalai  ||| S:39038 E:39046 ||| NNP
Tesque  ||| S:39046 E:39053 ||| NNP
( ||| S:39053 E:39054 ||| -LRB-
Kyoto ||| S:39054 E:39059 ||| NNP
,  ||| S:39059 E:39071 ||| ,
Japan ||| S:39071 E:39076 ||| NNP
) ||| S:39076 E:39077 ||| -RRB-
.  ||| S:39077 E:39079 ||| .
Anti-β-actin  ||| S:39079 E:39092 ||| JJ
mouse  ||| S:39092 E:39098 ||| NN
mAb  ||| S:39098 E:39102 ||| NNS
( ||| S:39102 E:39103 ||| -LRB-
A5441 ||| S:39103 E:39108 ||| NNP
) ||| S:39108 E:39109 ||| -RRB-
,  ||| S:39109 E:39111 ||| ,
anti-β-tubulin  ||| S:39111 E:39136 ||| JJ
mouse  ||| S:39136 E:39142 ||| NN
mAb  ||| S:39142 E:39146 ||| NNS
( ||| S:39146 E:39147 ||| -LRB-
T4026 ||| S:39147 E:39152 ||| NNP
) ||| S:39152 E:39153 ||| -RRB-
,  ||| S:39153 E:39155 ||| ,
anti-vinculin  ||| S:39155 E:39169 ||| JJ
mouse  ||| S:39169 E:39175 ||| NN
mAb  ||| S:39175 E:39179 ||| NNS
( ||| S:39179 E:39180 ||| -LRB-
V9131 ||| S:39180 E:39185 ||| NNP
) ||| S:39185 E:39186 ||| -RRB-
,  ||| S:39186 E:39198 ||| ,
anti-mouse  ||| S:39198 E:39209 ||| FW
IgG  ||| S:39209 E:39213 ||| FW
FITC  ||| S:39213 E:39218 ||| FW
conjugate  ||| S:39218 E:39228 ||| FW
( ||| S:39228 E:39229 ||| -LRB-
F2012 ||| S:39229 E:39234 ||| NNP
) ||| S:39234 E:39235 ||| -RRB-
,  ||| S:39235 E:39237 ||| ,
anti-rabbit  ||| S:39237 E:39249 ||| FW
IgG  ||| S:39249 E:39263 ||| FW
FITC  ||| S:39263 E:39268 ||| FW
conjugate  ||| S:39268 E:39278 ||| FW
( ||| S:39278 E:39279 ||| -LRB-
F1262 ||| S:39279 E:39284 ||| NNP
) ||| S:39284 E:39285 ||| -RRB-
,  ||| S:39285 E:39287 ||| ,
anti-rabbit  ||| S:39287 E:39299 ||| FW
IgG  ||| S:39299 E:39303 ||| FW
TRITC  ||| S:39303 E:39309 ||| FW
conjugate  ||| S:39309 E:39329 ||| FW
( ||| S:39329 E:39330 ||| -LRB-
T5268 ||| S:39330 E:39335 ||| NNP
) ||| S:39335 E:39336 ||| -RRB-
,  ||| S:39336 E:39338 ||| ,
and  ||| S:39338 E:39342 ||| CC
TRITC  ||| S:39342 E:39348 ||| NNP
labeled  ||| S:39348 E:39356 ||| VBD
phalloidin  ||| S:39356 E:39367 ||| RB
were  ||| S:39367 E:39372 ||| VBD
purchased  ||| S:39372 E:39382 ||| VBN
from  ||| S:39382 E:39397 ||| IN
Sigma ||| S:39397 E:39402 ||| NNP
.  ||| S:39402 E:39404 ||| .
Anti-mouse  ||| S:39404 E:39415 ||| JJ
IgG  ||| S:39415 E:39419 ||| JJ
rhodamine  ||| S:39419 E:39429 ||| JJ
conjugate  ||| S:39429 E:39439 ||| NNS
( ||| S:39439 E:39440 ||| -LRB-
AP124R ||| S:39440 E:39446 ||| NNP
)  ||| S:39446 E:39448 ||| -RRB-
was  ||| S:39448 E:39462 ||| VBD
obtained  ||| S:39462 E:39471 ||| VBN
from  ||| S:39471 E:39476 ||| IN
Chemicon  ||| S:39476 E:39485 ||| NNP
International  ||| S:39485 E:39499 ||| NNP
( ||| S:39499 E:39500 ||| -LRB-
Temecula ||| S:39500 E:39508 ||| NNP
,  ||| S:39508 E:39510 ||| ,
CA ||| S:39510 E:39512 ||| NNP
) ||| S:39512 E:39513 ||| -RRB-
.  ||| S:39513 E:39525 ||| .
Affinity-purified  ||| S:39525 E:39543 ||| JJ
polyclonal  ||| S:39543 E:39554 ||| JJ
antibodies  ||| S:39554 E:39565 ||| NNS
( ||| S:39565 E:39566 ||| -LRB-
95 ||| S:39566 E:39568 ||| CD
/ ||| S:39568 E:39569 ||| CD
1 ||| S:39569 E:39570 ||| CD
)  ||| S:39570 E:39572 ||| -RRB-
were  ||| S:39572 E:39577 ||| VBD
used  ||| S:39577 E:39592 ||| VBN
for  ||| S:39592 E:39596 ||| IN
the  ||| S:39596 E:39600 ||| DT
identification  ||| S:39600 E:39615 ||| NN
of  ||| S:39615 E:39618 ||| IN
moesin  ||| S:39618 E:39625 ||| NN
by  ||| S:39625 E:39628 ||| IN
immunoblotting  ||| S:39628 E:39643 ||| NN
and  ||| S:39643 E:39657 ||| CC
for  ||| S:39657 E:39661 ||| IN
immunofluorescence ||| S:39661 E:39679 ||| NN
.  ||| S:39679 E:39681 ||| .
The  ||| S:39681 E:39685 ||| DT
affinity-purified  ||| S:39685 E:39703 ||| JJ
polyclonal  ||| S:39703 E:39724 ||| JJ
antibodies  ||| S:39724 E:39735 ||| NNS
against  ||| S:39735 E:39743 ||| IN
threonine558-phospho-moesin  ||| S:39743 E:39771 ||| NNP
were  ||| S:39771 E:39786 ||| VBD
prepared  ||| S:39786 E:39795 ||| VBN
as  ||| S:39795 E:39798 ||| RB
described  ||| S:39798 E:39808 ||| VBN
previously  ||| S:39808 E:39819 ||| RB
[  ||| S:39819 E:39821 ||| -LRB-
43 ||| S:39821 E:39823 ||| CD
] ||| S:39823 E:39824 ||| -RRB-
.  ||| S:39824 E:39826 ||| .
Actin  ||| S:39826 E:39832 ||| NNP
was  ||| S:39832 E:39846 ||| VBD
prepared  ||| S:39846 E:39855 ||| VBN
as  ||| S:39855 E:39858 ||| RB
described  ||| S:39858 E:39868 ||| VBN
previously  ||| S:39868 E:39879 ||| RB
[  ||| S:39879 E:39881 ||| -LRB-
19 ||| S:39881 E:39883 ||| CD
] ||| S:39883 E:39884 ||| -RRB-
.  ||| S:39884 E:39886 ||| .
Tubulin  ||| S:39886 E:39894 ||| NNP
was  ||| S:39894 E:39908 ||| VBD
purchased  ||| S:39908 E:39918 ||| VBN
from  ||| S:39918 E:39923 ||| IN
Cytoskeleton  ||| S:39923 E:39936 ||| NNP
( ||| S:39936 E:39937 ||| -LRB-
Denver ||| S:39937 E:39943 ||| NNP
,  ||| S:39943 E:39945 ||| ,
CO ||| S:39945 E:39947 ||| NNP
) ||| S:39947 E:39948 ||| -RRB-
.  ||| S:39948 E:39978 ||| .
Cell  ||| S:39978 E:39983 ||| NN
culture  ||| S:39983 E:40001 ||| NN
NIH  ||| S:40001 E:40005 ||| NNP
3T3  ||| S:40005 E:40009 ||| NNP
fibroblasts  ||| S:40009 E:40021 ||| NN
were  ||| S:40021 E:40026 ||| VBD
grown  ||| S:40026 E:40032 ||| VBN
in  ||| S:40032 E:40035 ||| IN
DME  ||| S:40035 E:40039 ||| NNP
medium  ||| S:40039 E:40056 ||| NN
containing  ||| S:40056 E:40067 ||| VBG
1000  ||| S:40067 E:40072 ||| CD
mg ||| S:40072 E:40074 ||| CD
/ ||| S:40074 E:40075 ||| CD
liter  ||| S:40075 E:40081 ||| JJ
glucose ||| S:40081 E:40088 ||| NN
,  ||| S:40088 E:40090 ||| ,
supplemented  ||| S:40090 E:40103 ||| VBG
with  ||| S:40103 E:40108 ||| IN
10 ||| S:40108 E:40110 ||| CD
%  ||| S:40110 E:40122 ||| NN
FCS ||| S:40122 E:40125 ||| NNP
,  ||| S:40125 E:40127 ||| ,
4  ||| S:40127 E:40129 ||| CD
mM  ||| S:40129 E:40132 ||| JJ
L-glutamine ||| S:40132 E:40143 ||| NN
,  ||| S:40143 E:40145 ||| ,
penicillin  ||| S:40145 E:40156 ||| NNS
( ||| S:40156 E:40157 ||| -LRB-
100  ||| S:40157 E:40161 ||| CD
IU ||| S:40161 E:40163 ||| CD
/ ||| S:40163 E:40164 ||| CD
ml ||| S:40164 E:40166 ||| CD
) ||| S:40166 E:40167 ||| -RRB-
,  ||| S:40167 E:40169 ||| ,
and  ||| S:40169 E:40183 ||| CC
streptomycin  ||| S:40183 E:40196 ||| NNS
( ||| S:40196 E:40197 ||| -LRB-
100  ||| S:40197 E:40201 ||| CD
μg ||| S:40201 E:40203 ||| CD
/ ||| S:40203 E:40204 ||| CD
ml ||| S:40204 E:40206 ||| CD
) ||| S:40206 E:40207 ||| -RRB-
,  ||| S:40207 E:40209 ||| ,
at  ||| S:40209 E:40212 ||| IN
37°C  ||| S:40212 E:40217 ||| CD
in  ||| S:40217 E:40220 ||| IN
a  ||| S:40220 E:40222 ||| DT
humidified  ||| S:40222 E:40243 ||| JJ
atmosphere  ||| S:40243 E:40254 ||| NN
of  ||| S:40254 E:40257 ||| IN
5 ||| S:40257 E:40258 ||| CD
%  ||| S:40258 E:40260 ||| NN
CO  ||| S:40260 E:40274 ||| NNP
2  ||| S:40274 E:40276 ||| CD
in  ||| S:40276 E:40279 ||| IN
air ||| S:40279 E:40282 ||| NN
.  ||| S:40282 E:40284 ||| .
Cells  ||| S:40284 E:40290 ||| NNS
were  ||| S:40290 E:40295 ||| VBD
washed  ||| S:40295 E:40302 ||| VBN
with  ||| S:40302 E:40307 ||| IN
PBS  ||| S:40307 E:40321 ||| NNP
containing  ||| S:40321 E:40332 ||| VBG
1  ||| S:40332 E:40334 ||| CD
mM  ||| S:40334 E:40337 ||| JJ
CaCl  ||| S:40337 E:40353 ||| JJ
2  ||| S:40353 E:40355 ||| CD
and  ||| S:40355 E:40359 ||| CC
1  ||| S:40359 E:40361 ||| CD
mM  ||| S:40361 E:40364 ||| JJ
MgCl  ||| S:40364 E:40380 ||| JJ
2  ||| S:40380 E:40382 ||| CD
( ||| S:40382 E:40383 ||| -LRB-
PBS ||| S:40383 E:40386 ||| NNP
( ||| S:40386 E:40387 ||| -LRB-
+ ||| S:40387 E:40388 ||| NNP
) ||| S:40388 E:40389 ||| -RRB-
) ||| S:40389 E:40390 ||| -RRB-
,  ||| S:40390 E:40392 ||| ,
detached  ||| S:40392 E:40401 ||| VBN
by  ||| S:40401 E:40404 ||| IN
treating  ||| S:40404 E:40413 ||| VBG
with  ||| S:40413 E:40428 ||| IN
0.05 ||| S:40428 E:40432 ||| CD
%  ||| S:40432 E:40434 ||| NN
trypsin  ||| S:40434 E:40442 ||| NN
in  ||| S:40442 E:40445 ||| IN
PBS  ||| S:40445 E:40449 ||| NNP
or  ||| S:40449 E:40452 ||| CC
0.02 ||| S:40452 E:40456 ||| CD
%  ||| S:40456 E:40458 ||| NN
EDTA  ||| S:40458 E:40463 ||| NN
in  ||| S:40463 E:40466 ||| IN
PBS ||| S:40466 E:40469 ||| NNP
.  ||| S:40469 E:40471 ||| .
The  ||| S:40471 E:40475 ||| DT
suspended  ||| S:40475 E:40495 ||| JJ
cells  ||| S:40495 E:40501 ||| NNS
were  ||| S:40501 E:40506 ||| VBD
washed  ||| S:40506 E:40513 ||| VBN
with  ||| S:40513 E:40518 ||| IN
PBS ||| S:40518 E:40521 ||| NNP
,  ||| S:40521 E:40523 ||| ,
resuspended  ||| S:40523 E:40535 ||| VBG
in  ||| S:40535 E:40538 ||| IN
growth  ||| S:40538 E:40545 ||| NN
medium ||| S:40545 E:40551 ||| NN
,  ||| S:40551 E:40563 ||| ,
and  ||| S:40563 E:40567 ||| CC
plated  ||| S:40567 E:40574 ||| NN
on  ||| S:40574 E:40577 ||| IN
FCS-coated  ||| S:40577 E:40588 ||| JJ
glass  ||| S:40588 E:40594 ||| NN
coverslips  ||| S:40594 E:40605 ||| NN
for  ||| S:40605 E:40609 ||| IN
microscopy ||| S:40609 E:40619 ||| NN
,  ||| S:40619 E:40631 ||| ,
or  ||| S:40631 E:40634 ||| CC
onto  ||| S:40634 E:40639 ||| IN
35-mm  ||| S:40639 E:40645 ||| NNP
or  ||| S:40645 E:40648 ||| CC
100-mm  ||| S:40648 E:40655 ||| NNP
Falcon  ||| S:40655 E:40662 ||| NNP
plastic  ||| S:40662 E:40670 ||| NN
culture  ||| S:40670 E:40678 ||| NN
dishes  ||| S:40678 E:40695 ||| NNS
( ||| S:40695 E:40696 ||| -LRB-
Beckton  ||| S:40696 E:40704 ||| NNP
Dickinson ||| S:40704 E:40713 ||| NNP
,  ||| S:40713 E:40715 ||| ,
Lincoln ||| S:40715 E:40722 ||| NNP
,  ||| S:40722 E:40724 ||| ,
NJ ||| S:40724 E:40726 ||| NNP
)  ||| S:40726 E:40728 ||| -RRB-
or  ||| S:40728 E:40731 ||| CC
FCS-coated  ||| S:40731 E:40742 ||| JJ
glass  ||| S:40742 E:40758 ||| NN
culture  ||| S:40758 E:40766 ||| NN
dishes  ||| S:40766 E:40773 ||| NNS
for  ||| S:40773 E:40777 ||| IN
biochemical  ||| S:40777 E:40789 ||| JJ
experiments ||| S:40789 E:40800 ||| NNS
.  ||| S:40800 E:40802 ||| .
In  ||| S:40802 E:40805 ||| IN
some  ||| S:40805 E:40820 ||| DT
cases ||| S:40820 E:40825 ||| NNS
,  ||| S:40825 E:40827 ||| ,
detached  ||| S:40827 E:40836 ||| JJ
cells  ||| S:40836 E:40842 ||| NNS
were  ||| S:40842 E:40847 ||| VBD
resuspended  ||| S:40847 E:40859 ||| VBN
in  ||| S:40859 E:40862 ||| IN
growth  ||| S:40862 E:40869 ||| NN
medium  ||| S:40869 E:40886 ||| NN
without  ||| S:40886 E:40894 ||| IN
washing ||| S:40894 E:40901 ||| NN
.  ||| S:40901 E:40931 ||| .
Scanning  ||| S:40931 E:40940 ||| VBG
electron  ||| S:40940 E:40949 ||| JJ
microscopy  ||| S:40949 E:40970 ||| NN
For  ||| S:40970 E:40974 ||| IN
the  ||| S:40974 E:40978 ||| DT
observation  ||| S:40978 E:40990 ||| NN
of  ||| S:40990 E:40993 ||| IN
cellular  ||| S:40993 E:41002 ||| JJ
surface ||| S:41002 E:41009 ||| NN
,  ||| S:41009 E:41011 ||| ,
cells  ||| S:41011 E:41017 ||| NNS
were  ||| S:41017 E:41032 ||| VBD
rinsed  ||| S:41032 E:41039 ||| VBN
with  ||| S:41039 E:41044 ||| IN
PBS ||| S:41044 E:41047 ||| NNP
( ||| S:41047 E:41048 ||| -LRB-
+ ||| S:41048 E:41049 ||| NNP
)  ||| S:41049 E:41051 ||| -RRB-
and  ||| S:41051 E:41055 ||| CC
fixed  ||| S:41055 E:41061 ||| VBN
with  ||| S:41061 E:41066 ||| IN
PBS ||| S:41066 E:41069 ||| NNP
( ||| S:41069 E:41070 ||| -LRB-
+ ||| S:41070 E:41071 ||| NNP
)  ||| S:41071 E:41073 ||| -RRB-
containing  ||| S:41073 E:41084 ||| VBG
2 ||| S:41084 E:41085 ||| CD
%  ||| S:41085 E:41097 ||| NN
glutaraldehyde  ||| S:41097 E:41112 ||| NNS
( ||| S:41112 E:41113 ||| -LRB-
dilute  ||| S:41113 E:41120 ||| VB
70 ||| S:41120 E:41122 ||| CD
%  ||| S:41122 E:41124 ||| NN
glutaraldehyde  ||| S:41124 E:41139 ||| VBZ
just  ||| S:41139 E:41144 ||| RB
before  ||| S:41144 E:41161 ||| IN
use ||| S:41161 E:41164 ||| NN
)  ||| S:41164 E:41166 ||| -RRB-
at  ||| S:41166 E:41169 ||| IN
4°C  ||| S:41169 E:41173 ||| CD
for  ||| S:41173 E:41177 ||| IN
1  ||| S:41177 E:41179 ||| CD
hour ||| S:41179 E:41183 ||| NN
.  ||| S:41183 E:41185 ||| .
In  ||| S:41185 E:41188 ||| IN
most  ||| S:41188 E:41193 ||| JJS
references ||| S:41193 E:41203 ||| NNS
,  ||| S:41203 E:41205 ||| ,
cells  ||| S:41205 E:41211 ||| NNS
were  ||| S:41211 E:41226 ||| VBD
rinsed  ||| S:41226 E:41233 ||| VBN
with  ||| S:41233 E:41238 ||| IN
PBS  ||| S:41238 E:41242 ||| NNP
( ||| S:41242 E:41243 ||| -LRB-
although  ||| S:41243 E:41252 ||| IN
PBS ||| S:41252 E:41255 ||| NNP
,  ||| S:41255 E:41257 ||| ,
in  ||| S:41257 E:41260 ||| IN
some  ||| S:41260 E:41265 ||| DT
references ||| S:41265 E:41275 ||| NNS
,  ||| S:41275 E:41277 ||| ,
means  ||| S:41277 E:41293 ||| VBZ
PBS  ||| S:41293 E:41297 ||| NNP
that  ||| S:41297 E:41302 ||| WDT
contains  ||| S:41302 E:41311 ||| VBZ
CaCl  ||| S:41311 E:41327 ||| JJ
2  ||| S:41327 E:41329 ||| CD
and  ||| S:41329 E:41333 ||| CC
MgCl  ||| S:41333 E:41349 ||| JJ
2  ||| S:41349 E:41351 ||| CD
) ||| S:41351 E:41352 ||| -RRB-
,  ||| S:41352 E:41354 ||| ,
but  ||| S:41354 E:41358 ||| CC
we  ||| S:41358 E:41361 ||| PRP
preferred  ||| S:41361 E:41371 ||| VBD
PBS ||| S:41371 E:41374 ||| NNP
( ||| S:41374 E:41375 ||| -LRB-
+ ||| S:41375 E:41376 ||| NNP
)  ||| S:41376 E:41378 ||| -RRB-
because  ||| S:41378 E:41396 ||| IN
retraction  ||| S:41396 E:41407 ||| NN
of  ||| S:41407 E:41410 ||| IN
cells  ||| S:41410 E:41416 ||| NNS
were  ||| S:41416 E:41421 ||| VBD
observed  ||| S:41421 E:41430 ||| VBN
in  ||| S:41430 E:41433 ||| IN
a  ||| S:41433 E:41435 ||| DT
few  ||| S:41435 E:41439 ||| JJ
minutes  ||| S:41439 E:41447 ||| NNS
when  ||| S:41447 E:41462 ||| WRB
the  ||| S:41462 E:41466 ||| DT
cells  ||| S:41466 E:41472 ||| NNS
were  ||| S:41472 E:41477 ||| VBD
exposed  ||| S:41477 E:41485 ||| VBN
to  ||| S:41485 E:41488 ||| TO
PBS  ||| S:41488 E:41492 ||| NNP
even  ||| S:41492 E:41497 ||| RB
briefly ||| S:41497 E:41504 ||| RB
.  ||| S:41504 E:41506 ||| .
Samples  ||| S:41506 E:41514 ||| NNS
were  ||| S:41514 E:41529 ||| VBD
then  ||| S:41529 E:41534 ||| RB
washed  ||| S:41534 E:41541 ||| VBN
with  ||| S:41541 E:41546 ||| IN
distilled  ||| S:41546 E:41556 ||| JJ
water ||| S:41556 E:41561 ||| NN
,  ||| S:41561 E:41563 ||| ,
dehydrated  ||| S:41563 E:41574 ||| VBG
in  ||| S:41574 E:41577 ||| IN
a  ||| S:41577 E:41579 ||| DT
graded  ||| S:41579 E:41596 ||| JJ
series  ||| S:41596 E:41603 ||| NN
of  ||| S:41603 E:41606 ||| IN
ethanol ||| S:41606 E:41613 ||| NN
,  ||| S:41613 E:41615 ||| ,
transferred  ||| S:41615 E:41627 ||| VBN
into  ||| S:41627 E:41632 ||| IN
t-butylalchohol ||| S:41632 E:41647 ||| NNP
,  ||| S:41647 E:41649 ||| ,
and  ||| S:41649 E:41663 ||| CC
dried  ||| S:41663 E:41669 ||| VBD
in  ||| S:41669 E:41672 ||| IN
Freeze  ||| S:41672 E:41679 ||| NNP
Dryer  ||| S:41679 E:41685 ||| NNP
ES-2030  ||| S:41685 E:41693 ||| NNP
( ||| S:41693 E:41694 ||| -LRB-
Hitachi ||| S:41694 E:41701 ||| NNP
,  ||| S:41701 E:41703 ||| ,
Japan ||| S:41703 E:41708 ||| NNP
) ||| S:41708 E:41709 ||| -RRB-
.  ||| S:41709 E:41711 ||| .
Dried  ||| S:41711 E:41727 ||| JJ
samples  ||| S:41727 E:41735 ||| NNS
were  ||| S:41735 E:41740 ||| VBD
coated  ||| S:41740 E:41747 ||| VBN
with  ||| S:41747 E:41752 ||| IN
Pt-Pd  ||| S:41752 E:41758 ||| JJ
in  ||| S:41758 E:41761 ||| IN
Ion  ||| S:41761 E:41765 ||| NNP
Sputter  ||| S:41765 E:41773 ||| NNP
E-1030  ||| S:41773 E:41790 ||| NNP
( ||| S:41790 E:41791 ||| -LRB-
Hitachi ||| S:41791 E:41798 ||| NNP
,  ||| S:41798 E:41800 ||| ,
Japan ||| S:41800 E:41805 ||| NNP
)  ||| S:41805 E:41807 ||| -RRB-
for  ||| S:41807 E:41811 ||| IN
120  ||| S:41811 E:41815 ||| CD
seconds ||| S:41815 E:41822 ||| NNS
,  ||| S:41822 E:41824 ||| ,
and  ||| S:41824 E:41828 ||| CC
were  ||| S:41828 E:41833 ||| VBD
examined  ||| S:41833 E:41842 ||| VBN
under  ||| S:41842 E:41858 ||| IN
an  ||| S:41858 E:41861 ||| DT
S-4200  ||| S:41861 E:41868 ||| FW
scanning  ||| S:41868 E:41877 ||| FW
electron  ||| S:41877 E:41886 ||| FW
microscope  ||| S:41886 E:41897 ||| FW
( ||| S:41897 E:41898 ||| -LRB-
Hitachi ||| S:41898 E:41905 ||| NNP
,  ||| S:41905 E:41907 ||| ,
Japan ||| S:41907 E:41912 ||| NNP
)  ||| S:41912 E:41924 ||| -RRB-
at  ||| S:41924 E:41927 ||| IN
15  ||| S:41927 E:41930 ||| CD
kV ||| S:41930 E:41932 ||| NN
.  ||| S:41932 E:41934 ||| .
Micrographs  ||| S:41934 E:41946 ||| NNP
were  ||| S:41946 E:41951 ||| VBD
taken  ||| S:41951 E:41957 ||| VBN
at  ||| S:41957 E:41960 ||| IN
0°  ||| S:41960 E:41963 ||| NNP
or  ||| S:41963 E:41966 ||| CC
60°  ||| S:41966 E:41970 ||| CD
tilt ||| S:41970 E:41974 ||| NN
.  ||| S:41974 E:42004 ||| .
Fixation  ||| S:42004 E:42013 ||| NNP
and  ||| S:42013 E:42017 ||| CC
extraction  ||| S:42017 E:42028 ||| NN
for  ||| S:42028 E:42032 ||| IN
microscopy  ||| S:42032 E:42053 ||| JJ
Cells  ||| S:42053 E:42059 ||| NNS
on  ||| S:42059 E:42062 ||| IN
glass  ||| S:42062 E:42068 ||| NN
coverslips  ||| S:42068 E:42079 ||| NNS
were  ||| S:42079 E:42084 ||| VBD
rinsed  ||| S:42084 E:42091 ||| VBN
with  ||| S:42091 E:42096 ||| IN
PBS ||| S:42096 E:42099 ||| NNP
( ||| S:42099 E:42100 ||| -LRB-
+ ||| S:42100 E:42101 ||| NNP
) ||| S:42101 E:42102 ||| -RRB-
,  ||| S:42102 E:42114 ||| ,
fixed  ||| S:42114 E:42120 ||| VBN
and ||| S:42120 E:42123 ||| CC
/ ||| S:42123 E:42124 ||| NNP
or  ||| S:42124 E:42127 ||| CC
extracted  ||| S:42127 E:42137 ||| VBN
by  ||| S:42137 E:42140 ||| IN
one  ||| S:42140 E:42144 ||| CD
of  ||| S:42144 E:42147 ||| IN
the  ||| S:42147 E:42151 ||| DT
procedures  ||| S:42151 E:42162 ||| NNS
listed  ||| S:42162 E:42169 ||| VBN
in  ||| S:42169 E:42182 ||| IN
Table  ||| S:42182 E:42188 ||| NNP
1 ||| S:42188 E:42189 ||| CD
.  ||| S:42189 E:42191 ||| .
Methanol-free  ||| S:42191 E:42205 ||| JJ
formaldehyde  ||| S:42205 E:42218 ||| JJ
solution  ||| S:42218 E:42227 ||| NN
can  ||| S:42227 E:42231 ||| MD
be  ||| S:42231 E:42244 ||| VB
obtained  ||| S:42244 E:42253 ||| VBN
from  ||| S:42253 E:42258 ||| IN
commercial  ||| S:42258 E:42269 ||| JJ
sources ||| S:42269 E:42276 ||| NNS
,  ||| S:42276 E:42278 ||| ,
but  ||| S:42278 E:42282 ||| CC
it  ||| S:42282 E:42285 ||| PRP
has  ||| S:42285 E:42289 ||| VBZ
to  ||| S:42289 E:42292 ||| TO
be  ||| S:42292 E:42295 ||| VB
used  ||| S:42295 E:42310 ||| VBN
within  ||| S:42310 E:42317 ||| IN
a  ||| S:42317 E:42319 ||| DT
week  ||| S:42319 E:42324 ||| NN
and  ||| S:42324 E:42328 ||| CC
is  ||| S:42328 E:42331 ||| VBZ
more  ||| S:42331 E:42336 ||| RBR
expensive  ||| S:42336 E:42346 ||| JJ
than  ||| S:42346 E:42351 ||| IN
PFA  ||| S:42351 E:42355 ||| NNP
powder  ||| S:42355 E:42362 ||| NN
[  ||| S:42362 E:42374 ||| -LRB-
61 ||| S:42374 E:42376 ||| CD
] ||| S:42376 E:42377 ||| -RRB-
.  ||| S:42377 E:42379 ||| .
Although  ||| S:42379 E:42388 ||| IN
formaldehyde  ||| S:42388 E:42401 ||| NN
and  ||| S:42401 E:42405 ||| CC
PFA  ||| S:42405 E:42409 ||| NNP
were  ||| S:42409 E:42414 ||| VBD
used  ||| S:42414 E:42419 ||| VBN
in  ||| S:42419 E:42422 ||| IN
papers  ||| S:42422 E:42429 ||| NNS
as  ||| S:42429 E:42442 ||| RB
listed  ||| S:42442 E:42449 ||| VBN
in  ||| S:42449 E:42452 ||| IN
Table  ||| S:42452 E:42458 ||| NNP
1  ||| S:42458 E:42460 ||| CD
and  ||| S:42460 E:42464 ||| CC
formaldehyde  ||| S:42464 E:42477 ||| JJ
solutions  ||| S:42477 E:42487 ||| NNS
may  ||| S:42487 E:42491 ||| MD
have  ||| S:42491 E:42506 ||| VB
been  ||| S:42506 E:42511 ||| VBN
obtained  ||| S:42511 E:42520 ||| VBN
from  ||| S:42520 E:42525 ||| IN
commercial  ||| S:42525 E:42536 ||| JJ
sources ||| S:42536 E:42543 ||| NNS
,  ||| S:42543 E:42545 ||| ,
for  ||| S:42545 E:42549 ||| IN
our  ||| S:42549 E:42553 ||| PRP$
study  ||| S:42553 E:42559 ||| NN
a  ||| S:42559 E:42571 ||| DT
formaldehyde  ||| S:42571 E:42584 ||| JJ
aqueous  ||| S:42584 E:42592 ||| JJ
stock  ||| S:42592 E:42598 ||| NN
solution  ||| S:42598 E:42607 ||| NN
was  ||| S:42607 E:42611 ||| VBD
prepared  ||| S:42611 E:42620 ||| VBN
by  ||| S:42620 E:42633 ||| IN
dissolving  ||| S:42633 E:42644 ||| CD
20  ||| S:42644 E:42647 ||| CD
g  ||| S:42647 E:42649 ||| NN
of  ||| S:42649 E:42652 ||| IN
PFA  ||| S:42652 E:42656 ||| NNP
powder  ||| S:42656 E:42663 ||| NN
in  ||| S:42663 E:42666 ||| IN
90  ||| S:42666 E:42669 ||| CD
ml  ||| S:42669 E:42672 ||| NN
of  ||| S:42672 E:42675 ||| IN
double  ||| S:42675 E:42692 ||| JJ
distilled  ||| S:42692 E:42702 ||| JJ
water ||| S:42702 E:42707 ||| NN
.  ||| S:42707 E:42709 ||| .
The  ||| S:42709 E:42713 ||| DT
mixture  ||| S:42713 E:42721 ||| NN
was  ||| S:42721 E:42725 ||| VBD
heated  ||| S:42725 E:42732 ||| VBN
to  ||| S:42732 E:42735 ||| TO
60-65°C  ||| S:42735 E:42743 ||| CD
and  ||| S:42743 E:42757 ||| CC
the  ||| S:42757 E:42761 ||| DT
pH  ||| S:42761 E:42764 ||| NN
was  ||| S:42764 E:42768 ||| VBD
adjusted  ||| S:42768 E:42777 ||| VBN
to  ||| S:42777 E:42780 ||| TO
7.3  ||| S:42780 E:42784 ||| CD
with  ||| S:42784 E:42789 ||| IN
NaOH ||| S:42789 E:42793 ||| JJ
.  ||| S:42793 E:42795 ||| .
The  ||| S:42795 E:42799 ||| DT
solution  ||| S:42799 E:42808 ||| NN
was  ||| S:42808 E:42822 ||| VBD
diluted  ||| S:42822 E:42830 ||| VBN
with  ||| S:42830 E:42835 ||| IN
water  ||| S:42835 E:42841 ||| NN
to  ||| S:42841 E:42844 ||| TO
100  ||| S:42844 E:42848 ||| CD
ml  ||| S:42848 E:42851 ||| NNS
( ||| S:42851 E:42852 ||| -LRB-
final  ||| S:42852 E:42858 ||| JJ
concentration  ||| S:42858 E:42872 ||| NN
20 ||| S:42872 E:42874 ||| CD
% ||| S:42874 E:42875 ||| NN
)  ||| S:42875 E:42887 ||| -RRB-
and  ||| S:42887 E:42891 ||| CC
stored  ||| S:42891 E:42898 ||| VBD
at  ||| S:42898 E:42901 ||| IN
4°C  ||| S:42901 E:42905 ||| CD
for  ||| S:42905 E:42909 ||| IN
not  ||| S:42909 E:42913 ||| RB
more  ||| S:42913 E:42918 ||| JJR
than  ||| S:42918 E:42923 ||| IN
one  ||| S:42923 E:42927 ||| CD
week ||| S:42927 E:42931 ||| NN
.  ||| S:42931 E:42933 ||| .
In  ||| S:42933 E:42936 ||| IN
earlier  ||| S:42936 E:42954 ||| JJR
work ||| S:42954 E:42958 ||| NN
,  ||| S:42958 E:42960 ||| ,
formaldehyde  ||| S:42960 E:42973 ||| JJ
solutions  ||| S:42973 E:42983 ||| NNS
may  ||| S:42983 E:42987 ||| MD
have  ||| S:42987 E:42992 ||| VB
been  ||| S:42992 E:42997 ||| VBN
prepared  ||| S:42997 E:43006 ||| VBN
from  ||| S:43006 E:43021 ||| IN
formalin  ||| S:43021 E:43030 ||| NNS
that  ||| S:43030 E:43035 ||| WDT
contains  ||| S:43035 E:43044 ||| VBZ
37 ||| S:43044 E:43046 ||| CD
%  ||| S:43046 E:43048 ||| NN
formaldehyde  ||| S:43048 E:43061 ||| NN
and  ||| S:43061 E:43065 ||| CC
8∼  ||| S:43065 E:43068 ||| CD
15 ||| S:43068 E:43070 ||| CD
%  ||| S:43070 E:43082 ||| NN
methanol ||| S:43082 E:43090 ||| NN
.  ||| S:43090 E:43092 ||| .
Unless  ||| S:43092 E:43099 ||| IN
noted  ||| S:43099 E:43105 ||| VBN
as  ||| S:43105 E:43108 ||| IN
formalin ||| S:43108 E:43116 ||| NN
,  ||| S:43116 E:43118 ||| ,
formaldehyde  ||| S:43118 E:43141 ||| JJ
solutions  ||| S:43141 E:43151 ||| NNS
were  ||| S:43151 E:43156 ||| VBD
solely  ||| S:43156 E:43163 ||| RB
prepared  ||| S:43163 E:43172 ||| VBN
here  ||| S:43172 E:43177 ||| RB
as  ||| S:43177 E:43180 ||| RB
described  ||| S:43180 E:43190 ||| VBN
above ||| S:43190 E:43195 ||| IN
.  ||| S:43195 E:43207 ||| .
Therefore ||| S:43207 E:43216 ||| RB
,  ||| S:43216 E:43218 ||| ,
formaldehyde  ||| S:43218 E:43231 ||| NN
and  ||| S:43231 E:43235 ||| CC
PFA  ||| S:43235 E:43239 ||| NNP
are  ||| S:43239 E:43243 ||| VBP
essentially  ||| S:43243 E:43265 ||| RB
indistinguishable ||| S:43265 E:43282 ||| JJ
.  ||| S:43282 E:43284 ||| .
Buffers  ||| S:43284 E:43292 ||| NNP
were  ||| S:43292 E:43297 ||| VBD
prepared  ||| S:43297 E:43306 ||| VBN
as  ||| S:43306 E:43309 ||| IN
2×  ||| S:43309 E:43312 ||| NNP
or  ||| S:43312 E:43315 ||| CC
5×  ||| S:43315 E:43328 ||| CD
stock  ||| S:43328 E:43334 ||| NN
solutions ||| S:43334 E:43343 ||| NNS
.  ||| S:43343 E:43345 ||| .
Magnesium-and  ||| S:43345 E:43359 ||| NNP
calcium-free  ||| S:43359 E:43372 ||| NNP
PBS  ||| S:43372 E:43376 ||| NNP
was  ||| S:43376 E:43380 ||| VBD
used  ||| S:43380 E:43395 ||| VBN
unless  ||| S:43395 E:43402 ||| IN
noted  ||| S:43402 E:43408 ||| VBD
otherwise  ||| S:43408 E:43418 ||| RB
in  ||| S:43418 E:43421 ||| IN
the  ||| S:43421 E:43425 ||| DT
references ||| S:43425 E:43435 ||| NNS
.  ||| S:43435 E:43437 ||| .
When  ||| S:43437 E:43442 ||| WRB
detailed  ||| S:43442 E:43461 ||| JJ
descriptions  ||| S:43461 E:43474 ||| NNS
were  ||| S:43474 E:43479 ||| VBD
lacking ||| S:43479 E:43486 ||| VBG
,  ||| S:43486 E:43488 ||| ,
specimens  ||| S:43488 E:43498 ||| NNS
were  ||| S:43498 E:43503 ||| VBD
treated  ||| S:43503 E:43511 ||| VBN
as  ||| S:43511 E:43524 ||| RB
listed  ||| S:43524 E:43531 ||| VBN
in  ||| S:43531 E:43534 ||| IN
Table  ||| S:43534 E:43540 ||| NNP
1 ||| S:43540 E:43541 ||| CD
.  ||| S:43541 E:43571 ||| .
Confocal  ||| S:43571 E:43580 ||| FW
laser  ||| S:43580 E:43586 ||| FW
scanning  ||| S:43586 E:43595 ||| FW
microscopy  ||| S:43595 E:43616 ||| FW
Blocking  ||| S:43616 E:43625 ||| NNP
of  ||| S:43625 E:43628 ||| IN
nonspecific  ||| S:43628 E:43640 ||| JJ
binding  ||| S:43640 E:43648 ||| JJ
sites  ||| S:43648 E:43654 ||| NNS
and  ||| S:43654 E:43658 ||| CC
incubation  ||| S:43658 E:43679 ||| NN
with  ||| S:43679 E:43684 ||| IN
antibodies  ||| S:43684 E:43695 ||| NNS
basically  ||| S:43695 E:43705 ||| RB
followed  ||| S:43705 E:43714 ||| VBN
procedures  ||| S:43714 E:43725 ||| NNS
detailed  ||| S:43725 E:43734 ||| VBN
in  ||| S:43734 E:43747 ||| IN
references ||| S:43747 E:43757 ||| NNS
,  ||| S:43757 E:43759 ||| ,
but  ||| S:43759 E:43763 ||| CC
cells  ||| S:43763 E:43769 ||| NNS
were  ||| S:43769 E:43774 ||| VBD
stained  ||| S:43774 E:43782 ||| VBN
as  ||| S:43782 E:43785 ||| RB
follows  ||| S:43785 E:43793 ||| VBZ
when  ||| S:43793 E:43808 ||| WRB
descriptions  ||| S:43808 E:43821 ||| NNS
were  ||| S:43821 E:43826 ||| VBD
lacking ||| S:43826 E:43833 ||| VBG
.  ||| S:43833 E:43835 ||| .
After  ||| S:43835 E:43841 ||| IN
the  ||| S:43841 E:43845 ||| DT
cells  ||| S:43845 E:43851 ||| NNS
were  ||| S:43851 E:43856 ||| VBD
soaked  ||| S:43856 E:43863 ||| VBN
in  ||| S:43863 E:43876 ||| IN
1 ||| S:43876 E:43877 ||| CD
%  ||| S:43877 E:43879 ||| NN
BSA ||| S:43879 E:43882 ||| NNP
/ ||| S:43882 E:43883 ||| NNP
PBS  ||| S:43883 E:43887 ||| NNP
for  ||| S:43887 E:43891 ||| IN
30  ||| S:43891 E:43894 ||| CD
min ||| S:43894 E:43897 ||| NN
,  ||| S:43897 E:43899 ||| ,
they  ||| S:43899 E:43904 ||| PRP
were  ||| S:43904 E:43909 ||| VBD
treated  ||| S:43909 E:43917 ||| VBN
with  ||| S:43917 E:43922 ||| IN
the  ||| S:43922 E:43926 ||| DT
primary  ||| S:43926 E:43944 ||| JJ
antibodies  ||| S:43944 E:43955 ||| NNS
in  ||| S:43955 E:43958 ||| IN
1 ||| S:43958 E:43959 ||| CD
%  ||| S:43959 E:43961 ||| NN
BSA ||| S:43961 E:43964 ||| NNP
/ ||| S:43964 E:43965 ||| NNP
PBS  ||| S:43965 E:43969 ||| NNP
for  ||| S:43969 E:43973 ||| IN
1  ||| S:43973 E:43975 ||| CD
h ||| S:43975 E:43976 ||| NNS
.  ||| S:43976 E:43978 ||| .
The  ||| S:43978 E:43982 ||| DT
cells  ||| S:43982 E:43988 ||| NNS
were  ||| S:43988 E:43993 ||| VBD
then  ||| S:43993 E:44008 ||| RB
washed  ||| S:44008 E:44015 ||| VBN
with  ||| S:44015 E:44020 ||| IN
PBS  ||| S:44020 E:44024 ||| NNP
three  ||| S:44024 E:44030 ||| CD
times ||| S:44030 E:44035 ||| NNS
,  ||| S:44035 E:44037 ||| ,
followed  ||| S:44037 E:44046 ||| VBN
by  ||| S:44046 E:44049 ||| IN
incubation  ||| S:44049 E:44060 ||| NN
with  ||| S:44060 E:44075 ||| IN
secondary  ||| S:44075 E:44085 ||| JJ
antibodies  ||| S:44085 E:44096 ||| NNS
in  ||| S:44096 E:44099 ||| IN
1 ||| S:44099 E:44100 ||| CD
%  ||| S:44100 E:44102 ||| NN
BSA ||| S:44102 E:44105 ||| NNP
/ ||| S:44105 E:44106 ||| NNP
PBS  ||| S:44106 E:44110 ||| NNP
for  ||| S:44110 E:44114 ||| IN
1  ||| S:44114 E:44116 ||| CD
h ||| S:44116 E:44117 ||| NNS
.  ||| S:44117 E:44119 ||| .
For  ||| S:44119 E:44123 ||| IN
the  ||| S:44123 E:44137 ||| DT
detection  ||| S:44137 E:44147 ||| NN
of  ||| S:44147 E:44150 ||| IN
actin  ||| S:44150 E:44156 ||| JJ
filaments ||| S:44156 E:44165 ||| NN
,  ||| S:44165 E:44167 ||| ,
100  ||| S:44167 E:44171 ||| CD
ng ||| S:44171 E:44173 ||| CD
/ ||| S:44173 E:44174 ||| CD
ml  ||| S:44174 E:44177 ||| JJ
TRITC-phalloidin  ||| S:44177 E:44204 ||| NN
was  ||| S:44204 E:44208 ||| VBD
mixed  ||| S:44208 E:44214 ||| VBN
with  ||| S:44214 E:44219 ||| IN
the  ||| S:44219 E:44223 ||| DT
second  ||| S:44223 E:44230 ||| JJ
antibody  ||| S:44230 E:44239 ||| NN
solution ||| S:44239 E:44247 ||| NN
.  ||| S:44247 E:44249 ||| .
For  ||| S:44249 E:44253 ||| IN
double  ||| S:44253 E:44270 ||| JJ
staining ||| S:44270 E:44278 ||| NN
,  ||| S:44278 E:44280 ||| ,
secondary  ||| S:44280 E:44290 ||| JJ
antibodies  ||| S:44290 E:44301 ||| NNS
that  ||| S:44301 E:44306 ||| WDT
did  ||| S:44306 E:44310 ||| VBD
not  ||| S:44310 E:44314 ||| RB
cross-react  ||| S:44314 E:44336 ||| JJ
with  ||| S:44336 E:44341 ||| IN
each  ||| S:44341 E:44346 ||| DT
other  ||| S:44346 E:44352 ||| JJ
were  ||| S:44352 E:44357 ||| VBD
chosen ||| S:44357 E:44363 ||| VBN
.  ||| S:44363 E:44365 ||| .
Cells  ||| S:44365 E:44371 ||| NNS
were  ||| S:44371 E:44376 ||| VBD
washed  ||| S:44376 E:44383 ||| VBN
three  ||| S:44383 E:44399 ||| CD
times  ||| S:44399 E:44405 ||| NNS
in  ||| S:44405 E:44408 ||| IN
PBS  ||| S:44408 E:44412 ||| NNP
for  ||| S:44412 E:44416 ||| IN
5  ||| S:44416 E:44418 ||| CD
min  ||| S:44418 E:44422 ||| NNS
and  ||| S:44422 E:44426 ||| CC
rinsed  ||| S:44426 E:44433 ||| NN
with  ||| S:44433 E:44438 ||| IN
water  ||| S:44438 E:44444 ||| NN
at  ||| S:44444 E:44447 ||| IN
room  ||| S:44447 E:44462 ||| NN
temperature ||| S:44462 E:44473 ||| NN
,  ||| S:44473 E:44475 ||| ,
mounted  ||| S:44475 E:44483 ||| VBN
in  ||| S:44483 E:44486 ||| IN
PermaFluor  ||| S:44486 E:44497 ||| NNP
( ||| S:44497 E:44498 ||| -LRB-
Shandon ||| S:44498 E:44505 ||| NNP
,  ||| S:44505 E:44507 ||| ,
Pittsburgh ||| S:44507 E:44517 ||| NNP
,  ||| S:44517 E:44529 ||| ,
PA ||| S:44529 E:44531 ||| NNP
)  ||| S:44531 E:44533 ||| -RRB-
and  ||| S:44533 E:44537 ||| CC
observed  ||| S:44537 E:44546 ||| VBD
under  ||| S:44546 E:44552 ||| IN
a  ||| S:44552 E:44554 ||| DT
laser  ||| S:44554 E:44560 ||| FW
scanning  ||| S:44560 E:44569 ||| FW
confocal  ||| S:44569 E:44588 ||| FW
microscope  ||| S:44588 E:44599 ||| FW
( ||| S:44599 E:44600 ||| -LRB-
MRC-1024 ||| S:44600 E:44608 ||| NNP
,  ||| S:44608 E:44610 ||| ,
Bio-Rad  ||| S:44610 E:44618 ||| NNP
Laboratories ||| S:44618 E:44630 ||| NNPS
,  ||| S:44630 E:44632 ||| ,
Richmond ||| S:44632 E:44640 ||| NNP
,  ||| S:44640 E:44652 ||| ,
CA ||| S:44652 E:44654 ||| NNP
) ||| S:44654 E:44655 ||| -RRB-
.  ||| S:44655 E:44657 ||| .
Confocal  ||| S:44657 E:44666 ||| JJ
sections  ||| S:44666 E:44675 ||| NNS
were  ||| S:44675 E:44680 ||| VBD
taken  ||| S:44680 E:44686 ||| VBN
with  ||| S:44686 E:44691 ||| IN
an  ||| S:44691 E:44694 ||| DT
iris  ||| S:44694 E:44699 ||| JJ
aperture  ||| S:44699 E:44718 ||| NN
of  ||| S:44718 E:44721 ||| IN
2.0 ||| S:44721 E:44724 ||| CD
.  ||| S:44724 E:44726 ||| .
Images  ||| S:44726 E:44733 ||| NNS
were  ||| S:44733 E:44738 ||| VBD
processed  ||| S:44738 E:44748 ||| VBN
using  ||| S:44748 E:44754 ||| VBG
Adobe  ||| S:44754 E:44760 ||| NNP
Photoshop  ||| S:44760 E:44780 ||| NNP
software ||| S:44780 E:44788 ||| NN
.  ||| S:44788 E:44818 ||| .
Evaluation  ||| S:44818 E:44829 ||| NN
of  ||| S:44829 E:44832 ||| IN
crosslinking  ||| S:44832 E:44845 ||| NN
by  ||| S:44845 E:44848 ||| IN
polypeptide  ||| S:44848 E:44860 ||| JJ
analysis  ||| S:44860 E:44879 ||| NN
after  ||| S:44879 E:44885 ||| IN
fixation  ||| S:44885 E:44894 ||| NN
and  ||| S:44894 E:44898 ||| CC
extraction  ||| S:44898 E:44919 ||| JJ
Subconfluent  ||| S:44919 E:44932 ||| JJ
cultures  ||| S:44932 E:44941 ||| NNS
of  ||| S:44941 E:44944 ||| IN
NIH3T3  ||| S:44944 E:44951 ||| CD
cells  ||| S:44951 E:44957 ||| NNS
on  ||| S:44957 E:44960 ||| IN
3.5  ||| S:44960 E:44964 ||| CD
cm  ||| S:44964 E:44977 ||| JJ
plastic  ||| S:44977 E:44985 ||| NN
culture  ||| S:44985 E:44993 ||| NN
dishes ||| S:44993 E:44999 ||| NNS
,  ||| S:44999 E:45001 ||| ,
were  ||| S:45001 E:45006 ||| VBD
rinsed  ||| S:45006 E:45013 ||| VBN
with  ||| S:45013 E:45018 ||| IN
PBS ||| S:45018 E:45021 ||| NNP
( ||| S:45021 E:45022 ||| -LRB-
+ ||| S:45022 E:45023 ||| NNP
) ||| S:45023 E:45024 ||| -RRB-
,  ||| S:45024 E:45026 ||| ,
fixed  ||| S:45026 E:45042 ||| VBN
with  ||| S:45042 E:45047 ||| IN
4 ||| S:45047 E:45048 ||| CD
%  ||| S:45048 E:45050 ||| NN
paraformaldehyde  ||| S:45050 E:45067 ||| NN
in  ||| S:45067 E:45070 ||| IN
PBS ||| S:45070 E:45073 ||| NNP
( ||| S:45073 E:45074 ||| -LRB-
+ ||| S:45074 E:45075 ||| NNP
)  ||| S:45075 E:45077 ||| -RRB-
at  ||| S:45077 E:45080 ||| IN
room  ||| S:45080 E:45085 ||| NN
temperature  ||| S:45085 E:45097 ||| NN
or  ||| S:45097 E:45110 ||| CC
37°C ||| S:45110 E:45114 ||| NNP
,  ||| S:45114 E:45116 ||| ,
or  ||| S:45116 E:45119 ||| CC
fixed  ||| S:45119 E:45125 ||| VBN
and ||| S:45125 E:45128 ||| CC
/ ||| S:45128 E:45129 ||| NNP
or  ||| S:45129 E:45132 ||| CC
extracted  ||| S:45132 E:45142 ||| VBN
by  ||| S:45142 E:45145 ||| IN
one  ||| S:45145 E:45149 ||| CD
of  ||| S:45149 E:45152 ||| IN
the  ||| S:45152 E:45156 ||| DT
procedures  ||| S:45156 E:45177 ||| NNS
listed  ||| S:45177 E:45184 ||| VBN
in  ||| S:45184 E:45187 ||| IN
Table  ||| S:45187 E:45193 ||| NNP
1 ||| S:45193 E:45194 ||| CD
.  ||| S:45194 E:45196 ||| .
For  ||| S:45196 E:45200 ||| IN
some  ||| S:45200 E:45205 ||| DT
experiments ||| S:45205 E:45216 ||| NNS
,  ||| S:45216 E:45218 ||| ,
cells  ||| S:45218 E:45224 ||| NNS
after  ||| S:45224 E:45240 ||| IN
fixation  ||| S:45240 E:45249 ||| NN
were  ||| S:45249 E:45254 ||| VBD
treated  ||| S:45254 E:45262 ||| VBN
twice  ||| S:45262 E:45268 ||| RB
with  ||| S:45268 E:45273 ||| IN
0.5  ||| S:45273 E:45277 ||| CD
mg ||| S:45277 E:45279 ||| CD
/ ||| S:45279 E:45280 ||| CD
ml  ||| S:45280 E:45283 ||| CD
NaBH  ||| S:45283 E:45299 ||| JJ
4  ||| S:45299 E:45301 ||| CD
in  ||| S:45301 E:45304 ||| IN
PBS  ||| S:45304 E:45308 ||| NNP
for  ||| S:45308 E:45312 ||| IN
10  ||| S:45312 E:45315 ||| CD
min  ||| S:45315 E:45319 ||| NN
at  ||| S:45319 E:45322 ||| IN
room  ||| S:45322 E:45337 ||| NN
temperature ||| S:45337 E:45348 ||| NN
.  ||| S:45348 E:45350 ||| .
After  ||| S:45350 E:45356 ||| IN
rinsing  ||| S:45356 E:45364 ||| NN
with  ||| S:45364 E:45369 ||| IN
PBS ||| S:45369 E:45372 ||| NNP
,  ||| S:45372 E:45374 ||| ,
the  ||| S:45374 E:45378 ||| DT
any  ||| S:45378 E:45382 ||| DT
material  ||| S:45382 E:45401 ||| NN
remaining  ||| S:45401 E:45411 ||| VBG
on  ||| S:45411 E:45414 ||| IN
the  ||| S:45414 E:45418 ||| DT
dish  ||| S:45418 E:45423 ||| NN
was  ||| S:45423 E:45427 ||| VBD
extracted  ||| S:45427 E:45437 ||| VBN
with  ||| S:45437 E:45442 ||| IN
200  ||| S:45442 E:45446 ||| CD
μl  ||| S:45446 E:45449 ||| NN
of  ||| S:45449 E:45452 ||| IN
1×  ||| S:45452 E:45455 ||| NNP
SDS  ||| S:45455 E:45469 ||| NNP
sample  ||| S:45469 E:45476 ||| NN
buffer  ||| S:45476 E:45483 ||| NN
( ||| S:45483 E:45484 ||| -LRB-
62.5  ||| S:45484 E:45489 ||| CD
mM  ||| S:45489 E:45492 ||| JJ
Tris-HCl ||| S:45492 E:45500 ||| NN
,  ||| S:45500 E:45502 ||| ,
2 ||| S:45502 E:45503 ||| CD
%  ||| S:45503 E:45505 ||| NN
SDS ||| S:45505 E:45508 ||| NNP
,  ||| S:45508 E:45510 ||| ,
10 ||| S:45510 E:45512 ||| CD
%  ||| S:45512 E:45514 ||| NN
glycerol ||| S:45514 E:45522 ||| NN
,  ||| S:45522 E:45534 ||| ,
10 ||| S:45534 E:45536 ||| CD
%  ||| S:45536 E:45538 ||| NN
2-mercaptoethanol ||| S:45538 E:45555 ||| NN
,  ||| S:45555 E:45557 ||| ,
pH  ||| S:45557 E:45560 ||| JJ
6.8 ||| S:45560 E:45563 ||| CD
)  ||| S:45563 E:45565 ||| -RRB-
at  ||| S:45565 E:45568 ||| IN
room  ||| S:45568 E:45573 ||| NN
temperature  ||| S:45573 E:45585 ||| NN
for  ||| S:45585 E:45589 ||| IN
30  ||| S:45589 E:45602 ||| CD
min  ||| S:45602 E:45606 ||| NN
in  ||| S:45606 E:45609 ||| IN
preparation  ||| S:45609 E:45621 ||| NN
for  ||| S:45621 E:45625 ||| IN
SDS-PAGE ||| S:45625 E:45633 ||| JJ
.  ||| S:45633 E:45635 ||| .
The  ||| S:45635 E:45639 ||| DT
dissolved  ||| S:45639 E:45649 ||| JJ
material  ||| S:45649 E:45668 ||| NN
was  ||| S:45668 E:45672 ||| VBD
recovered  ||| S:45672 E:45682 ||| VBN
and  ||| S:45682 E:45686 ||| CC
heated  ||| S:45686 E:45693 ||| VBN
at  ||| S:45693 E:45696 ||| IN
95°C  ||| S:45696 E:45701 ||| CD
for  ||| S:45701 E:45705 ||| IN
10  ||| S:45705 E:45708 ||| CD
min  ||| S:45708 E:45712 ||| NNS
and  ||| S:45712 E:45716 ||| CC
resolved  ||| S:45716 E:45735 ||| VBN
by  ||| S:45735 E:45738 ||| IN
SDS-PAGE  ||| S:45738 E:45747 ||| JJ
on  ||| S:45747 E:45750 ||| IN
a  ||| S:45750 E:45752 ||| DT
9 ||| S:45752 E:45753 ||| CD
%  ||| S:45753 E:45755 ||| NN
polyacrylamide  ||| S:45755 E:45770 ||| NN
gel ||| S:45770 E:45773 ||| NN
.  ||| S:45773 E:45775 ||| .
Polypeptides  ||| S:45775 E:45788 ||| NNP
were  ||| S:45788 E:45803 ||| VBD
stained  ||| S:45803 E:45811 ||| VBN
with  ||| S:45811 E:45816 ||| IN
Coomassie  ||| S:45816 E:45826 ||| NNP
Brilliant  ||| S:45826 E:45836 ||| NNP
blue  ||| S:45836 E:45841 ||| JJ
or  ||| S:45841 E:45844 ||| CC
immunologically  ||| S:45844 E:45870 ||| JJ
stained  ||| S:45870 E:45878 ||| NN
with  ||| S:45878 E:45883 ||| IN
antibodies  ||| S:45883 E:45894 ||| NNS
after  ||| S:45894 E:45900 ||| IN
transfer  ||| S:45900 E:45909 ||| NN
to  ||| S:45909 E:45912 ||| TO
nitrocellulose  ||| S:45912 E:45937 ||| VB
or  ||| S:45937 E:45940 ||| CC
polyvinylidenedifluoride  ||| S:45940 E:45965 ||| JJ
membranes ||| S:45965 E:45974 ||| NN
.  ||| S:45974 E:46004 ||| .
Extraction  ||| S:46004 E:46015 ||| NNP
for  ||| S:46015 E:46019 ||| IN
western  ||| S:46019 E:46027 ||| JJ
blotting  ||| S:46027 E:46046 ||| JJ
NIH  ||| S:46046 E:46050 ||| NNP
3T3  ||| S:46050 E:46054 ||| NNP
cells  ||| S:46054 E:46060 ||| NNS
were  ||| S:46060 E:46065 ||| VBD
detached  ||| S:46065 E:46074 ||| VBN
from  ||| S:46074 E:46079 ||| IN
the  ||| S:46079 E:46083 ||| DT
dishes  ||| S:46083 E:46090 ||| NNS
in  ||| S:46090 E:46093 ||| IN
the  ||| S:46093 E:46107 ||| DT
presence  ||| S:46107 E:46116 ||| NN
of  ||| S:46116 E:46119 ||| IN
1  ||| S:46119 E:46121 ||| CD
μM  ||| S:46121 E:46124 ||| JJ
calyculin  ||| S:46124 E:46134 ||| JJ
A ||| S:46134 E:46135 ||| NN
,  ||| S:46135 E:46137 ||| ,
but  ||| S:46137 E:46141 ||| CC
not  ||| S:46141 E:46145 ||| RB
staurosporine  ||| S:46145 E:46159 ||| JJ
and  ||| S:46159 E:46173 ||| CC
pervanadate ||| S:46173 E:46184 ||| NN
.  ||| S:46184 E:46186 ||| .
In  ||| S:46186 E:46189 ||| IN
order  ||| S:46189 E:46195 ||| NN
to  ||| S:46195 E:46198 ||| TO
exclude  ||| S:46198 E:46206 ||| VB
the  ||| S:46206 E:46210 ||| DT
effect  ||| S:46210 E:46217 ||| NN
of  ||| S:46217 E:46220 ||| IN
attachment  ||| S:46220 E:46241 ||| NN
on  ||| S:46241 E:46244 ||| IN
the  ||| S:46244 E:46248 ||| DT
extractability  ||| S:46248 E:46263 ||| NN
of  ||| S:46263 E:46266 ||| IN
proteins ||| S:46266 E:46274 ||| NNS
,  ||| S:46274 E:46276 ||| ,
suspended  ||| S:46276 E:46286 ||| VBN
cells  ||| S:46286 E:46292 ||| NNS
were  ||| S:46292 E:46307 ||| VBD
used  ||| S:46307 E:46312 ||| VBN
as  ||| S:46312 E:46315 ||| IN
a  ||| S:46315 E:46317 ||| DT
control  ||| S:46317 E:46325 ||| NN
sample ||| S:46325 E:46331 ||| NN
.  ||| S:46331 E:46333 ||| .
The  ||| S:46333 E:46337 ||| DT
cells  ||| S:46337 E:46343 ||| NNS
were  ||| S:46343 E:46348 ||| VBD
cultured  ||| S:46348 E:46357 ||| VBN
on  ||| S:46357 E:46360 ||| IN
10  ||| S:46360 E:46373 ||| CD
cm  ||| S:46373 E:46376 ||| JJ
plastic  ||| S:46376 E:46384 ||| NN
culture  ||| S:46384 E:46392 ||| NN
dishes  ||| S:46392 E:46399 ||| NNS
as  ||| S:46399 E:46402 ||| RB
described  ||| S:46402 E:46412 ||| VBN
above ||| S:46412 E:46417 ||| IN
.  ||| S:46417 E:46419 ||| .
The  ||| S:46419 E:46433 ||| DT
subconfluent  ||| S:46433 E:46446 ||| JJ
cells  ||| S:46446 E:46452 ||| NNS
were  ||| S:46452 E:46457 ||| VBD
washed  ||| S:46457 E:46464 ||| VBN
three  ||| S:46464 E:46470 ||| CD
times  ||| S:46470 E:46476 ||| NNS
with  ||| S:46476 E:46481 ||| IN
PBS ||| S:46481 E:46484 ||| NNP
( ||| S:46484 E:46485 ||| -LRB-
+ ||| S:46485 E:46486 ||| NNP
) ||| S:46486 E:46487 ||| -RRB-
,  ||| S:46487 E:46499 ||| ,
once  ||| S:46499 E:46504 ||| RB
with  ||| S:46504 E:46509 ||| IN
PBS ||| S:46509 E:46512 ||| NNP
,  ||| S:46512 E:46514 ||| ,
detached  ||| S:46514 E:46523 ||| VBN
by  ||| S:46523 E:46526 ||| IN
treating  ||| S:46526 E:46535 ||| VBG
with  ||| S:46535 E:46540 ||| IN
0.02 ||| S:46540 E:46544 ||| CD
%  ||| S:46544 E:46546 ||| NN
EDTA  ||| S:46546 E:46551 ||| NN
in  ||| S:46551 E:46564 ||| IN
PBS ||| S:46564 E:46567 ||| NNP
.  ||| S:46567 E:46569 ||| .
The  ||| S:46569 E:46573 ||| DT
suspended  ||| S:46573 E:46583 ||| JJ
cells  ||| S:46583 E:46589 ||| NNS
were  ||| S:46589 E:46594 ||| VBD
collected ||| S:46594 E:46603 ||| VBN
,  ||| S:46603 E:46605 ||| ,
centrifuged  ||| S:46605 E:46617 ||| VBG
at  ||| S:46617 E:46630 ||| IN
1,000  ||| S:46630 E:46636 ||| CD
×  ||| S:46636 E:46649 ||| CD
g  ||| S:46649 E:46651 ||| NN
for  ||| S:46651 E:46655 ||| IN
5  ||| S:46655 E:46657 ||| CD
min ||| S:46657 E:46660 ||| NN
,  ||| S:46660 E:46662 ||| ,
and  ||| S:46662 E:46666 ||| CC
resuspended  ||| S:46666 E:46678 ||| NN
with  ||| S:46678 E:46693 ||| IN
PBS ||| S:46693 E:46696 ||| NNP
.  ||| S:46696 E:46698 ||| .
The  ||| S:46698 E:46702 ||| DT
suspensions  ||| S:46702 E:46714 ||| NNS
were  ||| S:46714 E:46719 ||| VBD
divided  ||| S:46719 E:46727 ||| VBN
and  ||| S:46727 E:46731 ||| CC
incubated  ||| S:46731 E:46741 ||| NN
with  ||| S:46741 E:46746 ||| IN
or  ||| S:46746 E:46759 ||| CC
without  ||| S:46759 E:46767 ||| IN
1  ||| S:46767 E:46769 ||| CD
μM  ||| S:46769 E:46772 ||| JJ
calyculin  ||| S:46772 E:46782 ||| JJ
A ||| S:46782 E:46783 ||| NN
,  ||| S:46783 E:46785 ||| ,
1  ||| S:46785 E:46787 ||| CD
μM  ||| S:46787 E:46790 ||| JJ
staurosporine ||| S:46790 E:46803 ||| NN
,  ||| S:46803 E:46805 ||| ,
or  ||| S:46805 E:46808 ||| CC
100  ||| S:46808 E:46812 ||| CD
μM  ||| S:46812 E:46825 ||| JJ
pervanadate  ||| S:46825 E:46837 ||| NN
in  ||| S:46837 E:46840 ||| IN
200  ||| S:46840 E:46844 ||| CD
μl  ||| S:46844 E:46847 ||| NN
of  ||| S:46847 E:46850 ||| IN
PBS ||| S:46850 E:46853 ||| NNP
( ||| S:46853 E:46854 ||| -LRB-
+ ||| S:46854 E:46855 ||| NNP
)  ||| S:46855 E:46857 ||| -RRB-
for  ||| S:46857 E:46861 ||| IN
10  ||| S:46861 E:46864 ||| CD
min  ||| S:46864 E:46868 ||| NN
at  ||| S:46868 E:46871 ||| IN
37°C ||| S:46871 E:46875 ||| CD
.  ||| S:46875 E:46877 ||| .
The  ||| S:46877 E:46891 ||| DT
cells  ||| S:46891 E:46897 ||| NNS
were  ||| S:46897 E:46902 ||| VBD
extracted  ||| S:46902 E:46912 ||| VBN
for  ||| S:46912 E:46916 ||| IN
5  ||| S:46916 E:46918 ||| CD
min  ||| S:46918 E:46922 ||| NN
on  ||| S:46922 E:46925 ||| IN
ice  ||| S:46925 E:46929 ||| NN
with  ||| S:46929 E:46934 ||| IN
200  ||| S:46934 E:46938 ||| CD
μl  ||| S:46938 E:46941 ||| NN
of  ||| S:46941 E:46944 ||| IN
2×  ||| S:46944 E:46957 ||| FW
detergent  ||| S:46957 E:46967 ||| FW
extraction  ||| S:46967 E:46978 ||| FW
buffer  ||| S:46978 E:46985 ||| FW
( ||| S:46985 E:46986 ||| -LRB-
2 ||| S:46986 E:46987 ||| CD
%  ||| S:46987 E:46989 ||| NN
of  ||| S:46989 E:46992 ||| IN
Triton  ||| S:46992 E:46999 ||| NNP
X-100  ||| S:46999 E:47005 ||| NNP
or  ||| S:47005 E:47018 ||| CC
DOTMAC ||| S:47018 E:47024 ||| NNP
,  ||| S:47024 E:47026 ||| ,
50  ||| S:47026 E:47029 ||| CD
mM  ||| S:47029 E:47032 ||| JJ
Tris-HCl ||| S:47032 E:47040 ||| NN
,  ||| S:47040 E:47042 ||| ,
10  ||| S:47042 E:47045 ||| CD
mM  ||| S:47045 E:47048 ||| JJ
EGTA ||| S:47048 E:47052 ||| NNP
,  ||| S:47052 E:47054 ||| ,
200  ||| S:47054 E:47058 ||| CD
mM  ||| S:47058 E:47061 ||| JJ
NaCl ||| S:47061 E:47065 ||| NN
,  ||| S:47065 E:47067 ||| ,
2  ||| S:47067 E:47069 ||| CD
mM  ||| S:47069 E:47082 ||| JJ
MgCl  ||| S:47082 E:47098 ||| JJ
2  ||| S:47098 E:47100 ||| CD
,  ||| S:47100 E:47102 ||| ,
protease  ||| S:47102 E:47111 ||| FW
inhibitor  ||| S:47111 E:47121 ||| FW
cocktail  ||| S:47121 E:47130 ||| FW
[ ||| S:47130 E:47131 ||| -LRB-
20  ||| S:47131 E:47144 ||| CD
μg ||| S:47144 E:47146 ||| CD
/ ||| S:47146 E:47147 ||| CD
ml  ||| S:47147 E:47150 ||| JJ
aprotinin ||| S:47150 E:47159 ||| NN
,  ||| S:47159 E:47161 ||| ,
20  ||| S:47161 E:47164 ||| CD
μM  ||| S:47164 E:47167 ||| JJ
E-64 ||| S:47167 E:47171 ||| NN
,  ||| S:47171 E:47173 ||| ,
200  ||| S:47173 E:47177 ||| CD
μM  ||| S:47177 E:47180 ||| JJ
leupeptin ||| S:47180 E:47189 ||| NN
,  ||| S:47189 E:47191 ||| ,
200  ||| S:47191 E:47195 ||| CD
μM  ||| S:47195 E:47208 ||| JJ
p-amidinophenylmethanesulfonyl  ||| S:47208 E:47239 ||| JJ
fluoride ||| S:47239 E:47247 ||| NN
] ||| S:47247 E:47248 ||| -RRB-
,  ||| S:47248 E:47250 ||| ,
2  ||| S:47250 E:47252 ||| CD
μM  ||| S:47252 E:47255 ||| JJ
calyculin  ||| S:47255 E:47275 ||| JJ
A ||| S:47275 E:47276 ||| NN
,  ||| S:47276 E:47278 ||| ,
10  ||| S:47278 E:47281 ||| CD
mM  ||| S:47281 E:47284 ||| JJ
sodium  ||| S:47284 E:47291 ||| JJ
pyrophosphate ||| S:47291 E:47304 ||| NN
,  ||| S:47304 E:47306 ||| ,
2  ||| S:47306 E:47308 ||| CD
μM  ||| S:47308 E:47311 ||| JJ
staurosporine ||| S:47311 E:47324 ||| NN
,  ||| S:47324 E:47326 ||| ,
20  ||| S:47326 E:47329 ||| CD
μM  ||| S:47329 E:47342 ||| JJ
phalloidin ||| S:47342 E:47352 ||| NN
,  ||| S:47352 E:47354 ||| ,
and  ||| S:47354 E:47358 ||| CC
20  ||| S:47358 E:47361 ||| CD
μg ||| S:47361 E:47363 ||| CD
/ ||| S:47363 E:47364 ||| CD
ml  ||| S:47364 E:47367 ||| CD
taxol ||| S:47367 E:47372 ||| CD
) ||| S:47372 E:47373 ||| -RRB-
.  ||| S:47373 E:47375 ||| .
The  ||| S:47375 E:47379 ||| DT
lysates  ||| S:47379 E:47387 ||| NN
were  ||| S:47387 E:47402 ||| VBD
centrifuged  ||| S:47402 E:47414 ||| VBN
at  ||| S:47414 E:47417 ||| IN
15,800  ||| S:47417 E:47424 ||| CD
×  ||| S:47424 E:47426 ||| CD
g  ||| S:47426 E:47428 ||| NN
for  ||| S:47428 E:47432 ||| IN
5  ||| S:47432 E:47434 ||| CD
min  ||| S:47434 E:47438 ||| NN
at  ||| S:47438 E:47441 ||| IN
4°C ||| S:47441 E:47444 ||| CD
.  ||| S:47444 E:47446 ||| .
The  ||| S:47446 E:47450 ||| DT
resulting  ||| S:47450 E:47470 ||| VBG
pellets  ||| S:47470 E:47478 ||| NNS
were  ||| S:47478 E:47483 ||| VBD
solubilized  ||| S:47483 E:47495 ||| VBN
in  ||| S:47495 E:47498 ||| IN
150  ||| S:47498 E:47502 ||| CD
μl  ||| S:47502 E:47505 ||| NN
of  ||| S:47505 E:47508 ||| IN
1×  ||| S:47508 E:47511 ||| NNP
SDS  ||| S:47511 E:47515 ||| NNP
sample  ||| S:47515 E:47532 ||| NN
buffer ||| S:47532 E:47538 ||| NN
.  ||| S:47538 E:47540 ||| .
Total  ||| S:47540 E:47546 ||| JJ
lysate  ||| S:47546 E:47553 ||| NN
was  ||| S:47553 E:47557 ||| VBD
prepared  ||| S:47557 E:47566 ||| VBN
by  ||| S:47566 E:47569 ||| IN
adding  ||| S:47569 E:47576 ||| VBG
150  ||| S:47576 E:47580 ||| CD
μl  ||| S:47580 E:47583 ||| NN
of  ||| S:47583 E:47586 ||| IN
1×  ||| S:47586 E:47599 ||| NNP
SDS  ||| S:47599 E:47603 ||| NNP
sample  ||| S:47603 E:47610 ||| NN
buffer  ||| S:47610 E:47617 ||| NN
to  ||| S:47617 E:47620 ||| TO
the  ||| S:47620 E:47624 ||| DT
pelleted  ||| S:47624 E:47633 ||| JJ
cells  ||| S:47633 E:47639 ||| NNS
after  ||| S:47639 E:47645 ||| IN
drug  ||| S:47645 E:47660 ||| NN
treatment  ||| S:47660 E:47670 ||| NN
described  ||| S:47670 E:47680 ||| VBD
above ||| S:47680 E:47685 ||| RB
.  ||| S:47685 E:47687 ||| .
All  ||| S:47687 E:47691 ||| DT
samples  ||| S:47691 E:47699 ||| NNS
were  ||| S:47699 E:47704 ||| VBD
heated  ||| S:47704 E:47711 ||| VBN
at  ||| S:47711 E:47724 ||| IN
95°C ||| S:47724 E:47728 ||| NNP
,  ||| S:47728 E:47730 ||| ,
sonicated  ||| S:47730 E:47740 ||| NN
and  ||| S:47740 E:47744 ||| CC
resolved  ||| S:47744 E:47753 ||| VBN
by  ||| S:47753 E:47756 ||| IN
SDS-PAGE  ||| S:47756 E:47765 ||| JJ
on  ||| S:47765 E:47768 ||| IN
a  ||| S:47768 E:47770 ||| DT
9 ||| S:47770 E:47771 ||| CD
%  ||| S:47771 E:47783 ||| NN
polyacrylamide  ||| S:47783 E:47798 ||| NNS
gel  ||| S:47798 E:47802 ||| VBP
electrophoresed  ||| S:47802 E:47818 ||| VBN
under  ||| S:47818 E:47824 ||| IN
reducing  ||| S:47824 E:47843 ||| VBG
conditions  ||| S:47843 E:47854 ||| NNS
as  ||| S:47854 E:47857 ||| RB
described  ||| S:47857 E:47867 ||| VBN
[  ||| S:47867 E:47869 ||| -LRB-
18 ||| S:47869 E:47871 ||| CD
] ||| S:47871 E:47872 ||| -RRB-
.  ||| S:47872 E:47874 ||| .
β-Actin ||| S:47874 E:47881 ||| UH
,  ||| S:47881 E:47883 ||| ,
moesin ||| S:47883 E:47889 ||| NN
,  ||| S:47889 E:47891 ||| ,
and  ||| S:47891 E:47905 ||| CC
phosphorylated  ||| S:47905 E:47920 ||| JJ
moesin  ||| S:47920 E:47927 ||| NN
were  ||| S:47927 E:47932 ||| VBD
detected  ||| S:47932 E:47941 ||| VBN
by  ||| S:47941 E:47944 ||| IN
immunoblotting  ||| S:47944 E:47959 ||| NN
and  ||| S:47959 E:47973 ||| CC
the  ||| S:47973 E:47977 ||| DT
enhanced  ||| S:47977 E:47986 ||| JJ
chemiluminescence  ||| S:47986 E:48004 ||| JJ
detection  ||| S:48004 E:48014 ||| JJ
system ||| S:48014 E:48020 ||| NN
.  ||| S:48020 E:48050 ||| .
Lipid  ||| S:48050 E:48056 ||| JJ
analysis  ||| S:48056 E:48065 ||| NN
of  ||| S:48065 E:48068 ||| IN
detergent-resistant  ||| S:48068 E:48098 ||| JJ
components  ||| S:48098 E:48119 ||| NNS
When  ||| S:48119 E:48124 ||| WRB
NIH  ||| S:48124 E:48128 ||| NNP
3T3  ||| S:48128 E:48132 ||| NNP
fibroblasts  ||| S:48132 E:48144 ||| NN
were  ||| S:48144 E:48149 ||| VBD
treated  ||| S:48149 E:48157 ||| VBN
with  ||| S:48157 E:48162 ||| IN
Triton  ||| S:48162 E:48179 ||| NNP
X-100  ||| S:48179 E:48185 ||| NNP
lysis  ||| S:48185 E:48191 ||| JJ
buffer ||| S:48191 E:48197 ||| NN
,  ||| S:48197 E:48199 ||| ,
most  ||| S:48199 E:48204 ||| JJS
of  ||| S:48204 E:48207 ||| IN
the  ||| S:48207 E:48211 ||| DT
cells  ||| S:48211 E:48217 ||| NNS
detached  ||| S:48217 E:48226 ||| VBN
from  ||| S:48226 E:48231 ||| IN
the  ||| S:48231 E:48245 ||| DT
culture  ||| S:48245 E:48253 ||| NN
dish ||| S:48253 E:48257 ||| NN
.  ||| S:48257 E:48259 ||| .
This  ||| S:48259 E:48264 ||| DT
made  ||| S:48264 E:48269 ||| VBN
it  ||| S:48269 E:48272 ||| PRP
impossible  ||| S:48272 E:48283 ||| JJ
to  ||| S:48283 E:48286 ||| TO
quantitatively  ||| S:48286 E:48311 ||| VB
analyze  ||| S:48311 E:48319 ||| JJ
lipids  ||| S:48319 E:48326 ||| NN
in  ||| S:48326 E:48329 ||| IN
the  ||| S:48329 E:48333 ||| DT
detergent-insoluble  ||| S:48333 E:48353 ||| JJ
fraction  ||| S:48353 E:48362 ||| NN
of  ||| S:48362 E:48375 ||| IN
attached  ||| S:48375 E:48384 ||| VBN
growing  ||| S:48384 E:48392 ||| VBG
cells ||| S:48392 E:48397 ||| NNS
.  ||| S:48397 E:48399 ||| .
Therefore ||| S:48399 E:48408 ||| RB
,  ||| S:48408 E:48410 ||| ,
the  ||| S:48410 E:48414 ||| DT
cells  ||| S:48414 E:48420 ||| NNS
were  ||| S:48420 E:48435 ||| VBD
suspended  ||| S:48435 E:48445 ||| VBN
using  ||| S:48445 E:48451 ||| VBG
EDTA  ||| S:48451 E:48456 ||| NNP
before  ||| S:48456 E:48463 ||| IN
lipid  ||| S:48463 E:48469 ||| JJ
analysis  ||| S:48469 E:48478 ||| NN
and  ||| S:48478 E:48482 ||| CC
extracted  ||| S:48482 E:48502 ||| VBN
with  ||| S:48502 E:48507 ||| IN
detergent  ||| S:48507 E:48517 ||| NN
extraction  ||| S:48517 E:48528 ||| NN
buffer  ||| S:48528 E:48535 ||| NN
as  ||| S:48535 E:48538 ||| IN
described  ||| S:48538 E:48548 ||| VBN
above ||| S:48548 E:48553 ||| IN
.  ||| S:48553 E:48555 ||| .
The  ||| S:48555 E:48569 ||| DT
lysates  ||| S:48569 E:48577 ||| NN
were  ||| S:48577 E:48582 ||| VBD
centrifuged  ||| S:48582 E:48594 ||| VBN
at  ||| S:48594 E:48597 ||| IN
15,800  ||| S:48597 E:48604 ||| CD
×  ||| S:48604 E:48606 ||| CD
g  ||| S:48606 E:48608 ||| NN
for  ||| S:48608 E:48612 ||| IN
5  ||| S:48612 E:48614 ||| CD
min  ||| S:48614 E:48618 ||| NN
at  ||| S:48618 E:48621 ||| IN
4°C ||| S:48621 E:48624 ||| CD
.  ||| S:48624 E:48636 ||| .
The  ||| S:48636 E:48640 ||| DT
supernatant  ||| S:48640 E:48652 ||| NN
was  ||| S:48652 E:48656 ||| VBD
discarded  ||| S:48656 E:48666 ||| VBN
and  ||| S:48666 E:48670 ||| CC
the  ||| S:48670 E:48674 ||| DT
pellet  ||| S:48674 E:48681 ||| NN
was  ||| S:48681 E:48685 ||| VBD
washed  ||| S:48685 E:48702 ||| VBN
with  ||| S:48702 E:48707 ||| IN
PBS ||| S:48707 E:48710 ||| NNP
.  ||| S:48710 E:48712 ||| .
The  ||| S:48712 E:48716 ||| DT
lipids  ||| S:48716 E:48723 ||| NN
were  ||| S:48723 E:48728 ||| VBD
extracted  ||| S:48728 E:48738 ||| VBN
with  ||| S:48738 E:48743 ||| IN
0.5  ||| S:48743 E:48747 ||| CD
ml  ||| S:48747 E:48750 ||| NN
of  ||| S:48750 E:48763 ||| IN
chloroform ||| S:48763 E:48773 ||| FW
/ ||| S:48773 E:48774 ||| FW
methanol  ||| S:48774 E:48783 ||| FW
( ||| S:48783 E:48784 ||| -LRB-
2 ||| S:48784 E:48785 ||| LS
: ||| S:48785 E:48786 ||| :
1 ||| S:48786 E:48787 ||| CD
,  ||| S:48787 E:48789 ||| ,
v ||| S:48789 E:48790 ||| FW
/ ||| S:48790 E:48791 ||| FW
v ||| S:48791 E:48792 ||| FW
)  ||| S:48792 E:48794 ||| -RRB-
in  ||| S:48794 E:48797 ||| IN
an  ||| S:48797 E:48800 ||| DT
ultrasonic  ||| S:48800 E:48811 ||| JJ
bath  ||| S:48811 E:48816 ||| NN
for  ||| S:48816 E:48830 ||| IN
30  ||| S:48830 E:48833 ||| CD
min  ||| S:48833 E:48837 ||| NN
at  ||| S:48837 E:48840 ||| IN
37°C  ||| S:48840 E:48845 ||| CD
from  ||| S:48845 E:48850 ||| IN
the  ||| S:48850 E:48854 ||| DT
pellet ||| S:48854 E:48860 ||| NN
.  ||| S:48860 E:48862 ||| .
After  ||| S:48862 E:48868 ||| IN
centrifugation  ||| S:48868 E:48883 ||| NN
at  ||| S:48883 E:48896 ||| IN
15,800  ||| S:48896 E:48903 ||| CD
×  ||| S:48903 E:48916 ||| CD
g  ||| S:48916 E:48918 ||| NN
for  ||| S:48918 E:48922 ||| IN
5  ||| S:48922 E:48924 ||| CD
min ||| S:48924 E:48927 ||| NN
,  ||| S:48927 E:48929 ||| ,
the  ||| S:48929 E:48933 ||| DT
supernatant  ||| S:48933 E:48945 ||| NN
was  ||| S:48945 E:48959 ||| VBD
concentrated  ||| S:48959 E:48972 ||| VBN
under  ||| S:48972 E:48978 ||| IN
nitrogen  ||| S:48978 E:48987 ||| NN
and  ||| S:48987 E:48991 ||| CC
spotted  ||| S:48991 E:48999 ||| VBD
on  ||| S:48999 E:49002 ||| IN
a  ||| S:49002 E:49004 ||| DT
10  ||| S:49004 E:49007 ||| CD
×  ||| S:49007 E:49009 ||| CD
10  ||| S:49009 E:49012 ||| CD
cm  ||| S:49012 E:49025 ||| FW
Silica  ||| S:49025 E:49032 ||| FW
gel  ||| S:49032 E:49036 ||| FW
thin  ||| S:49036 E:49041 ||| FW
layer  ||| S:49041 E:49047 ||| FW
glass  ||| S:49047 E:49053 ||| FW
plate  ||| S:49053 E:49059 ||| FW
( ||| S:49059 E:49060 ||| -LRB-
LHP-K ||| S:49060 E:49065 ||| NNP
,  ||| S:49065 E:49067 ||| ,
Whatman ||| S:49067 E:49074 ||| NNP
) ||| S:49074 E:49075 ||| -RRB-
.  ||| S:49075 E:49087 ||| .
Phospholipids  ||| S:49087 E:49101 ||| NNP
were  ||| S:49101 E:49106 ||| VBD
separated  ||| S:49106 E:49116 ||| VBN
by  ||| S:49116 E:49119 ||| IN
chromatography  ||| S:49119 E:49134 ||| NN
in  ||| S:49134 E:49147 ||| IN
100 ||| S:49147 E:49150 ||| CD
: ||| S:49150 E:49151 ||| :
75 ||| S:49151 E:49153 ||| CD
: ||| S:49153 E:49154 ||| :
7 ||| S:49154 E:49155 ||| CD
: ||| S:49155 E:49156 ||| :
4  ||| S:49156 E:49158 ||| CD
of  ||| S:49158 E:49161 ||| IN
chloroform ||| S:49161 E:49171 ||| NNS
: ||| S:49171 E:49172 ||| :
methanol ||| S:49172 E:49180 ||| NN
: ||| S:49180 E:49181 ||| :
acetic  ||| S:49181 E:49188 ||| JJ
acid ||| S:49188 E:49192 ||| NN
: ||| S:49192 E:49193 ||| :
water ||| S:49193 E:49198 ||| NN
.  ||| S:49198 E:49210 ||| .
Plates  ||| S:49210 E:49217 ||| NNP
were  ||| S:49217 E:49222 ||| VBD
stained  ||| S:49222 E:49230 ||| VBN
with  ||| S:49230 E:49235 ||| IN
40 ||| S:49235 E:49237 ||| CD
%  ||| S:49237 E:49239 ||| NN
sulfuric  ||| S:49239 E:49248 ||| NN
acid  ||| S:49248 E:49253 ||| NN
in  ||| S:49253 E:49256 ||| IN
water ||| S:49256 E:49261 ||| NN
.  ||| S:49261 E:49273 ||| .
L-α-phosphatidylethanolamine ||| S:49273 E:49301 ||| NNP
,  ||| S:49301 E:49303 ||| ,
L-α-phosphatidylcholine ||| S:49303 E:49326 ||| NNP
,  ||| S:49326 E:49338 ||| ,
L-α-phosphatidyl-L-serine ||| S:49338 E:49363 ||| NNP
,  ||| S:49363 E:49365 ||| ,
L-α-phosphatidylinositol ||| S:49365 E:49389 ||| NNP
,  ||| S:49389 E:49401 ||| ,
L-α-phosphatidylinositol  ||| S:49401 E:49426 ||| NNP
4,5-biphosphate ||| S:49426 E:49441 ||| NNP
,  ||| S:49441 E:49443 ||| ,
sphingomyelin  ||| S:49443 E:49467 ||| NN
were  ||| S:49467 E:49472 ||| VBD
identified  ||| S:49472 E:49483 ||| VBN
by  ||| S:49483 E:49486 ||| IN
using  ||| S:49486 E:49492 ||| VBG
a  ||| S:49492 E:49494 ||| DT
standard  ||| S:49494 E:49503 ||| JJ
solution ||| S:49503 E:49511 ||| NN
.  ||| S:49511 E:49523 ||| .
When  ||| S:49523 E:49528 ||| WRB
the  ||| S:49528 E:49532 ||| DT
cells  ||| S:49532 E:49538 ||| NNS
were  ||| S:49538 E:49543 ||| VBD
treated  ||| S:49543 E:49551 ||| VBN
with  ||| S:49551 E:49556 ||| IN
DOTMAC  ||| S:49556 E:49563 ||| NNP
lysis  ||| S:49563 E:49569 ||| JJ
buffer ||| S:49569 E:49575 ||| NN
,  ||| S:49575 E:49587 ||| ,
they  ||| S:49587 E:49592 ||| PRP
did  ||| S:49592 E:49596 ||| VBD
not  ||| S:49596 E:49600 ||| RB
detach  ||| S:49600 E:49607 ||| JJ
and ||| S:49607 E:49610 ||| CC
,  ||| S:49610 E:49612 ||| ,
therefore ||| S:49612 E:49621 ||| RB
,  ||| S:49621 E:49623 ||| ,
lipids  ||| S:49623 E:49630 ||| NNS
could  ||| S:49630 E:49636 ||| MD
be  ||| S:49636 E:49649 ||| VB
extracted  ||| S:49649 E:49659 ||| VBN
directly  ||| S:49659 E:49668 ||| RB
from  ||| S:49668 E:49673 ||| IN
the  ||| S:49673 E:49677 ||| DT
cells  ||| S:49677 E:49683 ||| NNS
on  ||| S:49683 E:49686 ||| IN
glass  ||| S:49686 E:49692 ||| NN
culture  ||| S:49692 E:49700 ||| NN
dishes  ||| S:49700 E:49717 ||| NNS
with  ||| S:49717 E:49722 ||| IN
1  ||| S:49722 E:49724 ||| CD
ml  ||| S:49724 E:49727 ||| NN
of  ||| S:49727 E:49730 ||| IN
chloroform ||| S:49730 E:49740 ||| FW
/ ||| S:49740 E:49741 ||| FW
methanol  ||| S:49741 E:49750 ||| FW
( ||| S:49750 E:49751 ||| -LRB-
2 ||| S:49751 E:49752 ||| LS
: ||| S:49752 E:49753 ||| :
1 ||| S:49753 E:49754 ||| CD
,  ||| S:49754 E:49756 ||| ,
v ||| S:49756 E:49757 ||| FW
/ ||| S:49757 E:49758 ||| FW
v ||| S:49758 E:49759 ||| FW
)  ||| S:49759 E:49761 ||| -RRB-
after  ||| S:49761 E:49777 ||| IN
treatment  ||| S:49777 E:49787 ||| NN
with  ||| S:49787 E:49792 ||| IN
the  ||| S:49792 E:49796 ||| DT
detergent  ||| S:49796 E:49806 ||| NN
extraction  ||| S:49806 E:49817 ||| NN
buffer ||| S:49817 E:49823 ||| NN
.  ||| S:49823 E:49825 ||| .
The  ||| S:49825 E:49839 ||| DT
solvents  ||| S:49839 E:49848 ||| NNS
and  ||| S:49848 E:49852 ||| CC
residues  ||| S:49852 E:49861 ||| NNS
were  ||| S:49861 E:49866 ||| VBD
collected  ||| S:49866 E:49876 ||| VBN
in  ||| S:49876 E:49879 ||| IN
a  ||| S:49879 E:49881 ||| DT
tube  ||| S:49881 E:49886 ||| NN
and  ||| S:49886 E:49900 ||| CC
sonicated  ||| S:49900 E:49910 ||| NN
in  ||| S:49910 E:49913 ||| IN
an  ||| S:49913 E:49916 ||| DT
ultrasonic  ||| S:49916 E:49927 ||| JJ
bath  ||| S:49927 E:49932 ||| NN
as  ||| S:49932 E:49935 ||| IN
described  ||| S:49935 E:49945 ||| VBN
above ||| S:49945 E:49950 ||| IN
.  ||| S:49950 E:49952 ||| .
After  ||| S:49952 E:49968 ||| IN
centrifugation  ||| S:49968 E:49983 ||| NN
at  ||| S:49983 E:49986 ||| IN
15,800  ||| S:49986 E:49993 ||| CD
×  ||| S:49993 E:50006 ||| CD
g  ||| S:50006 E:50008 ||| NN
for  ||| S:50008 E:50012 ||| IN
5  ||| S:50012 E:50014 ||| CD
min ||| S:50014 E:50017 ||| NN
,  ||| S:50017 E:50019 ||| ,
lipids  ||| S:50019 E:50026 ||| NN
were  ||| S:50026 E:50031 ||| VBD
analysed  ||| S:50031 E:50050 ||| VBN
from  ||| S:50050 E:50055 ||| IN
the  ||| S:50055 E:50059 ||| DT
supernatant  ||| S:50059 E:50071 ||| NN
as  ||| S:50071 E:50074 ||| IN
described  ||| S:50074 E:50084 ||| VBN
above ||| S:50084 E:50089 ||| IN
.  ||| S:50089 E:50119 ||| .
Transmission  ||| S:50119 E:50132 ||| NNP
electron  ||| S:50132 E:50141 ||| VBZ
microscopy  ||| S:50141 E:50162 ||| VBG
The  ||| S:50162 E:50166 ||| DT
phalloidin-stabilized  ||| S:50166 E:50188 ||| JJ
α-actin  ||| S:50188 E:50196 ||| JJ
filaments  ||| S:50196 E:50206 ||| NNS
( ||| S:50206 E:50207 ||| -LRB-
1  ||| S:50207 E:50209 ||| CD
μM ||| S:50209 E:50211 ||| NN
)  ||| S:50211 E:50223 ||| -RRB-
were  ||| S:50223 E:50228 ||| VBD
incubated  ||| S:50228 E:50238 ||| VBN
in  ||| S:50238 E:50241 ||| IN
buffer  ||| S:50241 E:50248 ||| JJ
F  ||| S:50248 E:50250 ||| NN
( ||| S:50250 E:50251 ||| -LRB-
5  ||| S:50251 E:50253 ||| CD
mM  ||| S:50253 E:50256 ||| JJ
Tris-HCl ||| S:50256 E:50264 ||| NN
,  ||| S:50264 E:50266 ||| ,
pH  ||| S:50266 E:50269 ||| JJ
7.5 ||| S:50269 E:50272 ||| CD
,  ||| S:50272 E:50274 ||| ,
0.5  ||| S:50274 E:50278 ||| CD
mM  ||| S:50278 E:50291 ||| JJ
Na  ||| S:50291 E:50305 ||| NNP
2  ||| S:50305 E:50307 ||| CD
ATP ||| S:50307 E:50310 ||| NNP
,  ||| S:50310 E:50312 ||| ,
2  ||| S:50312 E:50314 ||| CD
mM  ||| S:50314 E:50317 ||| JJ
MgCl  ||| S:50317 E:50333 ||| JJ
2  ||| S:50333 E:50335 ||| CD
,  ||| S:50335 E:50337 ||| ,
140  ||| S:50337 E:50341 ||| CD
mM  ||| S:50341 E:50344 ||| JJ
NaCl ||| S:50344 E:50348 ||| NN
,  ||| S:50348 E:50350 ||| ,
0.2  ||| S:50350 E:50354 ||| CD
mM  ||| S:50354 E:50357 ||| JJ
DTT ||| S:50357 E:50360 ||| NNP
,  ||| S:50360 E:50362 ||| ,
0.2  ||| S:50362 E:50366 ||| CD
mM  ||| S:50366 E:50379 ||| JJ
CaCl  ||| S:50379 E:50395 ||| JJ
2  ||| S:50395 E:50397 ||| CD
,  ||| S:50397 E:50399 ||| ,
0.005 ||| S:50399 E:50404 ||| CD
%  ||| S:50404 E:50406 ||| NN
sodium  ||| S:50406 E:50413 ||| NN
azide ||| S:50413 E:50418 ||| NN
)  ||| S:50418 E:50420 ||| -RRB-
with  ||| S:50420 E:50425 ||| IN
or  ||| S:50425 E:50438 ||| CC
without  ||| S:50438 E:50446 ||| IN
0.1  ||| S:50446 E:50450 ||| CD
%  ||| S:50450 E:50452 ||| NN
DOTMAC  ||| S:50452 E:50459 ||| NN
for  ||| S:50459 E:50463 ||| IN
10  ||| S:50463 E:50466 ||| CD
min  ||| S:50466 E:50470 ||| NN
at  ||| S:50470 E:50473 ||| IN
25°C ||| S:50473 E:50477 ||| CD
.  ||| S:50477 E:50479 ||| .
The  ||| S:50479 E:50493 ||| DT
taxol-stabilized  ||| S:50493 E:50510 ||| JJ
β-tubulin  ||| S:50510 E:50520 ||| NN
( ||| S:50520 E:50521 ||| -LRB-
1  ||| S:50521 E:50523 ||| CD
μM ||| S:50523 E:50525 ||| NN
)  ||| S:50525 E:50527 ||| -RRB-
was  ||| S:50527 E:50531 ||| VBD
also  ||| S:50531 E:50536 ||| RB
incubated  ||| S:50536 E:50546 ||| VBN
in  ||| S:50546 E:50559 ||| IN
PEM  ||| S:50559 E:50563 ||| NNP
buffer  ||| S:50563 E:50570 ||| NN
( ||| S:50570 E:50571 ||| -LRB-
100  ||| S:50571 E:50575 ||| CD
mM  ||| S:50575 E:50578 ||| JJ
PIPES ||| S:50578 E:50583 ||| NNP
,  ||| S:50583 E:50585 ||| ,
5  ||| S:50585 E:50587 ||| CD
mM  ||| S:50587 E:50590 ||| JJ
EGTA ||| S:50590 E:50594 ||| NNP
,  ||| S:50594 E:50596 ||| ,
2  ||| S:50596 E:50598 ||| CD
mM  ||| S:50598 E:50601 ||| JJ
MgCl  ||| S:50601 E:50617 ||| JJ
2  ||| S:50617 E:50619 ||| CD
,  ||| S:50619 E:50621 ||| ,
pH6.8 ||| S:50621 E:50626 ||| CD
)  ||| S:50626 E:50628 ||| -RRB-
containing  ||| S:50628 E:50639 ||| VBG
1  ||| S:50639 E:50641 ||| CD
mM  ||| S:50641 E:50644 ||| JJ
GTP  ||| S:50644 E:50648 ||| NN
with  ||| S:50648 E:50653 ||| IN
or  ||| S:50653 E:50666 ||| CC
without  ||| S:50666 E:50674 ||| IN
0.1  ||| S:50674 E:50678 ||| CD
%  ||| S:50678 E:50680 ||| NN
DOTMAC  ||| S:50680 E:50687 ||| NN
for  ||| S:50687 E:50691 ||| IN
10  ||| S:50691 E:50694 ||| CD
min  ||| S:50694 E:50698 ||| NN
at  ||| S:50698 E:50701 ||| IN
25°C.  ||| S:50701 E:50707 ||| CD
10  ||| S:50707 E:50710 ||| CD
μl  ||| S:50710 E:50713 ||| NN
of  ||| S:50713 E:50716 ||| IN
samples  ||| S:50716 E:50734 ||| NNS
were  ||| S:50734 E:50739 ||| VBD
adsorbed  ||| S:50739 E:50748 ||| VBN
for  ||| S:50748 E:50752 ||| IN
60  ||| S:50752 E:50755 ||| CD
s  ||| S:50755 E:50757 ||| NN
to  ||| S:50757 E:50760 ||| TO
carbon-coated  ||| S:50760 E:50774 ||| JJ
400  ||| S:50774 E:50778 ||| CD
mesh ||| S:50778 E:50782 ||| CD
/ ||| S:50782 E:50783 ||| CD
inch  ||| S:50783 E:50798 ||| NN
copper  ||| S:50798 E:50805 ||| NN
grids  ||| S:50805 E:50811 ||| NNS
that  ||| S:50811 E:50816 ||| WDT
were  ||| S:50816 E:50821 ||| VBD
rendered  ||| S:50821 E:50830 ||| VBN
hydrophilic  ||| S:50830 E:50842 ||| VBN
by  ||| S:50842 E:50845 ||| IN
glow  ||| S:50845 E:50860 ||| JJ
discharge  ||| S:50860 E:50870 ||| NN
for  ||| S:50870 E:50874 ||| IN
15  ||| S:50874 E:50877 ||| CD
s  ||| S:50877 E:50879 ||| NN
in  ||| S:50879 E:50882 ||| IN
air  ||| S:50882 E:50886 ||| NN
at  ||| S:50886 E:50889 ||| IN
low  ||| S:50889 E:50893 ||| JJ
pressure ||| S:50893 E:50901 ||| NN
.  ||| S:50901 E:50903 ||| .
The  ||| S:50903 E:50907 ||| DT
grids  ||| S:50907 E:50913 ||| NN
were  ||| S:50913 E:50928 ||| VBD
washed  ||| S:50928 E:50935 ||| VBN
with  ||| S:50935 E:50940 ||| IN
100  ||| S:50940 E:50944 ||| CD
mM  ||| S:50944 E:50947 ||| JJ
KCl  ||| S:50947 E:50951 ||| JJ
and  ||| S:50951 E:50955 ||| CC
stained  ||| S:50955 E:50963 ||| NN
for  ||| S:50963 E:50967 ||| IN
60  ||| S:50967 E:50970 ||| CD
s  ||| S:50970 E:50972 ||| NN
on  ||| S:50972 E:50975 ||| IN
six  ||| S:50975 E:50979 ||| CD
drops  ||| S:50979 E:50995 ||| NNS
of  ||| S:50995 E:50998 ||| IN
1 ||| S:50998 E:50999 ||| CD
%  ||| S:50999 E:51001 ||| NN
uranyl  ||| S:51001 E:51008 ||| NN
acetate ||| S:51008 E:51015 ||| NN
.  ||| S:51015 E:51017 ||| .
Microscopy  ||| S:51017 E:51028 ||| NNP
was  ||| S:51028 E:51032 ||| VBD
performed  ||| S:51032 E:51042 ||| VBN
on  ||| S:51042 E:51045 ||| IN
a  ||| S:51045 E:51057 ||| DT
HITACHI  ||| S:51057 E:51065 ||| NNP
H-8100  ||| S:51065 E:51072 ||| NNP
electron  ||| S:51072 E:51081 ||| JJ
microscope  ||| S:51081 E:51092 ||| NN
at  ||| S:51092 E:51095 ||| IN
an  ||| S:51095 E:51098 ||| DT
accelerating  ||| S:51098 E:51121 ||| JJ
voltage  ||| S:51121 E:51129 ||| NN
of  ||| S:51129 E:51132 ||| IN
100  ||| S:51132 E:51136 ||| CD
kV ||| S:51136 E:51138 ||| NN
.  ||| S:51138 E:51171 ||| .
List  ||| S:51171 E:51176 ||| NN
of  ||| S:51176 E:51179 ||| IN
abbreviations  ||| S:51179 E:51201 ||| CD
1PIPs ||| S:51201 E:51206 ||| CD
,  ||| S:51206 E:51208 ||| ,
polyphosphoinositides ||| S:51208 E:51229 ||| NNS
;  ||| S:51229 E:51231 ||| :
DOTMAC ||| S:51231 E:51237 ||| NNP
,  ||| S:51237 E:51247 ||| ,
dodecyltrimethylammonium  ||| S:51247 E:51272 ||| JJ
chloride ||| S:51272 E:51280 ||| NN
;  ||| S:51280 E:51282 ||| :
FA ||| S:51282 E:51284 ||| NNP
,  ||| S:51284 E:51286 ||| ,
formaldehyde ||| S:51286 E:51298 ||| NN
;  ||| S:51298 E:51300 ||| :
PFA ||| S:51300 E:51303 ||| NNP
,  ||| S:51303 E:51313 ||| ,
paraformaldehyde ||| S:51313 E:51329 ||| NNS
;  ||| S:51329 E:51331 ||| :
SEM ||| S:51331 E:51334 ||| NNP
,  ||| S:51334 E:51336 ||| ,
scanning  ||| S:51336 E:51345 ||| VBG
EM ||| S:51345 E:51347 ||| NNP
;  ||| S:51347 E:51349 ||| :
TEM ||| S:51349 E:51352 ||| NNP
,  ||| S:51352 E:51354 ||| ,
transmission  ||| S:51354 E:51367 ||| VBG
EM ||| S:51367 E:51369 ||| NNP
.  ||| S:51369 E:51379 ||| .
Other  ||| S:51379 E:51385 ||| JJ
abbreviations  ||| S:51385 E:51399 ||| NNS
are  ||| S:51399 E:51403 ||| VBP
indicated  ||| S:51403 E:51413 ||| VBN
in  ||| S:51413 E:51416 ||| IN
Table  ||| S:51416 E:51422 ||| NNP
1 ||| S:51422 E:51423 ||| CD
.  ||| S:51423 E:51440 ||| .
